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Abstract
This thesis presents an investigation into the development of enzyme catalysis of 
cycloaddition reactions.
Tyrosyl-tRNA synthetase was initially investigated as a catalyst for the 
cycloaddition between azides and alkynes and nitrile oxides and alkenes. From 
modeling studies, substrates were proposed based on the natural substrates of tyrosyl- 
tRNA synthetase. Each substrate was appended with either an azide, alkene, alkyne or 
nitrile oxide moiety. Tyrosyl-tRNA synthetase was expressed in E. coli and purified by 
FPLC. A variety of commercial and literature based assays were attempted to determine 
the activity of tyrosyl-tRNA synthetase but each assay failed to give a satisfactory 
result. An HPLC based assay was developed that could determine the amount of AMP 
produced by tyrosyl-tRNA synthetase and therefore the activity of the enzyme. The 
assay was found to be broadly applicable with the activities of pyruvate kinase and 
potato apyrase also being determined. The binding affinities of the azide and alkyne 
substrates and their corresponding cycloadducts were determined using the HPLC assay 
and these data were used to plan experiments to investigate catalysis of the cycloaddtion 
between the azide and alkyne. Under the experimental conditions, it was found that the 
rate of non-enzyme catalysed cycloaddition between the azide and alkyne was too slow 
to be measured. The rate of reaction in the presence of tyrosyl-tRNA synthetase was 
also too slow to be measured, therefore, it could not be determined if catalysis was 
occurring in this system. Copper catalysis of the cycloaddtion reaction was attempted to 
increase the non-enzyme catalysed rate, however, in the presence of the enzyme the
reaction was found to be inhibited. Due to the instability of the nitrile oxide and the 
alkene, catalysis was not investigated in this system. Also, as tyrosyl-tRNA synthetase 
was only accessible in small quantities, it was decided to continue investigating 
catalysis of cycloaddition reactions with Chymotrypsin as this enzyme could be bought 
in bulk and this meant the concentration of the enzyme could be increased and would 
allow a greater proportion of the substrates to be enzyme bound.
Chymotrypsin was investigated as a catalyst for the cycloaddition between 
benzonitrile oxide and alkenes. Initial modeling studies provided aliphatic alkenes as the 
complementary substrates to benzonitrile oxide. The binding affinities of the alkenes 
and the benzonitrile oxide precursor benzaldoxime as well as the corresponding 
cycloadducts were directly measured using isothermal titration calorimetry. The binding 
data were used to plan the experiments to investigate catalysis of the cycloaddition 
between the aliphatic alkene and benzonitrile oxide by Chymotrypsin. The results 
showed that the reaction between the alkene and benzonitrile oxide was too slow. 
Although the formation of the cycloadduct was detectable, impurities present in the 
mixture containing Chymotrypsin made it difficult to isolate the product by HPLC. The 
amount of cycloadduct produced in the presence of Chymotrypsin could not be 
accurately determined but at most was similar to that produced in the non-enzyme 
catalysed reaction. The alkene substrate was then redesigned to be more reactive 
towards cycloaddition with benzonitrile oxide to increase the rate of reaction. The 
reaction rate was found to be greater than that of the previous system by a factor of 
approximately 105. The reaction between the activated alkene and
benzonitrile oxide produced a mixture of regioisomers with the 5-substituted 
regioisomer being the major product. Under the chosen reaction conditions, the reaction
between the alkene and benzonitrile oxide was found to be too fast with the reaction 
being complete after an hour. On lowering the concentrations of both reactants it was 
found that the reaction still did not proceed beyond half an hour and also that the yields 
of the cycloadducts were lower. It was determined from these results that the 
benzonitrile oxide was taking part in a competing reaction which was likely to be first 
order rather than the second order dimerisation. As the benzonitrile oxide was reacting 
too quickly, the reaction rate between the alkene and benzonitrile oxide could not be 
determined. However, an increase in the ratio of the 5- to 4-substituted cycloadducts in 
the presence of Chymotrypsin indicated that approximately 10% of the reaction may be 
occurring on the enzyme if the reaction on the enzyme is completely regioselective.
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Chapter One
Introduction
1.1 Enzyme catalysis
Enzymes are biological catalysts that enhance the rates of specific reactions by many 
orders of magnitude.1 Many biological reactions occur very slowly in the absence of 
enzymes, for example, the decarboxylation of orotic acid has a half-life of 78 million 
years.2 This reaction is accelerated by a factor 1017 by the enzyme orotidine 5’- 
phosphate decarboxylase. Enzymes have evolved to efficiently catalyse reactions such 
as this under mild, physiological conditions, with rate enhancements of up to 10|l> being 
reported.3 Without enzymes, many, if not all, of the physiological process required to 
sustain life would not occur.
The catalytic power of enzymes is attributed to their ability to lower reaction 
activation energies. ’ ’ This is achieved, in part, by the interactions between the 
substrate and catalytic groups found at the enzyme active site. Enzymes are capable of 
various types of catalysis, for example, Chymotrypsin utilises nucleophilic catalysis and 
general acid-base catalysis to catalyse the hydrolysis of peptide bonds. The first steps in 
the hydrolysis mechanism of Chymotrypsin are displayed in Scheme 1.
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Scheme 1
The lydroxyl group of the Ser-195 residue would normally be uncharged at 
physioogical pH, however, in the enzyme it is hydrogen bonded through a catalytic 
triad t> the His-57 residue which is also hydrogen bonded to the Asp-102 residue. As 
the hylroxyl group attacks the carbonyl of the peptide substrate it is deprotonated by the 
His-5'/residue which acts as a general base and the positive charge that forms on His-57 
is stablised by the Asp-102 residue. These interactions prevent an unstable positive 
charge forming on the hydroxyl group and increase its nucleophilicity. As the transition 
state i: reached, a negative charge forms on the carbonyl oxygen which is stabilised by 
hydrojen bonds to the backbone NH groups of the Gly-195 and Ser-193 residues. This 
lowers the energy required to reach the transition state. The amino group is then 
activaed as a leaving group by general-acid catalysis by His-57 which provides a 
protonto convert it to the free amine and cleaves the peptide.
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Another important aspect of enzyme catalysis is the effective concentration of the 
reacting species 6 By removing the substrates from solution and binding them in the 
active site, their effective concentration is greatly increased to a level that is not 
achieveable in solution. The substrate and reacting groups effectively become parts of 
the same complex and react in a similar fashion to that of an intramolecular reaction. 
While other factors also contribute to enzyme catalysis, it is this particular feature of 
enzymes increasing the effective concentration of reacting substrates that formed the 
basis of the work in this thesis.
The simplest model to describe an enzyme catalysed reaction is depicted in 
Scheme 2.1
E + S ■ - ES ■■ EP -------- E + P
Scheme 2
Firstly, the substrate S binds to the enzyme E to form an enzyme-substrate complex ES. 
The enzyme-substrate complex ES is held together by numerous non-covalent 
interactions and its formation is assumed to be reversible. The dissociation constant of 
the enzyme-substrate complex ES is known as the Michaelis constant KM and defines 
the concentration of substrate where the rate of reaction is half its maximum rate 
(Vmax/2). Next, the chemical reaction takes place that transforms the substrate S to the 
enzyme product complex EP which dissociates to give the free enzyme E and product 
P. The first order rate constant A:cat, which is also known as the turnover number, 
describes the limiting rate of the enzyme catalysed reaction.4
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The initial reaction velocity v  of the enzyme catalysed reaction can be expressed 
by Equation 1 which is known as the Michaelis-Menten equation.
[E]0[S]A:cat
Km +  [S]
Equation l
In general, v  increases proportionally with increasing total enzyme concentration [E]0. 
however, v  follows saturation kinetics with respect to increasing substrate concentration 
[S] as shown in Figure 1.
Figure 1. Initial reaction velocity v  plotted against increasing substrate concentration [S] for 
an enzyme catalysed reaction obeying Michaelis-Menten kinetics.
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At sufficiently low values of [S], the initial reaction velocity v  varies linearly, however, 
as the concentration is increased further, the increases in v  are proportionally less and 
tend to the limit termed Vmax as the enzyme becomes saturated with substrate.4
1.2 Enzyme inhibition
As well as binding substrates, enzymes will also bind other molecules. These molecules 
may act as allosteric activators or inhibitors by binding at a site some distance from the 
enzyme active site. Other molecules may interact with the active site and inhibit the 
enzyme, either by a suicide mechanism, where the molecules covalently modify the 
active site, or by binding in the same position as the substrates blocking their entry. 
These inhibitors can be classed as competitive, non-competitive or mixed inhibitors. 
Throughout the Results and Discussion sections of this thesis it is assumed that the 
compounds discussed bind competitively at the active site. These compounds were 
designed to be novel substrates. Such compounds, which are analogous to competitive 
inhibitors I, bind reversibly to the active site of the enzyme E, according to Scheme 3.
E + I -  El
Scheme 3
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Thus the dissociation constant Kj for an inhibitor I, in the absence of turnover, can be 
written as shown by Equation 2 .7
K,
JEHU
[El]
Equation 2
The development of enzyme inhibitors receives particularly high attention as many 
enzymes are implicated with various diseases. Recently, the drug Isentress was 
approved as a treatment for HIV infection.' Isentress works by selectively inhibiting 
HIV-1 integrase, one of three enzymes required for HIV replication, making it a potent 
antiviral drug. Zyflo is a treatment for asthma that inhibits 5-lipoxygenase, preventing 
the synthesis of leukotrienes which are implicated in the pathophysiology of the 
disease.9 Glivec® is a drug used for the treatment of cancers, such as chronic 
myelogenous leukemia and inhibits a mutant tyrosine kinase.1
The development of new drugs often focusses on the design of an inhibitor of a 
particular enzyme. This may be through rational design of a ligand that resembles the 
natural substrates or cofactors of the enzyme, or mimics the transition state of the 
reaction. When these approaches are not fruitful, libraries containing thousands of 
compounds are often screened for activity, however, this approach has not been as 
successful as initially expected. ’ Over the past decade or so, attention has focussed 
on smaller libraries of less complex molecules which are targetted to a specific enzyme. 
By this method, known as the fragment-based approach to drug design, low molecular
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weight ligands, called fragments, that bind weakly with K) values typically in excess of 
100 pM are found then elaborated to produce potent inhibitors.13, 14 Libraries of the 
fragments, which are usually of low complexity and without reactive groups, are 
screened against a target enzyme. Once a ‘hit’ is discovered its structural analogues are 
investigated in order to determine if the binding efficiency can be improved. To develop 
potent inhibitors the fragments are then linked to fragments that bind to adjacent sites or 
are grown in a direction where it is believed additional binding interactions can be 
formed. Linking two or more fragments is already known to increase the binding 
affinity of the product which may be orders of magnitude greater than those of the 
original fragments. This concept was first pointed out by Page and Jencks,6 and later 
investigated by Murray and Verdonk,1^ and is attributed to the energy barriers that the 
fragments must overcome during binding. The barrier arises from the loss in rotational 
and translation entropy of the fragments upon binding, however, since the product 
possesses only one set of rotational and translational entropies, as opposed to two sets 
for the fragments, it should bind more tightly.
An example of a fragment linking approach to produce a novel inhibitor of the 
enzyme thrombin has been recently published.16 Thrombin catalyses the conversion of 
fibrinogen to fibrin in a cascade of reactions that take place during blood coagulation, 
therefore, inhibitors of this enzyme are used to treat conditions such as deep vein 
thrombosis and stroke. The initial design of the library was carried out by a virtual 
screening process which targeted the thrombin SI binding site and from this 80 
compounds were selected. These compounds could be categorised as neutral SI binders, 
charged SI binders, neutral SI binders with solubilising groups or larger binders with 
the aim of simultaneously binding in the SI and S2 binding sites. The fragments were
7
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then soaked into crystals of thrombin which were then analysed by X-ray 
crystallography to determine the binding interactions. Of the fragments, two were 
chosen that bound to the SI site of thrombin, and the strongest binder, fragment 1 , was 
found to have an IC50 value of 300 pM.
MeO
1 IC50 = 300 pM 2 IC50 = 12 pM
Fragment 2 was found to bind unexpectedly to the S2-S4 site whilst leaving the adjacent 
SI site vacant. This presented the opportunity to link the fragments which bind to the 
adjacent sites. The fragments were linked via an aminomethyl linker from the amino 
group of fragment 2 to the 3-position of the phenyl ring of fragment 1 to give the hybrid 
3 .
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MeO
1.4 nM
The hybrid 3 was found to have an IC50 value of 1.4 nM, demonstrating that linking the 
fragments 1 and 2 produced a potent inhibitor of thrombin.
An improved method to produce potent enzyme inhibitors was recently 
described by Sharpless et al.,11 known as in situ click chemistry. Similar to the fragment 
based approach to inhibitor design, ligands that bind to different pockets in the enzyme 
active site are linked together to give potent inhibitors, however, by this method the 
enzyme assembles its own inhibitor via a 1,3-dipolar cycloaddition reaction between 
azides and alkynes from a selection of fragments.
Azides and monosubstituted alkynes react to give 1,2,3-triazoles as a mixture of 
the 1,4- and 1,5-disubstituted regioisomers as depicted in Scheme 4.ls
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1,4-regioisomer 1,5-regioisomer
Scheme 4
The rates of reactions between azides and alkynes are slow at room temperature; 
however, they have been shown to be accelerated by up to 5 orders of magnitude 
through the binding of these groups in close proximity.19 By the same principle, 
acetyl:holinesterase was found to catalyse the formation of its own inhibitors. 
Acetycholinesterase normally catalyses the hydrolysis of acetylcholine and its active 
site is found at the bottom of a deep and narrow gorge. Fragments were designed based 
on the active site inhibitor tacrine and phenanthridium which binds at a peripheral site at 
the toa of the gorge. The tacrine based fragments 4-11 and phenanthridium fragments 
12-19 were each appended with an azide or alkyne attached by varying lengths of alkyl 
chain.
10
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12-16 17-19
Acetylcholinesterase was found to catalyse the formation of the triazole 20 from 
the azide 8 and the alkyne 16 when mixed with binary mixtures of each combination of 
the tacrine based fragments 4-11 and the phenanthridium fragments 12- 19.
---- N ©
1 1
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The triazole 20 was found to have a dissociation constant of 99 fM, a much 
stronger affinity for the enzyme than tacrine and phenanthridium, which are reported to 
have dissociation constants of approximately 10-100 nM and 10-100 pM, respectively. 
In a later study,20 three additional inhibitors were found to be assembled by the enzyme. 
In each case, the cycloaddition reaction catalysed by acetylcholinesterase was 
regioselective and gave the 1,5-regioisomer.
Through the course of the research presented in this thesis, inhibitors of carbonic
21 77anhydrase II and HIV-1 protease were also developed via in situ click chemistry. ’ 
The acetylenic benzenesulfonamide fragment 21 was derived from known inhibitors of 
carbonic anhydrase II and found to have a dissociation constant of 37 nM.
A variety of azides, including azido acid derivatives, ethyl azide derivatives, a 
piperidine derivative, a bicyclic compound, stilbene derivatives and a phenyl azide were 
designed to complement the alkyne. The azido acid derivatives were included in 
greatest numbers as peptide-based carboxybenzenesulfonamide inhibitors were 
previously reported." Of the twenty four possible combinations of the azides and the 
alkyne 21, twelve products were found to be assembled by the enzyme and with the 
exception of two, these were derived from the azido acids. As with acetylcholinesterase,
12
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the reactions were found to be highly regioselective with only the 1,4-regioisomers 
being assembled by carbonic anhydrase II in contrast to the non-enzyme catalysed 
reactions which the authors report to favour the 1,5-regioisomers. The products formed 
by the enzyme were all tighter binders with values ranging from 0.2 nM to 7.1 nM.
Similarly, an inhibitor of HIV-1 protease has also been developed by this 
method.22 The synthesis of the triazole 24 from the alkyne 22 and the azide 23 is 
presented in Scheme 5.
HIV-1 protease
Scheme 5
In this example, the fragments used had displayed a weak affinity for HIV-l 
protease with the azide 23 exhibiting an IC50 value of 4.2 pM while the alkyne 22 had 
an IC50 value greater than 100 uM. The enzyme templated the reaction to give the 
triazole 24 which was found to have an IC50 value of 6  nM, making it a stronger binder
13
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than ether the alkyne 22 or the azide 23. As in the previous examples, the enzyme was 
found to catalyse formation of the 1,4-regioisomer over the 1,5-regioisomer. The 
background reaction produced a 2:1 mixture of regioisomers, whereas the enzyme 
increased the proportion of the 1,4-regioisomer, with the ratio of 18:1.
1.3 Enzymes in chemical synthesis
Although enzymes are highly specific with regards to the reactions they catalyse, the 
range of the substrates they act on is often quite broad and therefore they have found 
uses in synthetic organic chemistry as well as in industry." ' There are several 
advanages in using enzymes over traditional chemical catalysts, for example, an 
enzyrre catalysed reaction may avoid the use of a toxic chemical catalyst, such as a 
heavy metal, and since enzymes are biodegradeable, they are environmentally friendly. 
Enzynes are active under mild conditions, at temperatures in the range of 20 to 40 °C 
and a pH of around 7, which can help avoid undesirable side reactions. Since most 
enzyrres are active under similar conditions, they can be used to catalyse sequential 
reactions by using a multi-enzyme mixture and linking enzyme catalysed reactions can 
shift an unfavourable equilibrium towards the products. Enzymes are also 
chemoselective, allowing one type of functional group to be acted on whilst leaving 
other sensitive parts of a substrate untouched, avoiding unwanted side reactions which 
might occur under chemical catalysis. The regioselectivity and stereoselectivity of 
enzyrres are also high due to their ability to differentiate between functional groups in
14
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chemically different parts of a substrate and since they are constructed from (S^-amino 
acids, they are chiral catalysts and therefore highly enantioselective.
Lipases, for example, normally hydrolyse and re-esterify triglycerides.“ The 
hydrolysis mechanism for this reaction is similar to the mechanism given for 
Chymotrypsin above with an acyl enzyme intermediate being formed which can be 
attacked either by water or another nucleophile such as alcohol in the transesterification 
process. Industrially, lipases are often used to prepare optically pure amines via kinetic 
resolution.29, 30An example of this is the BASF process which is depicted in Scheme 6.31
Scheme 6
Firstly, the lipase catalysed enantioselective acylation of the amine 25 gives the 
(/?)-amide 28 and the (S')-amine 27 in high enantiomeric excess. The (S')-amine 27 is 
then separated from the (/?)-amide 28 by distillation and further treatment of the amide 
28 under basic conditions releases the corresponding optically pure (/?)-amine. By this 
process, BASF produces in excess of 2500 tonnes of product each year.
15
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A large variety of enzyme catalysed reactions in organic synthesis are known, for 
example the hydrolysis-synthesis of esters,32 amides,31 lactones,33 lactams,34 epoxides,35
' 1 ' j  o o  o n
nitriles; acid anhydrides' and ethers, ' the oxidation-reduction of alcohols; 
alkenes,40 aldehydes and ketones,41,42 and the addition-elimination of water,43 hydrogen 
cyanide44 and ammonia45 to name a few.
In cases where a reaction is not catalysed by a known enzyme, screening can be 
performed to identify an enzyme or microbe that will catalyse the reaction 46 The 
deprotection of p-nitrobenzyl esters, for example, is normally carried out using a zinc 
catalyst; however, when this process is performed on an industrial scale in the 
preparation of cephalosporin antibiotics, large amounts of waste solvent contaminated 
with zinc are produced. An enzyme was sought to deprotect the p-nitrobenzyl ester of 
the cephalosporin antibiotic cephalexin 29 in order to avoid this waste. Several bacterial 
strains were screened and of these B. subtilis was found to most effectively catalyse the 
deprotection of 29 to cephalexin 30 as depicted in Scheme 7.
Bacillus subtilis
Scheme 7
Although the deprotection was efficient, it was not as efficient as the zinc 
catalysed reaction. Furthermore, the poor solubility of the /?-nitrobenzyl ester 29 in 
aqueous solution and the enzyme’s inactivity in aqueous organic solutions meant that
16
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the reaction continued to be carried out using zinc. In recent years, however, with 
growing attention on the environment the use of an enzyme to deprotect p-nitrobenzyl 
groups was again investigated.48 The gene responsible for expressing the p-nitrobenzyl 
esterase was isolated44 and overexpressed to provide large amounts of the enzyme to 
increase the efficiency of the deprotection, however, the p-nitrobenzyl ester 31 of the 
latest generation of antibiotic, Locarabef '0, was virtually insoluble in water.
31
Using directed evolution,5053 the gene was subjected to multiple rounds of 
random mutagenesis and screening to produce mutant enzymes that showed greater 
activity towards the protected Locarabef 31 and activity in aqueous DMF solution. 
This allowed the catalytic deprotection to be carried out in a solvent mixture in which 
the substrate is soluble and the enzyme is active. One mutant was found to have the 
same activity in a 30% solution of water in DMF as the wild type enzyme had in 100% 
water.
There are many other examples where directed evolution has been used to 
develop enzymes to be commercially viable which were once ineffective catalysts.54 For 
example, a peroxidase from the ink cap mushroom that can oxidise dyes under mild 
conditions was evolved to withstand an oxidative environment allowing the enzyme to
17
Chapter 1
be used as a detergent additive to prevent dye transfer55 and organophosphate-degrading 
enzymes have been evolved to hydrolyse man-made pesticides and nerve agents.56 57
1.4 Enzyme mimics
An alternative to enzyme catalysis is the use of enzyme mimics.^8' 59 These systems 
emulate enzymes by providing a binding site for the substrate and reactive groups to 
perform the desired reaction. A variety of catalytic systems have been developed using 
various scaffolds such as cavitands 60 cyclodextrins61 and metalloporphyrins.62 The most 
successful catalytic systems are derived from cyclodextrins which are cyclic oligomers 
of a( 1->4)-D-glucopyranose. The exterior of a cyclodextrin is hydrophilic, whereas 
the interior is hydrophobic, giving it the ability to be soluble in water and at the same 
time to bind non-polar substrates within its cavity in a similar manner to how an enzyme 
would bind its substrates. An example of an enzyme mimic derived from a cyclodexrin 
is the metallocyclodextrin 33 developed by Barr et al. (Scheme 8) 63
0 
II
1 OMe 
OMe
35
Scheme 8
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A diamino group attached to the face of the cyclodextrin forms a Cu(II) complex 
capable of hydrolysing phosphotriester bonds. The metallocyclodextrin 33 was found to 
accelerate the hydrolysis of the organophosphate 32 shown in Scheme 8 by a factor of 
31,000 over the background hydrolysis rate. The hydrolysis of the phosphotriester 32 
was attributed to metal-bound hydroxide and the cyclodextrin 33 was found to act as a 
true catalyst by displaying saturation kinetics and multiple turnover of the substrate 32.
One of the aims in developing enzyme mimics is to catalyse reactions of
sschemical processes that do not have numerous obvious biological analogues.' Of these, 
bimolecular reactions are often difficult to achieve since the reactions require the 
simultaneous binding of both substrates in the correct orientation. Sanders et al.,62 have 
reported the catalysis of Diels-Alder reactions between substrates such as 36 and 37 
with cyclic metalloporphyrins.
Binding of the substrates 36 and 37 occurs through coordination of the pyridyl 
nitrogens to the zinc of the porphyrin groups and in doing do increases their effective 
concentration and accelerates the reaction rate. Although catalysis was achieved in this 
system, very little substrate turnover occurred due to product inhibition and to achieve 
appreciable product formation the catalyst was required in a stoichiometric amount.
19
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While successful enzyme mimics have been developed, the rate enhancements 
they achieve are often poorer than those attained by enzymes. They are often hard to 
synthesise and once catalysis has been established it may be difficult to decide on 
changes that could be made to improve the catalyst.64 Using an existing enzyme to 
catalyse a new unnatural reaction may provide an alternative to enzyme mimics. The 
benefit of using an enzyme to catalyse a different class of reaction is that once enzyme 
catalysis is established the enzyme can be mutated to develop a catalyst with improved 
qualities. Thus, the aim of the work presented in this thesis was to develop enzyme 
catalysis of a different class of reaction to that the enzyme would normally catalyse.
1.5 Cycloaddition reactions
Cycloaddition reactions were chosen to investigate novel catalysis by enzymes since 
these pericyclic reactions rely only on the concentrations of the reacting groups and not 
on any catalytic groups to increase the rate of reaction. A cycloaddition reaction can be 
accelerated through the increased proximity of the reacting groups alone. ’ ' The
cycloadditions between azides and alkynes and nitrile oxides and alkenes were chosen 
to be investigated.
Cycloaddition reactions between azides and monosubstituted alkynes form 1,2,3- 
triazoles as shown in Scheme 4. The regioselectivity of these reactions is normally quite 
poor and mixtures of 1,4- and 1,5-disubstituted triazoles form. These observations can 
be explained by FMO theory, for example phenylacetylene has the greatest LUMO 
coefficient on the CH end of the alkyne which interacts with the phenylazide HOMO to
20
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give the 1,4-substituted 1,2,3-triazole. The phenylacetylene also has the highest HOMO 
coefficient at the CH end, so this lines up with phenylazide LUMO on the terminal 
nitrogen to give the 1,5-substituted 1,2,3-triazaole. Both of these reactions take place at 
approximately equal rates which gives the poor regioselectivity, however, by varying 
the substituents attached to the azide and the alkyne the regioselectivity can be affected, 
for example, if an electron withdrawing group is adjacent to the alkyne, the 1,4- 
regioisomer is favoured, whereas an electron withdrawing substituent on the azide 
favours formation of the 1,5-regioisomer. Recently Sharpless et a l reported the 
regioselective synthesis of 1,4-triazoles from azides and terminal alkynes via copper 
catalysis and also the regioselective synthesis of 1,5-triazoles using a ruthenium based 
catalyst.66 Wang et al.?7 also reported a regioselective synthesis of 1,4-triazoles by 
simply heating an aqueous solution of an azide and an alkyne to 120 °C.
Unlike cycloaddition reactions between azides and alkynes, cycloadditions 
between nitrile oxides and alkenes are regioselective. The reaction between a nitrile 
oxide and a monosubstituted alkene almost exclusively gives the 5-substituted 
isoxazoline regardless of electron withdrawing or donating sustituents (Scheme 9).
Scheme 9
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Similarly, cycloadditions of 1,1-disubstituted alkenes and nitrile oxides produce 
isoxazolines in which the oxygen of the nitrile oxide becomes attached to the more 
sterically hindered end of the alkene double bond.18'68
As mentioned, several cycloaddition reactions between azides and alkynes are 
reported to be induced by enzymes.17' 20 22 In these examples, however, the aim was to 
produce potent enzyme inhibitors which bound tightly to the enzyme’s active site. 
Although the cycloadditions were catalysed by the enzymes, the tight binding of the 
products lead to product inhibition. The aim of this work was to achieve enzyme 
catalysis with substrate turnover, but for this to be possible the binding affinity of the 
products has to be similar to that of the substrates. It must be somewhat stronger or 
catalysis would not be expected but if it was much stronger, product inhibition would 
occur as in the previous examples. To investigate this form of catalysis, an enzyme was 
required which could bind two different substrates in close proximity. Tyrosyl-tRNA 
synthetase was chosen as it fits this criteria and the development of inhibitors of this 
enzyme has previously been investigated.69
1.6 Tyrosvl-tRNA synthetase
As mentioned above, tyrosyl-tRNA synthetase (EC 6.1.1.1) was chosen as the enzyme 
to investigate catalysis of the cycloaddtion reactions. As with all other aminoacyl 
synthetase enzymes, tyrosyl-tRNA synthetase plays an important role in protein 
biosynthesis. Tyrosyl-tRNA synthetase catalyses the attachment of tyrosine 38 to its
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cognate tRNA via an aminoacylation reaction. The mechanism for the reaction 
catalysed by tyrosyl-tRNA synthetase is depicted in Scheme 10.
Tyrosyl-tRNA sy n th e tase
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Scheme 10
The aminoacylation reaction is carried out in two separate steps. Firstly, the 
carboxylate anion of tyrosine 38 attacks the a-phosphate of ATP 39 to form the enzyme 
bound adenylate 41 and pyrophosphate 42. Then, in the final step, the 2’-OFI group of 
the tRNA1" 40 reacts with the adenylate 41 to form the ester bond that links the 
tyrosine to the tRNAlyr and also forms AMP 44.1
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A number of interactions are formed upon binding the substrates to tyrosyl-tRNA 
synthetase. According to the crystal structure of tyrosine 38 bound to tyrosyl-tRNA 
synthetase, tyrosine 38 binds tightly within a deep cleft and forms hydrogen bonds with 
the Tyr37, Aspl82, G lnl79, G ln20l, Asp81, Tyrl75 and Thr76 residues.™ These 
interactions are mirrored in the crystal structure of the bound adenylate analogue 5’-0- 
|Ar-(5')-tyrosyl)sulfamoyl Jadenosine 45. 70
HN— S— O
45
The crystal structure of the adenylate analogue 45 indicates key interactions 
which are used to recognise the adenine and ribose moieties of ATP 39. 0 The adenine 
ring forms hydrogen bonds between its N1 and N6 atoms and the amino and carbonyl 
groups of the Leu228 residue, respectively. The ribose unit forms a hydrogen bond 
between its 2?-OH group and the NH group of the G lyl98 residue and with the Asp200 
residue. This interaction is conserved among aminoacyl synthetases to allow 
differentiation between ATP and dATP.
To investigate catalysis of cycloaddition reactions with tyrosyl-tRNA synthetase 
substrates were designed based on tyrosine 38 and ATP 39, which would give products 
that approximately fit the size of the adenylate 41 and the adenylate analogue 45. The 
design and synthesis of these compounds are presented in the following chapter.
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Chapter Two
Results and Discussion
Design and Synthesis of Substrates
2.1 Introduction
Due to the active site geometry of tyrosyl-tRNA synthetase, it was chosen to investigate 
the catalysis of cycloaddition reactions between azides and alkynes as well as nitrile 
oxides and alkenes. This chapter presents the design and synthesis of the substrates for 
this investigation.
2.2 Substrate design
As discussed in Chapter 1, tyrosyl-tRNA synthetase binds its substrates, tyrosine 38 and 
ATP 39, within two separate pockets in its active site.71 These substrates react to form 
the adenylate 41, which binds much more tightly to the enzyme than either of the 
substrates, with a dissociation constant of approximately 10 pM.71
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As the aim of the current work was to develop catalysis of cycloaddition 
reactions, corresponding substrates had to be designed that would bind to the enzyme 
and do so in the correct orientation. The binding geometry of the cycloadducts was also 
considered important for catalysis. Substrates bound with the correct orientation were 
expected to produce cycloadducts that bound tightly to the enzyme because the binding 
interactions of the substrates would be matched. It was expected that this would lead to 
catalysis; however, due to the tight binding of the cycloadducts, product inhibition 
would occur and substrate turnover would be limited. On the other hand, if  the 
substrates bound but not with the correct orientation, this would also be reflected in the 
binding affinity of the cycloadducts which would be expected to be lower than that of 
the substrates and catalysis would not be expected under these circumstances. 
Therefore, the desired binding affinity of the cycloadducts was to be close to, but 
greater than, that of the substrates to indicate the substrates are bound with the correct 
orientation for cycloaddition and also to minimise the effect of product inhibition.
As mentioned, a consequence of the substrates having the correct orientation for 
reaction is that the cycloadducts were expected to bind tighter to the enzyme. In 
designing substrates for tyrosyl-tRNA synthetase, strong binding, like that exhibited by 
the adenylate 41, was to be avoided as it would lead to product inhibition and prevent 
turnover of the substrates even in the early stages of the reaction. Therefore it was
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considered unnecessary and even undesirable for the proposed substrates and 
cycloadducts to very closely resemble the natural analogues 38, 39 and 41. A range of 
inhibitors have been previously developed for tyrosyl-tRNA synthetase based on the 
adenylate 4172 and it was found that altering or removing the phosphate or the ribose 
groups led to a decrease in binding affinity of the inhibitors,72 therefore, it was decided 
that these features be omitted from the proposed substrates. This left the adenine ring as 
the recognition feature of the substrates based on ATP 39. It was decided to attach the 
dipoles to adenine via an alkyl chain which was likely to impart some flexibility on the 
cycloadducts. Having a flexible cycloadduct was desirable over a more rigid one since if 
it had the correct geometry the latter could be expected to bind more tightly with the 
enzyme, increasing the chance of product inhibition. Alternatively a rigid cycloadduct 
could bind more poorly than the substrates if the structure does not fit well within the 
active site, but this would be a reflection that the substrates bound with the incorrect 
geometry for cycloaddition and catalysis would not be expected. The dipolarophiles 
were attached to tyrosine 38.
(g)
The structure of the adenylate 41 was used as a model in ChemDraw to 
determine the approximate dimensions the cycloadducts would have to fit. The 
proposed substrates were designed by overlapping their structures and those of their 
cycloadducts with that of the adenylate 41 in ChemDraw“ and optimising the number 
and types of bonds, usually in the alkyl chains of the dipole substrates, until a suitable 
pair of substrates was found that had the desired size and configuration. Two pairs of 
complementary substrates were proposed, one set comprising the azide 46 and the 
alkyne 47 and the other, the nitrile oxide 48 and the alkene 49.
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The azide 46 and the alkyne 47 were paired since cycloadditions between 
monosubstituted alkynes and alkyl azides have previously been reported, while the 
nitrile oxide 48 and the 1, 1 -disubstituted alkene 49 were paired since such species are 
known to readily react to give isoxazolines.18 This choice is somewhat arbitrary, 
however, and many others could have been selected. From the modelling it was 
expected that the 1,4-regioisomer would be the likely product of the reaction between 
the azide 46 and the alkyne 47 and the 4-substituted isoxazoline the product of the 
reaction between the nitrile oxide 48 and the alkene 49.
2.3 Synthesis of nitrile oxides
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Nitrile oxides are commonly synthesised from the corresponding aldehydes (Scheme 
17).68 Initially, an oxime is prepared by treatment of the corresponding aldehyde with 
hydroxylamine hydrochloride; this is then typically followed by chlorination with N- 
chlorosuccinimide to furnish the hydroximinoyl chloride. Dehydrochlorination of the 
hydroximinoyl chloride with base yields the nitrile oxide.6s
NH2OH.HCI
OH
NEt3 __ © ©
R----- -----N— O
Scheme 11
1HNitrile oxides are normally prepared in situ due to their instability, therefore, it 
was decided to prepare the more stable oxime 50 until the nitrile oxide 48 was required.
The general synthetic strategy involved synthesis of the corresponding alcohol which 
could be oxidised to the aldehyde and converted to the nitrile oxide 48 via the route 
depicted in Scheme 11. The oxidation of adenosine based alcohols is normally carried 
out whilst the amino group of adenine is protected,73’ 74 therefore, it was decided to
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prepare the amine 51 which could be deprotected by oxidation7> once the oxime had 
been formed.
Initially, synthesis of the analogue 52, which is two carbon atoms shorter than the 
designed nitrile oxide precursor 50 was investigated due to the ready availability of the 
starting material 1,3-propanediol 57.
Synthesis of the alcohol 56 was therefore required and had been previously reported76 
by treatment of 6-chloropurine 53 with 3-bromo-l -propanol and potassium carbonate 
followed by treatment with benzylamine, as depicted in Scheme 12.
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benzylamine
EtOH
Scheme 12
By this method, the A7-regioisomer 55 is also produced and would need to be separated 
from the desired AT--regioisomer 54 before treatment with benzylamine. Another 
procedure, with greater regioselectivity for the A^-isomer 59, has also been reported77 
and is depicted in Scheme 13.
Scheme 13
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By this method, the acetate 58 is coupled regioselectively to 6-chloropurine 53 via a 
Mitsunobu reaction. The acetate 59 would require deprotection later to give the 
corresponding alcohol but this only adds one step to the synthesis and due to the greater 
regioselectivity of this method it was decided to prepare the alcohol 56 via this route.
A series of trial reactions was conducted in order to develop the required 
synthetic methodology and an attempt was made to synthesise the aldehyde 61 as 
outlined in Scheme 14.
In the first step of the synthesis, an excess of 1,3-propanediol 57 was treated with acetic 
anhydride to give the monoacetate 58. An excess of 1,3-propanediol was used to 
increase the proportion of the monoacetate 58 formed over the corresponding diacetate. 
The crude product mixture was subjected to column chromatography to isolate the 
monoacetate 58 in a 74% yield. Formation of the product was confirmed by the
O '
52 61
Scheme 14
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presence of a peak at m/z 119 in the ESI(+ve) mass spectrum corresponding to the 
protonated molecular ion. The ‘H NMR spectrum showed a singlet resonance at 2.02 
ppm indicating the presence of the acetate group. These data are consistent with 
literature values.77 Next, the monoacetate 58 was coupled to 6-chloropurine 53 via a 
Mitsunobu reaction.77 The crude product was subjected to column chromatography but 
the chloride 59 was isolated as a mixture with triphenylphosphine oxide. The ‘H NMR 
spectrum of the chloride 59 presented singlet resonances at 8.18 and 8.73 ppm 
corresponding to the aromatic protons of the chloropurine group and a singlet resonance 
at 2.00 ppm corresponding to the acetate group. A signal for a proton attached at the 9 
position of 6-chloropurine 53 was not observed in the ‘H NMR spectrum of the chloride 
59 indicating coupling had taken place at this position. The chloride 59 was then treated 
with benzylamine to introduce the protected amino group and the amine 60 was 
obtained in a clean reaction. The ESI(-rve) mass spectrum of the amine 60 presented a 
peak at m/z 326 corresponding to the protonated molecular ion confirming the reaction 
was successful. Furthermore, the 'H NMR spectrum displayed resonances between 7.15 
and 7.30 ppm and singlet resonances at 8.33 and 7.51 ppm corresponding to the 
aromatic protons of the benzyl group and the protons of the adenine ring, respectively. 
Saponification of the amino ester 60 with lithium hydroxide gave the alcohol 56 in a 
clean reaction. The characteristic singlet resonance of acetate protons was no longer 
present in the 'H NMR of the alcohol 56, confirming the deprotection was successful. In 
addition, the 'H NMR spectrum displayed singlet resonances at 4.82 ppm for the 
benzylic protons and at 7.39 and 8.34 ppm for the adenine protons. Oxidation of the 
alcohol 56 under Swern conditions78 was then carried out. The 'H NMR spectrum of the 
crude product mixture displayed a singlet resonance at 9.75 ppm characteristic of an 
aldehyde proton. A 20% proportion of the aldehyde 61 was determined from the
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magnitude of the aldehyde proton resonance relative to those of the adenine protons; 
however, TLC analysis of the crude product mixture indicated the presence of a large 
number of impurities which prevented the isolation of the aldehyde 61 by column 
chromatography. After repeating the synthesis and failing to isolate the aldehyde 61, it 
was decided to investigate other reagents to synthesise the aldehyde 61. An alternative 
methcd to prepare the aldehyde 61 via a different oxidation procedure is outlined in 
Scheme 15.
DCC, d ich lo roacetic  acid 
oxalic acid
DMSO
Scheme 15
Accordingly, oxidation of the alcohol 56 under conditions described by Moffat et a l.74 
was performed. The 'H NMR spectrum of the crude product mixture displayed a 
chara;teristic peak at 9.75 ppm attributable to the aldehyde 61. TLC analysis of the 
mixture showed one major component and two minor components when visualised 
under UV light. Flash column chromatography on silica was performed to separate the 
components. The 'H NMR spectrum of the fractions containing the major component 
displayed a variety of peaks including the singlet resonance of an aldehyde; however, 
the relative magnitude of this resonance had significantly diminished compared to that 
obser/ed in the 'H NMR spectrum of the crude product mixture. It therefore seemed 
1 ikely that the aldehyde 61 was decomposing during the attempted purification process.
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To overcome this, the oxidation was carried out without isolation of the aldehyde 61 
and was immediately followed by treatment with hydroxylamine hydrochloride to form 
the oxime 62, as outlined by the process depicted in Scheme 16.
Scheme 16
Following oxidation of the alcohol 56, via the conditions described above, the reaction 
mixture was treated with hydroxylamine hydrochloride. The oxime 62 was separated 
from the crude product mixture by column chromatography (42% yield). A peak for the 
protonated molecular ion at mlz 297 in the ESI(+ve) mass spectrum of the oxime 62 
confirmed the successful outcome of the reaction. The *H NMR spectrum displayed a 
triplet resonance at 6.22 ppm, with an integration of 0.5 H, corresponding to the oxime 
proton of one isomer of the oxime 62. The resonance for the oxime proton of the isomer 
of the oxime 62 is presumed to coincide with the aromatic signals between 7.18 and 
7.42 ppm. The ‘H NMR specrum also displayed apparent quartet resonances at 2.83 
ppm and 2.55 ppm attributable to the methylene protons adjacent to the oxime moiety.
From the oxime 62, the next step in the proposed synthesis of the nitrile oxide 
precursor 52 was deprotection of the benzyl group through oxidation to the 
corresponding benzoyl moiety followed by treatment with ammonia,73 however, as the
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synthesis of the oxime 62 was carried out on only a small scale it was decided to 
investigate oxidation of the benzyl group on the model system 60 as depicted in Scheme 
17.
Nal04, RuCI3.xH20
DCM, ACN, H20
Scheme 17
Oxidation of the benzylamine 60 was attempted with sodium metaperiodate and a 
catalytic amount of ruthenium(III) chloride in a dichloromethane/acetonitrile/water 
solvent system following a modified standard oxidation procedure.7^  The modified 
protocol differed from the standard procedure in that the solvent dichloromethane was 
used instead of carbon tetrachloride as the availability of carbon tetrachloride was 
restricted; however, similar successful oxidations with ruthenium salts using 
dichloromethane as co-solvent have since been reported.79, 80 Analysis of the product 
mixture by TLC showed mostly starting material was present along with several other 
minor components. Column chromatography was performed to partially separate these 
components. The ESI(+ve) mass spectrum of one fraction displayed a peak at m/z 326 
corresponding to the protonated molecular ion of the starting material 60 and another 
signal at m/z 340 consistent with the protonated molecular ion of the benzamide 63. In
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addition, the ’H NMR spectrum of this material displayed signals between 7.48 and 
7.65 ppm, which are consistent with similar benzamides.74
The ESI(+ve) mass spectrum of another fraction displayed a peak at m/z 236 
corresponding to the amine 64 . The 'H NMR spectrum in this case presented a broad 
singlet at 5.92 ppm attributable to the amino protons. The 'H NMR spectrum also 
displayed resonances in agreement with the starting material 60 in a ratio of 1:3.5 with 
the amine 64 . Ruthenium catalysed reactions of benzamides similar to the benzamide 63 
are thought to produce amines through metal assisted hydrolysis.80 These reactions also 
produce benzoic acid which is likely to have caused inactivation of the ruthenium 
catalyst7> and caused the poor yield of the benzamide 63.  Attempts to optimise the 
oxidation reaction were not carried out as an alternative synthesis, which was being 
carried out in parallel to the above reactions, successfully gave the oxime 52.
o  1
The successful synthesis of the oxime 52 was based on a method published 
during the course of this investigation for the direct alkylation of adenine with the alkyl 
halide 65 and caesium carbonate to yield the amino ester 64 without the need for 
protection of the amino group, as outlined in Scheme 18. This route avoids the use of the 
benzyl protecting group which had been difficult to remove, and although it was 
reported that oxidation of similar adenosine based alcohols73, 74 should be carried out 
with the amino group protected, oxidation of the alcohol 67 was attempted without 
protection.
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adenine, Cs2C02
DMF
65 64
Scheme 18
Thus, the oxime 52 was successfully prepared following the route depicted in Scheme 
19. Following the methodology described above, it was expected that the oxime 52 
could be prepared through oxidation of the alcohol 67 then treatment with 
hydroxylamine hydrochloride. The alcohol 67 has been previously synthesised82 by 
treating adenine with methyl methacrylate to form 3-(adenine-9-yl)propionic acid which 
was esterified with diazomethane then reduced with sodium borohydride, however, the 
route depicted in Scheme 19 was followed since the starting materials were readily 
available and it was expected that the alcohol 67 would be obtained in the same number 
of steps as the previously reported synthesis.
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(i) DCC, dichloroacetic acid 
oxalic acid
(ii) sodium acetate, NH2OH.HCI 
DM SO
LiOH
MeOH
Scheme 19
The p-toluenesulfonate 66 was expected to be a suitable alternative and was prepared 
instead of the corresponding chloride 65. Thus, the alcohol 58 was converted to the p- 
toluenesulfonate 66 by treatment with p-toluenesulfonyl chloride in pyridine. The 
ESI(+ve) mass spectrum of the p-toluenesulfonate 66 presented a peak at m/z 295 
corresponding to the sodiated molecular ion. Additionally, the 'H NMR spectrum of this 
compound included doublet resonances at 7.45 and 7.75 ppm and a singlet resonance at 
2.43 ppm corresponding to the aromatic protons and the methyl protons of the p- 
toluenesulfonyl group, respectively. A singlet resonance at 1.94 ppm was also observed 
in the 'H NMR spectrum and corresponds to the acetate protons. The p-toluenesulfonate 
66 was obtained in 61% yield. Next, alkylation of adenine with the p-toluenesulfonate 
66 was achieved by treatment with caesium carbonate in A^A-dimethylformamide. A 
peak at m/z 236 in the ESI(+ve) mass spectrum of the acetate 64 for the protonated 
molecular ion confirmed the success of the reaction. The display of singlet resonances at 
8.36 ppm and 7.81 ppm in the ‘H NMR spectrum also verified the presence of the
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adenine group. A singlet resonance attributable to the acetate group at 2.04 ppm was 
also observed in the 'H NMR spectrum. Alkylation could be expected at a number of 
positions on the adenine ring, however, literature precedence and the fact that a signal 
for the proton attached at the A^-position of adenine was not observed in the 'H NMR 
spectrum of the acetate 64 indicated coupling had taken place at this position. A signal 
at 5.85 ppm attributable to the amino group protons was also observed indicating 
alkylation had not occurred at the amino group. The spectral data obtained for this
o o
compound are consistent with those reported in the literature. The acetate 64 was 
obtained in a 51% yield. Saponification of the acetate 64 with lithium hydroxide 
afforded the alcohol 67 in 93% yield. This was confirmed by the absence of the 
characteristic singlet resonance of an acetate group in the 'H NMR spectrum of the 
alcohol 67 . Additionally, the 'H NMR spectrum displayed triplet resonances and a 
multiplet resonance at 4.34 ppm, 3.45 ppm and 2.06 ppm, respectively, for the alkyl 
protons and singlet resonances at 8.19 ppm and 8.12 ppm for the adenine protons. These 
spectral data are consistent with published literature.83 Finally, the alcohol 67 was 
oxidised and the product treated with hydroxylamine hydrochloride in the two-step 
process described above for the synthesis of the oxime 62 . The ]H NMR spectrum of the 
oxime 52 ,  produced in this manner, displayed triplet resonances at 6.75 ppm and 7.39 
ppm corresponding to the oxime protons of the cis- and rra/zs-stereoisomers. Integration 
of these signals indicated the isomers were present in a 1:1 ratio. The high resolution 
ESI(+ve) mass spectrum presented a peak at m/z 207.0983 corresponding to the 
protonated molecular ion of the oxime 52 . The 'H NMR spectrum also presented singlet 
resonances at 8.21,8.20, 8.13 and 8.1 1 ppm for the adenine protons of the ds-and trans- 
i somers.
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Having established the oxime 52 could be prepared through oxidation of the 
alcohol 67 without protecting the amino group, it was expected that the oxime 50 could 
be prepared in an analogous fashion from the corresponding alcohol 72. The synthesis 
of the alcohol 72 has been previously reported84 and was achieved through coupling of 
5-bromovalerate to adenine with potassium carbonate followed by reduction with 
lithium aluminium hydride. Another synthesis of the alcohol 72 reports8^  the coupling 
between adenine and 5-bromopentyl acetate followed by saponification with sodium 
methoxide. In the present work, the alcohol 72 was synthesised via a method analogous 
to that given above and to that of the alcohol 67, since the starting materials were 
readily available and the method was successful for the preparation of the alcohol 67. 
The synthetic protocol followed to prepare the oxime 50 is displayed in Scheme 20. The 
preparation of the acetate 69 and the tosylate 70 has previously been reported.86'87
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Ac20 , pyridine, 
DMAP
DCM
68 69
LiOH
MeOH
(i) DCC,
d ich lo roacetic  acid 
oxalic acid
(ii) sodium  ace ta te , 
NH2OH.HCI, 
DMSO
Scheme 20
The diol 68 was treated with an equimolar amount of acetic anhydride to give the 
monoacetate 69. The monoacetate 69 was isolated by column chromatography in a 21 % 
yield, which is low due to the further reaction of the monoacetate 69 with acetic 
anhydride to give the corresponding diacetate. The spectral data obtained for this 
compound are consistent with published literature.86 Next, the tosylate 70 was 
synthesised by treating the acetate 69 with p-toluenesulfonyl chloride. A peak at m/z 
323 for the sodiated molecular ion was observed in the ESI(+ve) mass spectrum of the 
tosylate 70. The 'H NMR spectrum displayed doublet resonances at 7.75 ppm and 7.32
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ppm for the aromatic protons and a singlet resonance at 2.42 ppm corresponding to the 
methyl protons of the /?-toluenesulfonyl group. The 'H NMR spectrum also presented a
87singlet resonance for the acetate protons at 2.00 ppm, consistent with literature data. 
The tosylate 70 was obtained in a 40% yield. Coupling of the tosylate 70 to adenine was 
performed with caesium carbonate (36% yield). A peak at m/z 264 corresponding to the 
protonated molecular ion was observed in the ESI(+ve) mass spectrum of the acetate 71 
confirming the reaction was successful. Furthermore, the ’H NMR spectrum displayed 
resonances at 8.13 ppm and 8.20 ppm attributable to the adenine group and a singlet 
resonance at 1.98 for the acetate group. The melting point obtained for the acetate 71 is 
consistent with reported data.s  ^Saponification of the acetate 71 was then carried out in a 
solution of lithium hydroxide in methanol to give the alcohol 72 in an 89% yield. 
Formation of the alcohol 72 was confirmed by the display of a peak at m/z. 222 in the 
ESI(+ve) mass spectrum corresponding to the protonated molecular ion. The !H NMR 
spectrum displayed signals for the alkyl protons between 1.39 ppm and 4.24 ppm and 
singlet resonances at 8.19 ppm and 8.13 ppm for the adenine group. The melting point 
for the alcohol 72 is consistent with that given in the literature.M For the final two steps, 
firstly the oxidation reaction was performed under conditions described by Moffat et 
al.,14 then, treatment with hydroxylamine hydrochloride afforded a mixture of the cis- 
and trans-isomers of the oxime 50. The success of these reactions was confirmed by the 
presence of a peak at m/z 235 in the ESI(+ve) mass spectrum of the oxime 50, 
corresponding to the protonated molecular ion. The 'H NMR spectrum of the oxime 50 
displayed triplet resonances of equal intensity at 7.33 and 6.64 ppm corresponding to 
the oxime protons of the cis- and trans-isomers indicating the isomers were present in a 
1:1 ratio.
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2 .4  A z id e  syn th esis
The synthetic protocol followed to synthesise the azide 46 is displayed in Scheme 21. 
The synthetic strategy involved mono-substitution of the ditosylate 74 with sodium 
azide followed by coupling of the azide 75 to adenine. The synthesis of the tosylate 74 
has been previously reported88 and the synthesis of the azide 75 was reported during the 
course of this work through conversion of the diol 73 to the corresponding bromo 
alcohol via treatment with hydrogen bromide followed by treatment with sodium azide
O Q
and then /7-toluenesulfonyl chloride.
Scheme 21
The ditosylation of 1,4-butanediol 73 was achieved via a previously reported 
procedure*8 and furnished the ditosylate 74 in a 36% yield. The spectral data for the 
ditosylate 74 match those given in the literature.88 The ditosylate 74 was treated with an
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equimolar amount of sodium azide to give the monoazide 75. The monoazide 75 was 
isolated by column chromatography in a 37% yield, which is low due to the further 
reaction of the monoazide 75 with sodium azide to give the corresponding diazide. The 
ESI(+ve) mass spectrum of the azide 75 presented a peak at m/z 292 corresponding to 
the sodiated molecular ion. The ‘H NMR spectrum displayed doublet resonances at 7.79 
ppm and 7.34 ppm for the p-toluenesulfonyl group and resonances at 4.04 ppm, 3.26 
ppm, 1.74 ppm and 1.61 ppm for the methylene protons. Additionally, the IR spectrum 
displayed a strong absorbance at 2099 cm 1 attributable to the asymmetric stretch of the 
azido group. The direct alkylation of adenine with the azide 75 was accomplished by 
mixing adenine, the azide 75 and caesium carbonate in A,A-dimethylformamide to give 
the azide 46 in a 42% yield. The successful outcome of the reaction was confirmed by 
the presence of a peak at m/z 233 in the ESI(+ve) mass spectrum of the product 
corresponding to the protonated molecular ion of the azide 46. The 'H NMR spectrum 
displayed singlet resonances at 8.34 ppm and 7.81 ppm of the protons on the adenine 
group. The alkylation reaction was expected to be regioselective and the fact that a 
signal for the proton attached to the A^-position of adenine was not observed in the ‘H 
NMR spectrum of the azide 46 indicates coupling had occurred at this position. A broad 
singlet for the protons of the amino group at 6.41 ppm was also observed indicating that 
coupling had not occurred at the amino group. Furthermore, the IR spectrum displayed a 
strong absorbance at 2098 cm"1 for the azido group.
Since only a basic level of modeling was carried during the design of the 
substrates, the azide 76 was also prepared with a view to possibly investigating the 
effect of shortening the alkyl chain on the catalysis of the cycloaddition reaction.
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The azide 76 is a known compound and was previously prepared through the coupling 
of the methanesulfonate equivalent of the p-toluenesulfonate 78 to adenine with sodium 
hydride.90 The p-toluenesulfonate 78 was prepared as it was expected to be a suitable 
alternative to the methanesulfonate and the starting materials were readily available. 
Thus, the experimental protocol used to synthesise the azide 76 is outlined in Scheme 
22.
77
1. NaN3 
EtOH, 100°C
2. TsCI 
pyridine, 0 °C
TsO.
78
adenine, Cs2C 02 N
Scheme 22
The p-toluenesulfonate 78 w'as prepared via a two-step process by treating 2- 
bromoethanol 77 with sodium azide followed by treatment of the crude product with p- 
toluenesulfonyl chloride. The /7-toluenesulfonate 78 was obtained in a 23% yield and 
the 'H NMR spectral data obtained for the p-toluenesulfonate 78 are in agreement with
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published literature.91 Finally, adenine was alkylated with the p-toluenesulfonate 78 and 
caesium carbonate in a solution of A,A-dimethylformamide. Formation of the desired 
product was confirmed by the presence of a peak at mlz 205 in the ESI(+ve) mass 
spectrum of the azide 76, which can be assigned to the protonated molecular ion. The 
‘H NMR spectrum presents singlet resonances at 8.34 ppm and 7.86 ppm which can be 
attributed to the protons of the adenine ring and triplet resonances at 4.34 ppm and 3.80 
ppm for the alkyl protons. In addition, the X-ray crystal structure of the azide 76 was 
solved and is displayed in Figure 2. (Full details are provided in the Appendix).
Figure 2. Molecular structure of the azide 76 as determined through X-ray crystal structure
analysis.
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2.5 Alkyne Synthesis
The first step in the synthesis of both the alkyne 47 and the alkene 49 required the 
starting material A^,0-di(/m-butoxycarbonyi)-(5')-tyrosine 80. Protection of the 
hydroxyl and amino groups of tyrosine 79 was required to ensure coupling occurred 
between the carboxyl group of tyrosine 79 and the desired amine. The method used to 
prepare this compound is displayed in Scheme 23.
Scheme 23
Following the procedure described by Pozdnev,92 (S)-tyrosine 79 was treated with di- 
rm-butyldicarbonate at pH 12, in a mixture of water and propan-2-ol to give N,0- 
di(7crf-butoxycarbonyl)-(S')-tyrosine 80 in a 56% yield. The ESI(+ve) mass spectrum of 
A^O-di(terf-butoxycarbonyl)-(S)-tyrosine 80 displayed a peak at m/z 404 for the 
sodiated molecular ion. In addition, the 'H NMR spectrum presented singlet resonances 
at 1.51 and 1.37 ppm corresponding to the rm-butoxycarbonyl groups and doublet 
resonances at 7.25 ppm and 7.04 ppm for the aromatic protons.
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The following steps, outlined in Scheme 24, were used to prepare the alkyne 47. 
It was expected that propargylamine could be coupled to the protected tyrosine 80 via 
peptide coupling to give the alkyne 80 which could be deprotected to give the desired 
substrate 47.
Scheme 24
The coupling of A^O-di(/m-butoxycarbon\i)-(S)-tyrosine 80 and propargylamine was 
performed with Af-ethyl4V'-(3-dimethylaminopropyl)carbodiimide hydrochloride and 1- 
hydroxybenzotriazole hydrate. The presence of a peak for the protonated molecular ion 
at m/z 419 in the ESI(+ve) mass spectrum of the alkyne 81 confirmed the coupling 
reaction was successful. The *H NMR spectrum of the alkyne 81 displayed a triplet 
resonance at 2.19 ppm corresponding to the alkyne proton and a doublet resonance at 
3.97 ppm for the methylene group adjacent to the alkyne moiety. The *H NMR 
spectrum also presented singlet resonances for the rm-butoxycarbonyl groups at 1.54
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ppm and 1.39 ppm. The alkyne 81 was obtained in a 64% yield. Next, the alkyne 81 was 
deprotected by treatment with hydrochloric acid. The 'H NMR spectrum for the alkyne 
47 no longer displayed the characteristic singlet resonances of the rcrt-butoxycarbonyl 
groups, indicating the reaction was successful (67% yield). Furthermore, the 'Hi NMR 
spectrum displayed a triplet resonance at 3.45 ppm for the methine proton alpha to the 
amino group and a triplet resonance at 2.57 ppm for the alkyne proton. Also, the high 
resolution ESI(+ve) mass spectrum presented a peak at m/z 219.1134 for the protonated 
molecular ion of the alkyne 47.
2.6 Alkene Synthesis
The synthetic protocol performed to sythesise the alkene 49 is depicted in Scheme 25. 
The synthetic strategy involved formation of the benzoate 83 which could be converted 
to the alkene 84 via an elimination reaction then deprotection with acid was expected to 
yield the alkene 49.
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Scheme 25
Firstly, AkO-di(tert-butoxycarbonyl)-(S)-tyrosine 80 was coupled with (RS)-serine 
methyl ester hydrochloride using A^ethyl7V'-(3-dimethylaminopropyl)carbodiimide 
hydrochloride and 1-hydroxybenzotriazole hydrate to give the dipeptide 82 in a 67% 
yield. Formation of the product was confirmed by the presence of a peak at m/z 505 in 
the ESI(+ve) mass spectrum corresponding to the sodiated molecular ion. The ‘H NMR 
spectrum displayed two singlet resonances of equal intensity at 3.74 and 3.72 ppm, 
characteristic of the methyl ester groups of the diastereomers indicating the isomers 
were present in a 1:1 ratio. The 'H NMR spectrum also displayed multiplet resonances 
at 7.27 ppm and 7.04 ppm for the aromatic protons. Next, the dipeptide 82 was treated
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with benzoyl chloride. A peak at m/z 609 for the sodiated molecular ion was observed in 
the ESI(+ve) mass spectrum of the benzoate 83. Additionally, the 'H NMR spectrum 
displayed peaks in the aromatic region between 7.94 ppm and 7.40 ppm corresponding 
to the benzoyl group and singlet resonances at 3.74 ppm and 3.72 for the methyl ester 
protons. Next, the elimination reaction was performed by treating the benzoate 83 with 
l,8-diazabicyclo[5.4.0)undec-7-ene to give the alkene 84 (73% yield). This was 
confirmed by the presence of a peak at m/z 487 in the ESI(+ve) mass spectrum 
corresponding to the sodiated molecular ion. Furthermore, broad singlet resonances at 
6.59 ppm and 5.88 ppm attributable to the alkene protons were observed in the ’H NMR 
spectrum. Multiplet resonances at 7.19 ppm and 7.11 ppm for the aromatic protons were 
also displayed in the 'H NMR spectrum. Finally, the alkene 84 was treated with 
trifluoroacetic acid to give the alkene 49 (27% yield). The characteristic singlet 
resonances of the rcrt-butoxycarbonyl groups were no longer visible in the 'H NMR 
spectrum indicating the reaction was successful. The 'H NMR spectrum also displayed 
multi plet resonances at 7.09 ppm and 6.76 ppm corresponding to the aromatic protons 
and broad singlet resonances at 6.38 ppm and 5.94 ppm for the alkene protons. In 
addition, the high resolution ESI(+ve) mass spectrum presented a peak at m/z 265.1184 
for the protonated molecular ion.
To summarise, the dipolarophiles 47 and 49, the dipoles 46 and 76, and the 
nitrile oxide precursors 50 and 52 were successfully synthesised, completing the two 
sets of the required substrates. In the following chapters, the investigation into the 
binding affinity of these substrates with tyrosyl-tRNA synthetase is described.
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Chapter Three
Results and Discussion
Investigation into Determining the Activity of 
Tyrosyl-tRNA Synthetase
3.1 Introduction
Having prepared the proposed substrates, as described in the previous chapter, tyrosyl- 
tRNA synthetase was now required. A suitable assay to measure the activity of this 
enzyme was also needed as this was to be used to determine the binding affinity of the 
substrates. The binding affinities were to be used to determine the proportion of 
substrate bound to the enzyme for a given concentration of substrate. The simplest 
method would be to determine the IC 50 values of the compounds which in this context 
are inhibitors of the normal reaction. An IC 50 value is defined as the concentration of a 
compound required to lower an enzyme’s activity by 50%.93 The IC 50 can be linked to 
the dissociation constant Kj by the Cheng-Prusoff relationship (Equation 3).
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ICso =  K, (1 + f 1)
Equation 3
From the Kj value, enzyme concentration [EJ, inhibitor concentration [I] and using 
Equation 2,7 the concentration of enzyme bound with inhibitor [El] can then be 
calculated.
K, = [E][l]
[El]
Equation 2
The reaction catalysed by tyrosyl-tRNA synthetase is depicted in Scheme 10 and 
takes place in two distinct steps.1 Firstly, the reaction between tyrosine 38 and ATP 39 
produces the enzyme bound adenylate 41 and pyrophosphate 42. Then, in the final step, 
tRNAl;>' 40 reacts with the adenylate 41 to from the ester bond that links tyrosine 38 to 
tRNA1N' 40 which also produces AMP 44.
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Tyrosyl-tRNA synthetase
44
Scheme 10
The activity of tyrosyl-tRNA synthetase is normally determined via radiolabelled 
assays,94'h o w e v e r, a number of spectrophotometric assays have been developed that 
detect pyrophosphate 42 or AMP 44 and it was decided to investigate the use of these 
assays for tyrosyl-tRNA synthetase since they were expected to be straightforward, 
produce less waste and be less labour intensive than the radiolabelled alternatives.
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3.2 Preparation of tyrosyl-tRNA synthetase
Tyrosyl-tRNA synthetase was overexpressed in E. coli and purified according to an 
established protocol.96 E. coli cells (RSC2288) harbouring the expression plasmid 
pBH941 from a DMSO freezer stock were grown overnight on LBTA agar plates 
incubated at 30 °C. Individual colonies were picked and streaked out onto a master plate 
which was also grown overnight at 30 °C. Colonies from the master plate were used to 
inoculate starter cultures of LBTA medium and were incubated with agitation in an 
orbital shaker overnight at 30 °C. A portion of each starter culture was used to inoculate 
LBTA medium (1 L) in 2 L baffle flasks and cultures were grown with agitation at 30 
°C to an optical density of 0.6 at 595 nin. Overexpression of tyrosyl-tRNA synthetase 
was initiated by rapid heating of the cultures to 42 °C which were then incubated for a 
further three hours at this temperature to allow overexpression of the enzyme. The cells 
were then collected by centrifugation at 16,000 rpm for 30 minutes at 4 °C.
The cell pellet was resuspended in lysis buffer (20 mM tris-HCl, pH 8.0 
containing 1 mM ethylenediaminetetraacetic acid (EDTA), 0.5 mM 
phenylmethylsulphonyl fluoride and 10 mM ß-mercaptoethanol) and lysed by passing 
through a French press twice. Spermidine was added to the lysate to give a 
concentration of 20 mM before centrifugation at 16,000 rpm. The supernatant was 
saturated with ammonium sulfate (0.42 g/mL) to precipate the crude tyrosyl-tRNA 
synthetase which was collected by centrifugation (16.000 rpm, 30 minutes). The 
enzyme pellet was resuspended in buffer A (50 mM Tris-HCl, pH 8.0, 1 mM EDTA, 1 
mM dithiothreitol) and dialysed in a 12,000 molecular weight cut-off dialysis bag for 2
56
Chapter 3
hours against 2 L of buffer A then overnight against 2 L of fresh buffer A. The crude 
enzyme was purified by FPLC with the dialysis residue applied to a DEAE fractogel 
anion exchange column and eluted with buffer B (1M NaCl solution prepared in buffer 
A) according to the gradient displayed in Table 1.
Tim e (m inutes) % Buffer B
0 0
100 0
400 20
425 100
450 100
475 0
Table 1. FPLC conditions for the purification of tyrosyl-tRNA synthetase using DEAE
fractogel' anion exchange column
The fractions were analysed by SDS-PAGE electrophoresis (12% acrylamide, 0.1% 
sodium dodecylsulfate, coomassie blue stain) and fractions with the correct molecular 
weight (-47,000) were pooled and dialysed overnight against 2 L of buffer A in a 
12,000 molecular weight cut-off dialysis bag. The partially purified tyrosyl-tRNA 
synthetase was purified further by applying the dialysis residue to a Q Sepharose anion 
exchange column and eluting with buffer B according to the gradient displayed in Table 
2 .
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Tim e (m inutes) % Buffer B
0 0
60 0
360 30
390 100
450 100
Table 2. FPLC conditions for the purification of tyrosyl-tRNA synthetase using a Q-
sepharose* anion exchange column
The fractions containing tyrosyl-tRNA synthetase were pooled and dialysed against a 2 
L solution of 50% glycerol in buffer A with sodium chloride (50 mM). The dialysis 
residue was concentrated using an Amicon Centriplus concentrator with a 10,000 
molecular weight cut-off to a concentration of 16 mg/mL. The concentration was 
calculated from the absorbance of a solution of tyrsoyl-tRNA synthetase in buffer A at 
280 nM using the extinction coefficient £ 49765 M 1 cm'1.97
3.2 Investigation into the use of spectrophotometric assays to 
determine the activity of tyrosyl-tRNA synthetase
The first enzyme assay that was investigated was the EnzChek pyrophosphate assay. 
This was a commercially available enzyme assay kit for use to detect pyrophosphate 42 
spectrophotometrically through a coupled reaction. The kit consisted of the enzymes
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inorganic pyrophosphatase and purine nucleoside phosphorylase and the substrate 2- 
amino-6-mercapto-7-methylpurine ribonucleoside 86. The assay detects pyrophosphate 
42 by coupling its production to the formation of 2-amino-6-mercapto-7-methylpurine 
87 from 2-amino-6-mercapto-7-methylpurine ribonucleoside 86 which causes a shift in 
the absorption maximum from 330 nm for the substrate 86 to 360 nm for the product 87 
(,Scheme 26).
The first step in the analysis sequence is the conversion of pyrophosphate 42 to 
phosphate 85 by inorganic pyrophosphatase. Then, the phosphate 85 and 2-amino-6- 
mercapto-7-methylpurine ribonucleoside 86 is enzymatically converted into 2-amino-6- 
mercapto-7-methylpurine 87 and ribose 1-phosphate 88 by the enzyme purine 
nucleoside phosphoryase. The change in absorbance at 360 nm is monitored using a 
UV-VIS spectrophotometer.
The assay was conducted with the enzyme concentrations and substrate 
concentration according to the instructions that were supplied with the kit. The 
concentration of tyrosyl-tRNA synthetase chosen was 10 nM. The concentrations of the 
substrates used were above their KM values to ensure the enzyme was sufficiently bound 
with substrate. The Km values of the substrates are displayed in Table 3.
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Substrate Km
Tyrosine 38 3 pM
ATP 39 0.5 mM
tRNAT,r 40 20 nM
Table 3. KM values of tyrosyl-tRNA synthetase substrates
The initial concentration of tyrosine 38 used was 10 pM and was 1 mM for ATP 
39. A commercial mixture of tRNA from E. coli (Roche) was used with a final 
concentration of 100 //g/mL, which is consistent with that used in cell free protein 
expression experiments.96
The assay was conducted by preparing a solution containing all of the assay 
components and the substrates with the exception of tyrosyl-tRNA synthetase. The 
solution was then incubated for 10 minutes to ensure any background pyrophosphate 42 
or phosphate 85 was consumed before initiating the assay. The spectrophotometer was 
‘zeroed’ and then the measurement at 360 nm was started followed by the addition of 
tyrosyl-tRNA synthetase. The absorbance was monitored for several minutes but failed 
to show any increase. Addition of extra tyrosyl-tRNA synthetase, then tRNA and ATP 
39 also failed to give an increase in absorbance. In order to check if the assay 
components were working properly, 1 pL of a 50 mM solution of sodium 
pyrophosphate was added to the same mixture and this resulted in an immediate 
increase in absorbance indicating the coupling reaction was functioning.
It was thought that the assay components may be inhibiting tyrosyl-tRNA 
synthetase, for example, due to the similar structures of 2-amino-6-mercapto-7-
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methylpurine ribonucleoside 86 and ATP 39. the nucleoside 86 may be acting as a 
competitive inhibitor of tyrosyl-tRNA synthetase, preventing turnover of the substrates. 
Accordingly, the treatment of tyrosyl-tRNA synthetase with its substrates was carried 
out separate to the analysis reaction and an aliquot of the reaction mixture was added to 
the analysis mixture to determine the amount of pyrophosphate 42 produced. A solution 
of tyrosyl-tRNA synthetase and its substrates, under the conditions previously noted, 
except that the tyrosine 38 concentration was increased to 50 pM, was incubated at 37 
°C for 2 minutes. A portion of this solution was added to the analysis mixture and the 
absorbance of this mixture at 360 nm was measured. Again no increase in absorbance 
was observed against a blank which contained no tyrosyl-tRNA synthetase. Addition of 
another aliquot of the reaction mixture after a further 10 minutes also failed to produce 
an increase in absorbance. A variety of conditions were then attempted such as raising 
the concentration of tyrosyl-tRNA synthetase to 50 nM, the ATP 39 concentration to 4 
mM, the tyrosine 38 concentration to 100 pM and 200 pM and the tRNA concentration 
to 0.5 mg/mL and 1 mg/mL, however, in each case pyrophosphate 42 was not detected 
by this method. In another attempt, a much greater concentration of tyrosyl-tRNA 
synthetase of 10 mM was used. Since tyrosyl-tRNA synthetase was in excess and the 
first step of the reaction produces the adenylate 41 and pyrophosphate 42 regardless of 
the presence of the tRNA, it would be assumed that a concentration of pyrophosphate 
42 equal to that of the tyrosine 38 which w^ as 50 pM would be produced, which, 
according to the standard curve provided with the kit, would produce a change in 
absorbance of 1 absorbance unit, however, the absorbance did not increase. At this point 
it appeared that the enzyme may be inactive and a fresh batch of tyrosyl-tRNA 
synthetase was prepared by the method given above and was again tested, however, this
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also failed to show any activity. A partially purified sample of tyrosyl-tRNA synthetase 
was also tested using the assay, but this also failed to show any activity.
Having attempted this assay under various conditions that failed to give a 
satisfactory result, it was decided to no longer pursue this method for determining the 
activity of tyrosyl-tRNA synthetase.
G O  (g)
It was later reported that the EnzChek pyrophosphate assay also failed to 
detect pyrophosphate 42 produced by the enzyme pantothenate synthetase whilst 
another method was found to show activity of pantothenate synthetase. Shortly after this 
report, the enzyme assay kit became no longer available for purchase and was replaced, 
again indicating that it was not reliable. It was later found that the same solutions of 
tyrosyl-tRNA synthetase used here were determined to be active by another assay and 
given that tyrosyl-tRNA synthetase produces pyrophosphate 42 during the formation of 
the adenylate 41 and this assay did not detect this, it would seem that this assay is not 
satisfactory.
The next assay investigated for determining the activity of tyrosyl-tRNA 
synthetase was the PjPer™ Pyrophosphate Assay. This is a commercially available 
assay and is the replacement of the EnzChek pyrophosphate assay previously 
investigated.
This assay also detects pyrophosphate 42 or phosphate 85 through a series of 
coupled reactions as shown in Scheme 27.
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Firstly, pyrophosphate 42 is converted to phosphate 85 by inorganic pyrophosphatase, 
which along with maltose 89 is converted to glucose 91 and glucose-1-phosphate 90 by 
maltose phosphorylase. Next, the glucose 91 is oxidised by glucose oxidase to 
gluconolactone 93 and hydrogen peroxide 94. Horseradish peroxidase then catalyses the 
reaction between the hydrogen peroxide 94 and the substrate 10-acetyl-3,7- 
dihydroxyphenoxazine 95 to form resorufin 96. Formation of this product, and hence 
formation of pyrophosphate 42, can be monitored by observing the change in 
absorbance at 576 nm.
The solutions of substrates and enzymes were prepared according to the 
instructions provide with the kit. The protocol for determining enzyme activity was 
followed which stated the assay was best carried out using a microplate absorbance 
reader with the wavelength set to 565 nm, however, a filter for this wavelength was not 
available and one with the closest wavelength to the absorbance maximum of resorufin 
96, which was 540 nm, was used instead.
A set of reactions with tyrosyl-tRNA concentrations ranging from 10 nM to 10 
pM were prepared. In each case the concentration of the substrates was 25 pM for 
tyrosine 38, 2.5 mM for ATP 39 and 175 pg/mL for tRNA. A series of blank 
experiments was also conducted which either had no enzyme or no substrates added. A 
positive control experiment was performed by adding hydrogen peroxide to the assay 
mixture. The reaction mixtures were prepared in a 96-well plate and the reactions were 
initiated by adding the substrates of tyrosyl tRNA, buffer or hydrogen peroxide last, 
depending on the experiment. The reactions were incubated for 1 hour whilst the 
absorbance at 540 nm was recorded. The sample with no substrate or no enzyme 
showed no increase in absorbance with time as expected while the sample with added
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hydrogen peroxide showed an immediate increase in absorbance indicating the 
hydrogen peroxide had been consumed and that component of the assay was working 
properly. Each of the samples which contained the full set of substrates and tyrosyl- 
tRNA synthetase showed a slight increase in absorbance with time; however this did not 
seem to be enzyme dependent as the change in absorbance did not increase with 
increasing enzyme concentration. A trend which was noted was that the absorbance 
when the experiment was started was greater for the samples with higher concentrations 
of tyrosyl-tRNA synthetase; this could have been due to the pyrophosphate 42 released 
during the formation of the tyrosyl adenylate 41 or contaminating phosphate 85. It 
seemed more likely that contaminating phosphate 85 was causing the increase in 
absorbance as the absorbance change was too great to have been produced by the 
formation of the adenylate 41 when the concentration of pyrophosphate 42 was 
calculated from a standard curve provided with the kit.
After scaling up a selection of reactions to 1 mL and repeating, whilst measuring 
the absorbance at 576 nm, the activity of tyrosyl-tRNA synthetase still could not be 
determined. Later, it was found that the mixture of tRNAs used was the most likely 
reason for the failure of this assay, as pure tRNAlyi was required to measure the activity 
of tyrosyl-tRNA synthetase by a different method which is described in the following 
section.
Another coupled assay, developed by Hill et al., 99 for alanyl-tRNA synthetase 
was also investigated for use with tyrosyl-tRNA synthetase. This assay detects the AMP 
44 which is produced in the final step of the reaction catalysed by tRNA synthetase 
enzymes. The AMP 44 that is produced is coupled to the oxidation of NADH 100 as 
depicted in Scheme 28. The AMP 44 produced and ATP 39 are firstly converted to ADP
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97 by myokinase. Then, ADP 97 and phosphoenol pyruvate 98 are converted to 
pyruvate 99 and ATP 39 by pyruvate kinase. Next, NADH 100 is oxidized in the 
presence of pyruvate 99 by lactate dehydrogenase to give lactate 102 and NAD+ 101. 
The oxdation of the NADH 100 causes a decrease in absorbance at 340 nm which can 
be monitored.
Hie concentrations of the enzymes and substrates used in the coupling reaction 
were icentical to those reported by Hill et al., 99 and initially a concentration of 50 nM 
for tyrcsyl-tRNA synthetase, 100 pM  for tyrosine 38 . 1 mM for ATP 39 and 100 pg/mL  
of tRNA were used in the assay. A blank reaction which did not include tyrosine 38 was 
also rmnitored for the background rate. In both instances the absorbance at 340 nm 
droppei steadily with time, however, the rate was slightly greater in the reaction which 
contaired all of the substrates. To investigate if this AMP 44 production was enzyme 
catalysed, a series of reactions were performed with tyrosyl-tRNA synthetase 
concentrations of 500 nM. 2 pM and 4 pM. In each case the rate was practically 
identicil to that observed with 50 nM of enzme present and it did not appear that the 
enzyme was catalysing the reaction. Conceivably, the rate observed was the maximum 
rate fo* the coupled reaction due to the inactivity of the one or more of the enzymes 
required for the coupling reaction. Accordingly, the reactions were repeated with a two 
and four fold increase in concentration of myokinase, pyruvate kinase and lactate 
dehydrogenase, however, the rate still did not increase.
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Next, the coupling assay was tested by adding a solution of AMP 44 to the assay 
mixture and monitoring the absorbance at 340 nm, however, the absorbance did not 
decrease. Consequently, fresh solutions of the substrates were prepared and each part of 
the assay was tested from the last reaction sequence to the first to determine if an 
enzyme or substrate was not active. It was found that the reaction catalysed by pyruvate 
kinase was not functioning and was due to the substrate phosphoenol pyruvate 98. 
Although the solution of this compound was prepared shortly before the test and was 
kept on ice, it was found the substrate had to be prepared immediately before use for the 
assay to work. Surprisingly the first reaction in the sequence also failed to cause the 
oxidation of NADH 100 through the coupling reaction. It was then discovered that ATP 
39 also had to be prepared and used immediately for the assay to detect AMP 44. 
Having made these discoveries, the assay was repeated but no improvement in the rate 
was observed.
At this point it was decided to investigate the tRNA concentration used in the 
assay since the concentration of this substrate had not been varied significantly. The 
assay was conducted with a tyrosyl-tRNA synthetase concentration of 500 nM, a 
tyrosine 38 concentration of 100 pM, an ATP 39 concentration of 1 mM and the tRNA 
concentration was 50 fold of that previously used, however, the decrease in absorbance 
was similar to that previously observed. Next, the concentration of the enzyme was 
increased 10 fold; this led to a significant rate increase with the absorbance dropping 
from 0.9 units to 0.6 units over a 2 minute period. The experiment was repeated but 
failed to give a similar result. To determine if the tRNA was at saturating level, the 
concentration of this substrate was increased by a factor of 5 and 10 and the previous 
experiment was repeated. In each case, however, a precipitate formed when tyrosyl-
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tRNA synthetase was added to start the reaction and it could not be determined if the 
enzyme was active.
As mentioned previously, it was later suspected that the mixture of tRNA was not 
suitable for use in these assays since pure tRNA1)1 was required in a method developed 
later for the activity of tyrosyl-tRNA synthetase to be measured. At the time, it seemed 
that this assay, as well as the other coupled assays that were attempted, were too 
complicated since a variety of enzymes and their substrates had to be maintained for 
these assays to operate properly and given that a variety of conditions were attempted 
for tyrosyl-tRNA synthetase with none giving a satisfactory result, it was decided to 
develop a simpler assay, without any coupling enzymes or extra reagents that would 
directly measure the amount of AMP 44 produced by HPLC.
3.3 Development of an HPLC based assay for tyrosyl-tRNA synthetase
Firstly, an HPLC method to separate AMP 44 and ATP 39 was required. A method has 
previously been described1**0 using a Grace Adsorbosphere Nucleotide analytical HPLC 
column and, to separate the nucleotides, gradient conditions were used eluting with 60 
mM ammonium phosphate pH 5.0 with 5 mM tetrabutylammonium phosphate (A) and 
5 mM tetrabutylammonium phosphate in methanol (B) in a proportion of 5% B, initially 
then increasing to 18% B over 10 minutes followed by isocratic conditions for 10 
minutes. This method was attempted with an Alltech Alltima C l8 column as this was 
expected to be a suitable alternative as the specified HPLC column was not available 
immediately. Solutions of ATP 39, ADP 97 and AMP 44, in the same buffer as that
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used for the reaction of tyrosyl-tRNA synthetase, at a concentration of 1 mM were 
prepared. The solutions were injected onto the HPLC column whilst the UV absorbance 
was monitored at 259 nm. In each case a sharp peak eluted with a broad peak that eluted 
over several minutes. An injection of the buffer also gave this broad peak, indicating it 
was due to the buffer. An attempt to eliminate this was made by changing the HPLC 
method from the gradient method previously described to an isocratic method of 18% A 
: 82% B. An injection of each nucleotide in buffer, under these conditions, gave sharp 
peaks at 5, 8 and 14 minutes for AMP 44, ADP 97 and ATP 39, respectively, without 
the broad peak that was observed previously. The chromatogram of a mixture of all 
three nucleotides at 1 mM concentration showed three peaks with the same retention 
times as the individual nucleotides (Figure 3).
Figure 3. HPLC chromatogram showing the separation of AMP, ADP and ATP.
The integration of these peaks gave approximately equal values for ATP 39 and AMP 
44, whilst the ADP 97 peak area was approximately 1.2 times that of the area of the
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ATP 39 peak. Therefore, the concentration of AMP 44 produced by tyrosyl tRNA could 
easily be calculated from the integrations of the AMP 44 and ATP 39 peaks.
With a suitable method to separate the product, AMP 44, and substrate, ATP 39 , 
the assay could be attempted. Initially, reaction mixtures containing the substrates and 
tyrosyl-tRNA synthetase were incubated in the sample chamber of the HPLC 
instrument, as the temperature in the sample chamber could be adjusted to 37°C and a 
method could then be set up that would automatically sample the reaction mixture and 
inject the samples at specific time points to build up a time course. Since turnover had 
not been conclusively observed with the previous assays, a high concentration of 4.7 
jaM of tyrosyl-tRNA synthetase was used in the initial experiments. Concentrations of 
100 pNl for tyrosine 38 . 1 mM for ATP 39 and 5.25 mg/mL of tRNA were also present 
in the reaction mixture. Long reaction times were also employed to increase the chance 
of seeing turnover with samples being injected after 0, 1, 2, 4, and 12 hours. Control 
experiments were carried out without tyrosyl-tRNA synthetase to determine any 
background rate of formation of AMP 44 . The control experiment showed no turnover 
of ATP 39 , with background levels of AMP 44 and ADP 97 detected in the samples. 
The sample that contained all the substrates showed an increase in the AMP 44 
concentration with time, however, the concentration of ADP 97 also increased and 
another peak appeared and increased in intensity at a faster rate than those of AMP 44 
or ADP 97 . The peak of the unknown compound was found to have the same UV 
profile as ATP 39 , ADP 97 and AMP 44 . It was speculated that the peak belonged to 
adenosine and that the enzyme solution may be contaminated with phosphatase 
enzymes that were producing adenosine. Thus, the retention time of an authentic sample 
of adenosine was determined and found to be the same as the previously unidentified
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peak in the reaction mixture. The reaction mixture was spiked with the adenosine 
solution and the peak area was found to increase accordingly, confirming the peak 
belonged to adenosine. Next, separate solutions of ATP 39, ADP 97 and AMP 44 were 
treated with tyrosyl-tRNA synthetase and then analysed by the HPLC method. In each 
case, adenosine was produced, confirming that the tyrosyl-tRNA synthetase solution 
was contaminated with enzymes causing the conversion of these nucleotides to 
adenosine.
To overcome this, a sample of tyrosyl-tRNA synthetase, which had been purified 
further by FPLC, was used in the assay. A similar set of reactions was carried out to that 
above, except, the tyrosyl-tRNA concentration was 6 pM and the control experiment 
contained no tRNA. Both samples showed no adenosine was produced; however, the 
AMP 44 was also produced in each sample. In the case of the control reaction, the AMP 
44 could have been produced by hydrolysis of the adenylate intermediate since the 
enzyme was present in high concentration. The sample that contained all substrates and 
tyrosyl-tRNA synthetase showed a greater amount of AMP 44 was present, however, 
the concentration was calculated to be 140 pM, which is greater than the tyrosine 
concentration, therefore, the AMP 44 could not have been produced by the action of 
tyrosyl-tRNA synthetase alone. It seemed likely that the tRNA mixture was causing this 
effect. Commercially available tRNA1)1 40 was then obtained and a solution was 
prepared in the reaction buffer. This assay was attempted with a concentration of 1 pM 
for tyrosyl-tRNA synthetase, 1 mM for ATP 39, 100 pM for tyrosine 38 and 40 pM for 
tRNA 40. The HPLC method was altered so that the peaks eluted faster and each run 
was complete in 10 minutes. The reaction mixture was sampled immediately after the 
reaction was initiated by the addition of tyrosyl-tRNA synthetase then after 10 minutes.
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The first injection showed a significant peak for AMP 44 which was calculated to be at 
a concentration of 37 pM, then after 10 minutes this rose slightly to 39 pM. A set of 
blank reactions which contained no tRNAl>' 40 . no tyrosine 38 or no tyrosyl-tRNA 
synthetase showed no increase in AMP 44 . The result clearly indicated the formation of 
AMP 44 was due to tyrosyl-tRNA synthetase catalysing the reaction.
Since a linear increase in AMP 44 production was desired to easily determine the 
rate of the reaction, a variety of conditions were attempted to achieve this. The tRNA 
concentration could have been increased but due to the expense of the substrate this was 
not practical. Instead, the concentration of tyrosyl-tRNA synthetase was lowered, firstly 
to 100 nM and the assay was repeated but the reaction was too fast, with 50% of the 
reaction being complete in the short period between starting the reaction and the first 
injection. The concentration of tyrosyl-tRNA synthetase was lowered further to 10 nM 
but the rate was still too high, resulting in a curve when the concentration of AMP 44 
against time was plotted. Lowering the concentration of tyrosyl-tRNA synthetase to 5 
nM, 2 nM and 1 nM led to complete inactivity, presumably due to losses caused by the 
enzyme adhering to pipette tips and the walls of the tubes that were used during the 
dilutions. From this observation, it was decided to take aliquots at 1 minute intervals 
from a reaction mixture then quench the reaction by diluting the sample into buffer. 
Initially, this method appeared to be successful, however, when repeated it failed. It was 
found that the stock solution of tyrosyl-tRNA synthetase of 512 nM concentration, 
prepared shortly before the reaction, quickly lost its activity and further dilutions from 
this also quickly deactivated.
To prevent an enzyme from adhering to the walls of reaction vessels and pipette 
tips, often a sacrificial protein such as bovine serum albumin (BSA) is included in the
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reaction mixture.101 This protein coats the walls of the reaction vessel preventing any 
other enzymes from sticking and becoming inactivated or being removed from solution. 
Thus, the assay was carried out with 0.1 mg/mL of BSA and a range of tyrosyl-tRNA 
synthetase concentrations was investigated; although most gave a reaction rate that was 
too fast, the rate at 2 nM appeared acceptable. On repeating the experiment however, 
the assay failed to detect any AMP 44, again and it seemed likely that the dilutions 
required to accurately prepare a 2 nM solution were quickly inactivating.
It was decided that the assay would have to be carried out at a higher tyrosyl- 
tRNA synthetase concentration and samples would have to be taken early in the reaction 
and quenched since the rate would be too fast for automated sampling to be done. The 
simplest way to stop the reaction would be to denature the enzyme, either by changing 
the pH of the solution or by adding a chaotropic agent102' 103 such as potassium 
thiocyanate, guanidine hydrochloride or sodium dodecyl sulfate (SDS) to disrupt the 
hydrogen bonding of the enzyme. The quenching methods were firstly applied to a 
solution of ATP 39 to assess if  they affected the composition of the solution. Thus, a 1 
mM solution of ATP 39 was treated with 0.1 M hydrochloric acid then 0.1 M sodium 
hydroxide. Integration of the peaks in the chromatogram showed that the concentration 
of AMP 44 in the mixture had increased by a factor of three and the ADP 97 
concentration had doubled. Two other unidentified peaks also appeared in the 
chromatogram. Next solutions of ATP 39 were treated with 8 M potassium thiocyanate, 
16 M guanindine hydrochloride and 5% SDS solution. Both chromatograms of the 
potassium thiocyanate and guanidine hydrochloride showed no resemblance to a 
chromatogram of an ATP 39 solution, however, the chromatogram of the ATP 39 in 
SDS solution showed no change. Next, to determine the effectiveness of SDS as a
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quench for the reaction catalysed by tyrosyl-tRNA synthetase, a reaction mixture was 
prepared containing all the substrates, tyrosyl-tRNA synthetase and SDS in a final 
concentration of 5% w/v. After 1 hour the mixture was analysed by HPLC and showed 
no turnover of ATP 39 to AMP 44 . whilst a solution containing no SDS showed 
turnover, indicating the presence of SDS inhibited the reaction completely.
Having developed a quenching method that did not affect the proportions of ATP 
39 and AMP 44 , the assay was attempted. A variety of reaction conditions were 
investigated and samples were taken at various time points and quenched into an equal 
volume of a 10% solution of SDS; it was found that this produced foam upon mixing 
the solutions and since small volumes were being handled this caused problems for the 
HPLC autosampler in drawing the sample. It was found that lowering the concentration 
of SDS to 0.01% still inhibited the enzyme yet produced no bubbles upon mixing, when 
care was taken. Initially reactions with concentrations of 50 nM of tyrosyl-tRNA, ImM 
for ATP 39. 40 pM for tyrosine 38 and 20 pM or 40 pM for tRNA were analysed by 
taking 20 pL portions at 1, 2, 3, 4 and 5 minutes after the reaction was started and 
quenched by mixing with an equal volume of 0.02% SDS solution. The quenched 
reaction mixtures were analysed by the HPLC method and the concentration of AMP 44 
was plotted against time. In most cases the concentration of AMP 44 increased linearly 
with time, however, the rate varied considerably for samples of duplicate reactions; 
therefore the assay was not reproducible under the conditions used. It seemed likely that 
the concentration of tyrosyl-tRNA synthetase was still too low at 50 nM and the enzyme 
was inactivating over the course of the assay. The assay was then attempted with a 
concentration of 150 nM for tyrosyl-tRNA synthetase. Samples were taken at 60 second 
intervals from 60 seconds to 300 seconds and quenched and analysed by HPLC as
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described above. A duplicate reaction was also carried out and the results were plotted 
and shown in Figure 4.
60 160 260
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160 260
Time(s)
Figure 4. Concentration of AMP produced by tyrosyl-tRNA synthetase plotted against time for
duplicate reactions.
At this concentration of tyrosyl-tRNA synthetase, the assay gave highly reproducible 
results, however, due to the increased rate the tRNA was consumed quickly and led to 
the curves shown in Figure 4. Subsequently, the concentration of tRNA was doubled, 
and the tyrosine concentration was also increased to ensure these substrates would not 
be depleted so quickly. The reaction mixture was also sampled over a shorter time 
interval earlier in the reaction where the rate was more likely to be linear. The results 
are shown in Figure 5.
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Figure 5. Concentration of AMP produced by tyrosyl-tRNA synthetase plotted against time for
duplicate reactions.
Under these conditions, the assay gave the reproducible results with a linear increase in 
AMP 44 concentration with time being measured. The assay could now be used to 
easily measure the rate of AMP 44 production and to determine the IC50 values of the 
proposed substrates described in the previous chapter.
In comparison to the coupled assays that were investigated, the use of this HPLC 
based assay has several advantages, for example, there are no extra enzymes or reagents 
required which need to be active for turnover to be detected, the HPLC assay directly 
measures to amount of AMP 44 produced while the coupled assays indirectly detect the 
formation of the products through a series of intermediates and since AMP 44 is 
measured directly it proves the enzyme is active, unlike the coupled assays which 
measure activity indirectly. The HPLC based assay also produces little waste unlike the 
radiolabelled assays and due to the simple quenching technique it is expected that the 
assay could be fully automated.
80
Chapter 3
3.4 Applying the HPLC assay to other enzymes
Having developed the assay for tyrosyl-tRNA synthetase, it was anticipated that the 
method could be adapted for use with other enzymes that interconvert ATP 39, ADP 97 
and AMP 44. Accordingly, the enzymes pyruvate kinase and potato apyrase were 
chosen to be investigated as they were commercially available and each utilises ADP 97 
as one of its substrates.
Pyruvate kinase is an enzyme involved in glycolysis and catalyses the formation of ATP 
39 and pyruvate 99 from ADP 97 and phosphoenol pyruvate 98,104 as depicted in 
Scheme 29.
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The activity of pyruvate kinase is normally determined by coupling the formation of 
pyruvate 99 to the oxidation of NADH 100 which can be monitored 
spectrophotometrically. It was decided to investigate if the quenching method used in 
the tyrosyl-tRNA synthetase assay and the HPLC method could be used to directly 
monitor the formation of ATP 39. Thus, a solution of phosphoenol pyruvate 98 and 
ADP 97 each in a concentration of 100 mM was prepared in buffered solution. The 
reaction was initiated by the addition of pyruvate kinase to give a final concentration of 
1 U/mL. At 1, 2, 3, 4 and 5 minutes, 20 pL  samples were taken and quenched into a 
0.02% solution of SDS then analysed by the HPLC method described previously. The 
chromatograms showed an increase in the ratio of ATP 39 to ADP 97 with time and 
from this the ATP 39 concentration was determined for each time point and was plotted 
as shown in Figure 6.
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Figure 6. Concentration of ATP produced by pyruvate kinase plotted against time.
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Therefore, using this method, an assay was developed which could be used to directly 
follow the reaction catalysed by pyruvate kinase.
Next, the development of an assay for the diphosphohydrolase enzyme, apyrase, 
was investigated. Apyrase catalyses the hydrolysis of ATP 39 and ADP 97 to AMP 
44.l<b The activity of this enzyme has been determined by radiolabelled11*6 and 
colourimetric assays, however, it is not believed an HPLC method has yet been 
developed for this enzyme. In the assay developed for tyrosyl-tRNA synthetase and 
pyruvate kinase, samples were quenched at different time points then analysed by 
HPLC for the products. Initially the assay for tyrosyl-tRNA synthetase was attempted 
without quenching, however due to the rate of the reaction and low concentration of the 
tRNA substrate, this method was found not to be practical. Since apyrase only requires 
one substrate which could be obtained in large quantities, it seemed likely that the assay 
could be developed that required no quenching and the HPLC could be programmed to 
take samples automatically. Thus, a reaction mixture with a 0.4 mM concentration of 
ADP 97 and 0.025 U/mL concentration of apyrase was incubated at 30 °C in the HPLC 
sample compartment. The HPLC was programmed to inject samples onto the column at 
10 minute intervals over one hour. The results showed the appearance of the peak 
attributable to AMP 44 in the chromatograms confirming the reaction could be 
monitored by this method; however, the reaction was complete by 20 minutes. To 
establish if a rate could be determined for an apyrase catalysed reaction, the reaction 
rate would have to be lowered. Thus, the concentration of apyrase was lowered 3 fold, 
and the assay was repeated. The concentration of AMP 44 at the different time points 
was calculated from the ratios of the ADP 97 and AMP 44 peak areas and was plotted 
against time as shown in Figure 7.
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Figure 7. Concentration of AMP produced by potato apyrase plotted against time.
From this graph, it can be seen that a linear increase in AMP 44 could be determined 
using this method and therefore the assay could be used to determine the activity of 
apyrase.
In summary, the spectrophotometric assays that were investigated could not be 
used to determine the activity of tyrosyl-tRNA synthetase; this may have been due to 
the fact the assays did not work, as in the case of the Enzchek assay or the use of the 
mixture of tRNA rather than the pure tRNA1^  40 , or other factors. As a result, a simple, 
straightforward and robust assay was developed for tyrosyl-tRNA synthetase which 
could also be applied to other enzymes that interconvert AMP 44 , ADP 97 and ATP 39 . 
With this assay in hand, the binding affinities of the novel substrates and their 
cycloadducts could now be determined and this work is presented in the following 
chapter.
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Chapter Four
Results and Discussion
Investigation into Tyrosyl-tRNA Synthetase as a 
Catalyst for Cycloaddition Reactions
4.1 Introduction
In the previous chapter, the assay developed for tyrosyl-tRNA synthetase was described 
which could now be used to determine the binding affinities of the proposed substrates 
46, 47. 48 and 49. The binding affinities of the cycloadducts were also required as these 
would give information on the likelihood of catalysis of the cycloaddition reactions by 
tyrosyl-tRNA synthetase and be used together with the binding affinities of the 
substrates 46, 47, 48 and 49 to decide the concentrations of the substrates 46, 47, 48 and 
49 that were to be used in the catalysis experiments. This chapter presents the synthesis 
of the cycloadducts, the determination of the binding affinities of the substrates 46, 47, 
48 and 49 and cycloadducts and the investigation into the use of tyrosyl-tRNA 
synthetase as a catalyst for the cycloadditon reactions.
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4.2 Cycloadduct synthesis
Catalysis of the cycloadditon reaction between the azide 46 and the alkyne 47 was 
initially investigated and therefore required the synthesis of the triazoles 103 and 104. 
which were prepared by the route shown in Scheme 30.
h2o 
100 °c
V ' '  N
N— N
Scheme 30
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The triazoles 103 and 104 were prepared by heating a concentrated aqueous solution of 
the azide 46 and the alkyne 47 to reflux overnight. The crude material then was 
subjected to reverse phase HPLC. The chromatograph showed three major components 
were present and fractions were collected for peaks which eluted at 21.9, 22.9 and 28.3 
minutes and were analysed by ESI(+ve) mass spectrometry. A signal at m/z 451 was 
observed in the ESI(+ve) mass spectra of the fractions collected of the peaks that eluted 
at 21.9 and 22.9 minutes corresponding to the protonated molecular ion of the 
regioisomers 103 and 104 while the peak that eluted at 28.3 minutes was assigned to the 
unreacted azide 46 by the presence of a peak at m/z 233 for the protonated molecular 
ion. The regioisomers were assigned based on their *H NMR spectra as the signal for 
the triazole proton of 1,4-disubstituted triazoles is always shifted downfield compared to 
that of the corresponding 1,5-disubstituted triazole.67 The fractions collected of the peak 
with a retention time of 21.9 minutes displayed a singlet resonance at 7.46 ppm in the 
'H NMR spectrum which was assigned to the triazole proton of the 1,5-disubstituted 
triazole 104. This signal is consistent with that of other 1,5-disubstituted triazoles.108 
The 'H NMR spectrum of the triazole 104 also presented singlet resonances at 8.29 ppm 
and 8.27 ppm for the adenine ring protons and doublet resonances at 6.93 and 6.52 ppm 
corresponding to the aromatic protons of the tyrosine group. The fraction collected of 
the peak which eluted at 22.9 minutes displayed a singlet resonance at 7.66 ppm in the 
'FI NMR spectrum and was assigned to the triazole proton of the 1,4-regioisomer 103 
which is consistent with literature examples.109' 110 The ’ll NMR spectrum of the 
triazole 103 also presented doublet resonances at 6.96 ppm and 6.66 ppm corresponding 
to the aromatic protons of the tyrosine group and singlet resonances at 8.35 and 8.34 for 
the adenine ring protons. The ratio of formation of the 1,5- and 1,4-regioisomers 104 
and 103 was determined to be 33:67 from integration of the HPLC chromatogram when
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monitored at 259 nm, where standard curves showed the molar response of both 
compounds 103 and 104 is equivalent.
4.3 Binding studies
With the substrates 46 and 47 and the cycloadducts 103 and 104 now prepared, their 
binding affinities could be determined. As mentioned in Chapter Two, the binding 
affinities of the substrates 46 and 47 and the cycloadducts 103 and 104 were required as 
these would give an indication of the likelihood of catalysis occurring. The binding 
affinities of the substrates 46 and 47 were also required as these would be used to 
determine the concentrations of the substrates 46 and 47 that would be used in the 
experiments. Since a modest level of catalysis was expected, the background rate of 
reaction between the azide 46 and the alkvne 47 had to be kept to a minimum so 
catalysis could be detected. This would require working at a concentration equal to, or 
below, that of the dissociation constants of the substrates 46 and 47, since the proportion 
of the substrates bound to the enzyme varies almost linearly with changes in substrate 
concentration in this range. At concentrations above the dissociation constant, where the 
enzyme becomes saturated with substrate, the amount of substrate in free solution 
increases disproportionately to that bound to the enzyme. The consequent increases in 
background reaction rate would potentially hide any enzyme catalysis from being 
detected.
In the context of this work, the novel substrates 46 and 47 and their 
corresponding cycloadducts 103 and 104 are inhibitors of tyrosyl-tRNA synthetase. The
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most useful parameter to describe the binding affinity of the substrates 46 and 47 and 
cycloadducts 103 and 104 would be the inhibition constant Kj which is analogous to a 
dissociation constant of a compound and is defined by the relationship given in 
Equation 2.
K, [B][I][El]
Equation 2
From the Kj value, enzyme concentration [E|, inhibitor concentration [I ] and using 
Equation 2,7 the concentration of enzyme bound with inhibitor [El] can be calculated. 
To directly determine a Ki value, however, would require many rate measurements to be 
taken and would use vast amounts of the enzyme and the tRNAlvi substrate 40 which 
was expensive, therefore, it was decided to determine the IC50 values which could be 
determined in far fewer measurements. An IC50 value is defined as the concentration of
q o
an inhibitor required to lower an enzyme’s activity by 50% percent, ' and from the IC50 
value the Ki value can be calculated using the Cheng-Prusoff relationship (Equation 
3).93
•Cso =  ^ / ( l +  — ■)
K m
Equation 3
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The enzyme assay presented in the previous chapter was used to determine the 
IC50 values of the substrates 46 and 47 and the cycloadducts 103 and 104. This was 
achieved by measuring the concentration of AMP 44 produced over a 2 minute period at 
various concentrations of the substrates 46 and 47 and the cycloadducts 103 and 104. 
These values were then plotted against the concentration of the compound being 
investigated and the IC50 was determined as the concentration of the compound which 
lowered the AMP 44 concentration to half its maximum value. The plot obtained for the 
alkyne 47 is displayed in Figure 8 as a typical example.
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Figure 8. Concentration of AMP 44 plotted against concentration of the alkyne 47.
The IC50 values for the compounds 46, 47, 103 and 104 determined in this manner are 
displayed in Table 4.
The IC50 values of the azide 46 and the alkyne 47 were 14 mM and 8  mM, 
respectively and the cycloadducts 103 and 104 both exhibited lower values than either
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of the substrates 46 and 47 individually with IC50 values of 3.5 mM and 2.5 mM, 
respectively. From these IC50 values, the Kj values were calculated using the Cheng- 
Prusoff equation (Equation 3). The value of [S| and the Km value used in the calculation 
depended on the compound being investigated. The alkyne 47 was expected to compete 
for the same binding site as tyrosine 38, therefore the concentration of tyrosine 38 used 
in the assay and the KM 111 value of tyrosine 38 were used in the calculation. Similarly, 
the Km 112 value and the concentration of ATP 39 used in the assay was used to 
calculate the Ki of the azide 46. For the cycloadducts 103 and 104 the KM value and 
concentration of the tighter binding substrate, tyrosine 38, was used. The calculated Kj 
values are presented in Table 4. A Ki value of 0.1 mM was calculated for the alkyne 47 
and a Kj value of 4.5 mM was calculated for the azide 46. The Ki values calculated for 
the cycloadducts 103 and 104 were 0.06 mM and 0.04 mM, respectively. The tighter 
binding of the cycloadducts 103 and 104 indicates that the binding interactions of the 
substrates 46 and 47 are matched in the cycloadducts 103 and 104. This means that the 
substrates 46 and 47 bind to tyrosyl-tRNA synthetase with the correct geometry for 
reaction and under these conditions catalysis could be expected. Although the binding 
affinities of the cycloadducts 103 and 104 are tighter than those of the substrates 46 and 
47, which was to be expected if catalysis was to occur, they are not too much greater.
I C 5 0 Kj
Compound
(mM) (mM)
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ly, this meant that conditions could be chosen that would allow the enzyme to be 
sufficiently bound with the substrates 46 and 47 whilst any initial product formation 
would not reach such a concentration, especially in the early stages of the reaction, that 
would inhibit the enzyme binding substrates.
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Therefore, it was decided to carry out the experiments with concentrations of the 
substrates 46 and 47 equal to their Kj  values, 4.5 mM and 0.1 mM, respectively. This 
would allow approximately half the enzyme to be bound with the substrates 46 and 47 
and since a limiting concentration of the alkyne 47 was chosen, this would lead to a 
maximum concentration of 0.1 mM of the cycloadducts 103 and 104. Then, even as the 
reaction neared completion, 30-40% of the enzyme would be free in solution to bind the 
substrates for catalysis.
The concentration of enzyme used also had to be considered since enzymes are 
usually extremely efficient catalysts and often used at nanomolar concentrations but for 
the purpose described here, where a modest level of catalysis was expected, the 
concentration of enzyme used had to be as high as practicable to obtain the greatest 
possible ratio of enzyme bound to free substrate in solution. Thus, a concentration of 
100 j a M  was chosen as this was the highest concentration that was practical due the 
limited amount of enzyme accessible.
A pair of reactions were set up under the conditions stated above, one with 
enzyme and one, a blank, without enzyme. The purpose of the blank reaction was to 
allow the background rate of reaction to be determined and also to measure the 
distribution of the regioisomers 103 and 104 under these reaction conditions. Since
1 o
cycloadditions between azides and alkynes typically afford mixtures of regioisomers 
this would allow the effect of the enzyme on the regioselectivity to be investigated. 
After times up to 1 week incubating at 37 °C, the reaction mixtures were analysed by 
HPLC, however, peaks for neither of the cycloadducts 103 nor 104 could be detected. A 
duplicate experiment was also conducted, however, analysis by HPLC also failed to 
detect the peaks of the cycloadducts 103 and 104 in this instance. As the cycloadducts
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103 and 104 could not be detected even in the control experiment it was not possible to
determine if catalysis had occurred. To determine why the cycloadducts 103 and 104
were not formed at detetable levels, it was decided to measure the second order rate
constant of the non-catalysed reaction between the azide 46 and alkyne 47 . A reaction
was therefore conducted in which both of the substrates 46 and 47 were present at
concentrations of 100 mM and the mixture was incubated at 37 °C for 8 days, then
analysed by HPLC. The chromatogram of the reaction mixture showed peaks for the
regioisomers 103 and 104 which were determined to be present at concentrations of
1.75 mM and 0.75 mM, respectively, representing a total product concentration of 2.5
mM. Thus, the rate of this reaction was determined to be 3.6 x 10 9 M s '1. From this
11^result the second order rate constant k was calculated using Equation 4.
Rate = /cl A 11B1
Equation 4
In this manner, the second order rate constant k  for the reaction between the 
azide 46 and the alkyne 47 was calculated to be 3.6 x 10 M s ' .  The cycloadducts 103 
and 104 could probably be detected at 1 pM concentrations, even though this would be 
difficult at very early stages of reactions involving very large excesses of the substrates 
46 and 47. Then, under the conditions of the original non-enzyme catalysed control 
experiment it would take approximately half a year for the cycloadducts 103 and 104 to 
reach detectable levels. In the presence of the enzyme, detectable levels could form in 
shorter times through catalysis. However, given the relatively small proportions of the
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substrates 46 and 47 bound to the enzyme, a 100-fold increase in the rate of the reaction 
of the bound substrates 46 and 47 would less than double the overall and therefore 
measurable rate of product formation. A more than 2000-fold increase would be 
required for detectable product formation within the week of the original experiment. 
Since catalysis was only expected to be reliant on the increased effective concentration 
of the bound substrates 46 and 47 and no other forms of catalysis, such as catalytically 
active groups, catalysis of this efficiency was not expected. A much lower level of 
catalysis was anticipated and would have been welcomed, had it been detectable, since 
the long term goal was to optimise the enzyme through mutagenesis.
In principle, the experimental conditions could have been altered to increase the 
rate of formation of the cycloadducts 103 and 104. The temperature could have been 
raised, however, this would almost certainly lead to denaturation of the enzyme. It is 
likely that significant degradation of the enzyme had already occured over the long 
reaction time periods used. The concentrations of the substrates 46 and 47 given above 
were carefully chosen from the binding data and significantly varying these was 
impractical. Lowering the concentrations of the substrates 46 and 47 would slow the 
rate of reaction and already the concentrations of the products 103 and 104 were too low 
to be detected. Increasing the concentrations of the substrate 46 and 47 would 
disproportionately increase the non-enzyme catalysed reaction as the enzyme became 
saturated, which would mask any catalysis. The concentrations of the substrates 46 and 
47 would have to be significantly increased to detect the reaction and the proportion of 
reaction taking place in solution would be much larger than that occurring on the 
enzyme. Had the Kj  values been much greater, however, then higher concentrations of 
the substrates 46 and 47 could have been used but this wras not a predictable property
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and could not be controlled. The concentration of tyrosyl-tRNA synthetase could have 
been increased to increase the proportion of the substrates 46 and 47 bound to the 
enzyme, however as mentioned previously only small amounts of the enzyme were 
accessible and to increase the concentration was not practical.
In summary, after determining the binding affinities of the putative substrates 46 
and 47, determining the rate of reaction between these and knowing the detection limits, 
the measurement of catalysis was not practical in this system.
Given it was impractical to increase the concentrations of the substrates 46 and 
47, it was decided to investigate the use of Cu(I) as a catalyst to increase the reaction 
rate to a detectable level. The Cu(I)-catalysed azide/alkyne cycloaddition reaction was 
introduced by Sharpless et al.,65 and can be used to prepare 1,4-disubstituted-l ,2,3- 
triazoles under mild conditions without the need for heating the reaction mixture. The 
proposed mechanism"4 for the catalytic cycle is depicted in Scheme 31. The catalytic 
cycle begins with the formation of the copper acetylide complex 108. The azide 109 
then forms a complex with the 2nd copper of the complex 108 to form species 110 which 
activates the azide 109 towards nucleophilic attack on the alkyne 106. After a series of 
steps, the triazole 112 is formed and the copper catalyst 105 is regenerated.
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Scheme 31
It was thought that as well as increasing the non-enzyme catalysed reaction rate, 
binding the copper acetylide of the alkyne 47 to the enzyme might increase the binding 
affinity of the azide 46 in the active site of tyrosyl-tRNA synthetase, since the copper 
would provide an extra binding site and could therefore potentially increase the catalytic 
ability of the enzyme. To investigate this form of catalysis, the background rate of 
reaction had to be determined. To achieve this, reaction mixtures containing the azide 
46 and the alkyne 47 at concentrations of 4.5 mM and 100 pM, respectively, were 
treated with copper sulfate and sodium ascorbate, as a reducing agent, under standard 
conditions63 at 1 pM (1 mol %) and 10 pM concentrations, respectively. The reaction 
mixture was incubated at 37 °C then analysed by HPLC at 35 minute intervals over a 
period of 315 minutes, however, no product was detected. It was decided to increase the
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concentrations of both the copper sulfate and sodium ascorbate to 10 pM and 100 pM to 
attempt to increase the reaction rate, however, at 175 minutes still no product was 
detectable by HPLC. The concentrations of copper sulfate and sodium ascorbate were 
increased further to 50 pM and 5 mM and under these conditions a peak corresponding 
to the product 103 was detected by HPLC with the reaction being complete in 105 
minutes. Having determined the background reaction rate, an experiment was conducted 
with the enzyme at a concentration of 100 pM, the azide at 4.5 mM, the alkyne at 100 
pM, copper sulfate at 50 pM and sodium ascorbate at 5 mM, and the mixture was 
incubated at 37 °C then analysed by HPLC, however no product was detected. It was 
thought that the reaction was being inhibited by the presence of one or more 
components in the enzyme stock solution such as EDTA or 2-mercaptoethanol which 
are capable of forming complexes with copper ions.115 The enzyme was therefore 
dialysed against fresh buffer containing no EDTA or 2-mercaptoethanol. The 
experiment was repeated, however, due to the dilution during dialysis the concentration 
of enzyme used was 50 pM. In this case, the triazole 103 also failed to form. A 
literature survey then presented a possible explanation. In most cases where a Cu(I) 
catalysed cycloadditon reaction is conducted in the presence of proteins,116 viruses117 
and whole cells118 the concentration of copper sulfate required is often at vast excess 
compared to that of the substrates and the copper is often used in combination with a 
rate enhancing ligand116 to obtain a significant level of reaction. The concentration of 
the copper sulfate used in the system described here is most likely already at the 
maximum practical level, as increasing the concentration of the copper sulfate further 
would lead to the reaction reaching completion too quickly in the absence of enzyme 
and therefore a comparable background rate would not be able to be determined. In 
addition, it has been reported117 that if alkynes are not present in excess when copper
98
Chapter 4
catalysed cycloaddition reactions are carried out in biological systems, and at low 
concentrations, an unknown decomposition pathway of the copper acetylide may be
117favoured over the cycloadditon reaction.
In addition to the azide 46 and the alkyne 47, the azide 76, the nitrile oxide 
precursors 50 and 52 and the alkene 49 were also prepared as possible enzyme 
substrates, or substrate precursors, as described in Chapter 2. The investigation into 
catalysis of the cycloaddition reactions between the azide 76 and the alkyne 47 and 
between the nitrile oxides, of the corresponding oximes 50 and 52, and the alkene 49 
were also to be investigated. However, due to the problems encountered investigating 
catalysis between the azide 46 and the alkyne 47, it was expected that detecting and 
measuring catalysis would not be practical in these systems. Given the similarity 
between the azide 46 and the azide 76 it was expected that the cycloaddition between 
the azide 76 and the alkyne 47 would be too slow for a detectable amount of the 
products to be formed in a reasonable period of time as with that of the reaction between 
the azide 46 and the alkyne 47. The alkene 49 was found to quickly decompose, with a 
half-life of approximately 12 hours, which posed problems for investigating catalysis 
with this substrate since experiments were likely to be carried out over several days. 
Moreover, the complementary nitrile oxide substrate 48 and the corresponding nitrile 
oxide of the oxime 52 were likely to be very unstable and dimerise to the corresponding 
furoxans.1* Similar nitrile oxides, such as ethane nitrile oxide and propane nitrile oxide 
are reported120 122 to dimerise immediately at room temperature, therefore developing an 
experiment that would be monitored over several days would be impractical due to the 
dimerisation of these species. As an alternative, it was decided to investigate catalysis in 
a different system with a more stable nitrile oxide. Benzonitrile oxide 116 is reported12'
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to dimerise only over several days at 40 °C at a concentration of 0.1 M, therefore an 
experiment could be carried out with this species that allowed a reaction time of several 
days. It was decided to use Chymotrypsin as the enzyme as it could be bought in bulk, 
unlike tyrosyl-tRNA synthetase, and therefore its concentration could be controlled 
more easily and increased which would allow more of the substrates to be enzyme 
bound. Benzonitrile oxide 116 is also easily prepared and was expected to bind within 
the active site of Chymotrypsin, since Chymotrypsin normally binds aromatic side chains 
of amino acids in a hydrophobic pocket at its active site.
Thus, the investigation into chymotrypsin as a catalyst for cycloaddition 
reactions is presented in the following chapter.
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Chapter Five
Results and Discussion
Investigation into Chymotrypsin as a Catalyst for 
Cycloaddition Reactions
5.1 Introduction
In the previous chapter, tyrosyl-tRNA synthetase was investigated as a catalyst for 
cycloaddition reactions, however, for various reasons it was found to be impractical to 
measure catalysis in this system. In this chapter, the investigation into Chymotrypsin as 
a catalyst for cycloaddition reactions is presented.
5.2 Substrate design
Chymotrypsin is a serine protease that hydrolyses peptide bonds adjacent to aromatic 
amino acid residues.4 The surface of Chymotrypsin is characterised by a series of 
subsites (S„) that have differing affinities for the amino acid residues (Pn) of peptides, as 
shown in Figure 9.124
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The Si subsite of Chymotrypsin is a deep hydrophobic pocket which preferentially binds 
the aromatic side chains of tyrosine, tryptophan and phenylalanine. The catalytically 
active residues of Chymotrypsin are located close to this pocket and are aligned to attack 
the carbonyl group, indicated by the arrow, in the first step of the hydrolysis reaction. 
This cleaves the peptide and leads to an acyl-enzyme intermediate. Hydrolysis of this 
intermediate regenerates the free enzyme.4
Chymotrypsin has also been shown to catalyse the formation of peptide bonds 
through nucleophilic attack on the acyl-enzyme intermediate by suitable amino acid 
based nucleophiles in the reverse of the hydrolysis reaction. ~ By treating the acyl- 
enzyme intermediate with different amino acid nucleophiles, the ST subsite specificity 
has previously been determined. Nucleophiles bearing hydrophobic groups at the Pi’ 
position were found to bind strongly at the Si’ site, however, nucleophiles with 
positively charged side chains, such as arginine, were found to bind even more strongly. 
Conversely, amino acids with negatively charged side chains were much less efficient 
nucleophiles. Chymotrypsin has also been shown to preferentially hydrolyse peptides 
with lysine or arginine residues at the P |’ position. 126 These specificities have been 
attributed to the negatively charged residues that line the Si’ subsite.
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As with the substrates developed for tyrosyl-tRNA synthetase, the substrates 
designed to investigate catalysis with Chymotrypsin would have to bind to Chymotrypsin 
and do so in the correct orientation for reaction. Based on the information above, it was 
decided to use the dipeptide 113 as a model in ChemDraw* which the proposed 
substrates and cycloadducts would have to fit, as this model includes both the aromatic 
residue expected to bind to the Si subsite of Chymotrypsin and the positively charged 
residue that would bind to the S i’ subsite.
As mentioned in Chapter 4, benzonitrile oxide 114 was chosen as the dipole substrate 
and was expected to bind in the same position as a phenyl group would of the dipeptide 
113 at the Si subsite of Chymotrypsin. The dipolarophile substrates were based on 
arginine, with an alkene attached via an alkyl chain to a guanidine group.
114
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Since cycloadditons between monosubstituted aliphatic alkenes and nitrile oxides are 
highly regioselective,127 it was expected that the product of the cycloadditon between 
benzonitrile oxide 114 and the proposed dipolarophiles would be the corresponding 5- 
substituted isoxazolines. Therefore, in an analogous fashion to that carried out with 
tyrosyl-tRNA synthetase, the substrates were designed by overlapping their structures 
and those of their cycloadducts with that of the dipeptide 113 in ChemDraw'< and 
optimising the numbers and types of bonds until a suitable pair of substrates with the 
desired size and configuration was found. Thus, the alkenes 115 and 116 were proposed 
as putative substrates to bind to the Sj’ subsite of Chymotrypsin.
115 116
5.3 Substrate synthesis
Due to the instability of nitrile oxides, benzohydroximinoyl chloride 119 was initially 
prepared instead of benzonitrile oxide 114. When required, benzonitrile oxide 114 could 
be generated in situ by treating a solution of benzohydroximinoyl chloride 119 with 
base. Thus, benzohydroximinoyl chloride 119 was synthesised via a standard 
procedure,128 as depicted in Scheme 32.
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Firstly, benzaldehyde 117 was treated with hydroxylamine hydrochloride to give 
benzaldoxime 118. The 'H NMR spectrum of benzaldoxime 118 displayed multiplet 
resonances at 7.59 ppm and 7.40 ppm for the aromatic protons and a singlet resonance 
at 8.16 ppm corresponding to the oxime proton. These signals identify129 the material as 
the f-isomer. The Z-isomer of benzaldoxime 118 is reported to be unstable and 
quickly reverts to the £-isomer 118 upon work-up and handling, therefore only the E- 
isomer 118 was isolated. Next, benzaldoxime 118 was converted to 
benzohydroximinoyl chloride 119 via treatment with yV-chlorosuccinimde. A melting 
point of 46-48 °C was recorded for benzohydroximinoyl chloride 119, which is
13 1comparable to the published data.
Synthesis of the alkenes 115 and 116 required the starting material N,N’-d\(tert- 
butoxycarbonyl)-S'-methy! isothiourea 121. The method used to prepare this material is 
displayed in Scheme 33.
NH ^2 H2S 0 4
Ah2n s
120
di-f-butyl d ica rbona te
propan-2-ol/w ater 
pH 12
NBocD
B o c H N ^ ^ S "
121
Scheme 33
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S-Methylisothiourea sulfate 120 was treated with di-rm-butyl dicarbonate under the 
conditions developed by Gers et a/.,132 to give MN’-bisCerf-butoxycarbonyO-S- 
methylisothiourea 121 in a 26% yield. The 'id NMR spectrum of N,AT-bis(terr- 
butoxycarbonyl)-.S-methyl isothiourea 121 displayed a singlet resonance at 2.40 ppm for 
the methyl group protons and singlet resonances at 1.50 ppm and 1.52 ppm 
corresponding to the /err-butoxycarbonyl groups. A melting point of 119-120 °C was 
recorded for N,A^-bis(te^butoxycarbonyl)-S-methylisothiourea 121. These data are 
consistent with published literature.132
The alkene 115 was prepared by the method displayed in Scheme 34.
NBoc
A / 1-am ino-3-butene hydrochloride. NEt3, DMAP
NBOC
A/-BocHN S
DMF
BocHN NH
1 2 1 1 2 2
© ©
cf3co2 nh2
TFA
DCM
Scheme 34
Coupling of Ar,A^ ,-di(rerr-butoxycarbonyl)-5-methylisothiourea 121 and l-amino-3- 
butene hydrochloride was accomplished with 4-(dimethylamino)pyridine and 
triethylamine in a solution of AA^dimethylformamide, according to the general 
procedure described by Gers et a/.132 The 'H NMR spectrum of the alkene 122 
displayed multiplet resonances at 5.75 ppm and 5.13 ppm attributable to the terminal
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alkene and singlet resonances at 1.46 ppm and 1.45 ppm for the rm-butoxycarbonyl 
groups. A peak at m/z 336 was observed in the ESI(+ve) mass spectrum for the sodiated 
molecular ion. The alkene 122 was obtained in a 69% yield. Next, deprotection of the 
alkene 122 was carried out in a solution of trifluoroacetic acid in dichloromethane to 
give the alkene 115. The successful outcome of the reaction was confirmed by the 
presence of a peak at m/z 114 in the ESI(+ve) mass spectrum of the alkene 115 
corresponding to the protonated molecular ion. The 'H NMR spectrum no longer 
displayed the characteristic signals of rm-butoxycarbonyl groups but did show signals 
at 5.81 ppm and 5.16 ppm for the alkene group. The alkene 115 was obtained in a yield 
of 90%.
The alkene 116 was prepared according to the method presented in Scheme 35.
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Scheme 35
Firstly, the imide 124 was prepared by treating 1 -bromopent-4-ene with potassium 
phthalimide in A^N-dimethylformamide according to the method described by Gange et 
al. The EI(+ve) mass spectrum displayed a peak at m/z 215 for the molecular ion 
confirming the reaction was successful. The 'H NMR spectrum displayed resonances 
between 7.92 ppm and 7.49 ppm for the aromatic protons and multiplet resonances at 
5.78 ppm and 5.00 ppm corresponding to the alkene protons. Next, the imide 124 was 
deprotected by treatment with hydrazine hydrate, followed by treatment with 
hydrochloric acid to yield the amine 125. The 'H NMR spectrum no longer displayed 
the aromatic signals for the phthaloyl group. It did exhibit multiplet resonances at 5.85 
ppm and 5.04 ppm for the alkene protons. The ESI(+ve) mass spectrum displayed a 
peak at m/z 86 for the protonated molecular ion. The amine 125 was used without
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purification and coupled to A,A’-bis(rm-butoxycarbonyl)-.S-rnethylisothiourea 121 in a 
60% yield, according to the procedure described above. The success of the reaction was 
confirmed by the presence of a peak for the sodiated molecular ion at m/z 350 in the 
ESI(+ve) mass spectrum. The 'H NMR spectrum displayed singlet resonances at 1.46 
ppm and 1.45 ppm for the rm-butoxycarbonyl groups and multiplet resonances at 5.75 
ppm and 4.98 ppm corresponding to the alkene protons. Next, the alkene 126 was 
deprotected by treatment with trifluoroacetic acid in dichloromethane to give the alkene 
116. The ESI(+ve) mass spectrum of the alkene 116 presented a signal at m/z 128 for 
the protonated molecular ion, confirming the reaction was successful. The 'H NMR 
spectrum showed an absence of signals attributable to rm-butoxycarbonyl groups. The 
'H NMR spectrum displayed signals for the alkene protons at 5.88 ppm and 5.07 ppm. 
The alkene 116 was prepared in a 46% yield.
5.4 Cycloadduct synthesis
As with the experiments carried out with tyrosyl-tRNA synthetase the products of 
cycloaddition between the alkenes 115 and 116 and benzonitrile oxide 114 were 
required so that the binding affinities of these compounds with Chymotrypsin could be 
determined, as these data were necessary for developing the catalysis experiments. 
Thus, the cycloadducts 127 and 128 were prepared via the method depicted in Scheme 
36.
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The alkene 115 was treated with a concentrated solution of benzohydroximinoyl 
chloride 119 and triethylamine in a mixed solvent system of chloroform and ethanol. A 
mixed solvent system was required due to the differing solubilities of the substrates 115 
and 119. The ESI(+ve) mass spectrum of the cycloadduct 127 displayed a signal at mJz 
233 for the protonated molecular ion. The !H NMR spectrum presented multiplet 
resonances at 7.69 ppm and 7.53 ppm for the aromatic protons. In addition, the 'H NMR 
spectrum displayed doublet of doublet resonances at 3.64 ppm and 3.24 ppm 
corresponding to the methylene protons of the isoxazoline ring. A signal at 4.90 ppm in 
the 'H NMR spectrum, which was partially obscured by the HOD resonance was 
assigned to the methine proton of the isoxazoline ring. These signals are consistent with 
those of similar 5-substituted isoxazolines.127 The 'H NMR spectrum of the crude 
product mixture indicated that the 5-substituted isoxazoline 127 is the sole product of 
the cycloaddtion reaction as signals for the corresponding 4-substituted isoxazoline 
were not observed. Signals attributable to the methylene protons of 4-substituted 
isoxazolines are normally shifted downfield relative to those of 5-substituted 
isoxazolines by approximately 1 ppm and the signal for the methine proton of a 4- 
substituted isoxazoline is shifted upfield by approximately 1 ppm relative to that of the 
corresponding 5-substituted isoxazoline.134 The isoxazoline 127 is assumed to have
benzohydroximinoyl chloride 1 1 9  
NEt3
CHCI3 /  EtOH
0 ©
cf3co2 nh2r I ' l l  I  /■— ___
127 n = 1
128 n = 2
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been prepared as the racemic mixture since no external influence on the chirality was 
applied.
The isoxazoline 128 was prepared in an analogous fashion to the isoxazoline 127, 
by treating the alkene 116 with benzohydroximinoyl chloride 119 and triethylamine. A 
signal at m/z 247 was displayed in the ESI(+ve) mass spectrum of the cycloadduct 128 
for the protonated molecular ion. The 'H NMR spectrum displayed multiplet resonances 
at 7.71 ppm and 7.54 ppm attributable to the aromatic protons. Additionally, the ’H 
NMR spectrum presented doublet of doublet resonances at 3.64 ppm and 3.22 ppm 
corresponding to the methylene protons of the isoxazoline ring and a signal at 4.86 ppm, 
which was partially obscured by the HOD resonance, was assigned to the methine 
proton of the isoxazoline ring. These signals are consistent with those of 5-substituted 
regioisomers of similar isoxazolines.127 The 5-substituted isoxazoline 128 was found to 
be the sole product of the cycloaddition reaction as signals attributable to the 4- 
substituted isoxazoline, as described above, were not observed in the 'H NMR spectrum 
of the crude product mixture. It is assumed that the isoxazoline 128 was prepared as a 
racemic mixture since no external influence on the stereochemical outcome of the 
reaction had been applied.
5.5 Binding studies
As mentioned in Chapter 4, the binding affinities of the proposed substrates and their 
cycloadducts were important as these were to be used to determine the concentrations of 
the substrates used in experiments and would also give an indication if catalysis was 
likely. With the putative substrates 115 and 116, the substrate precursor 119 and the
1 1 1
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cycloadducts 127 and 128 prepared, their binding affinities could now be determined. It 
was impractical to determine the binding affinity of benzonitrile oxide 114 due to the 
reactivity of this species, therefore, as a compromise, the binding affinity of 
benzaldoxime 118 was determined as it was expected to be a reasonable alternative due 
to its structural similarity to benzonitrile oxide 114 and would be unreactive. As 
mentioned previously, it was expected that the cycloadducts 127 and 128 had been 
prepared as racemic mixtures, but for reasons given below it was considered 
unnecessary and impractical to isolate each enantiomer, therefore the binding affinities 
of the racemic mixtures were determined. Since Chymotrypsin was commercially 
available in large quantities it was decided to use isothermal titration calorimetry to 
directly measure the binding affinities of the substrates and cycloadducts.
Isothermal titration calorimetry (ITC) can be used to directly determine the 
energetics of protein-ligand binding interactions and from a single experiment, the 
binding constant K, stoichometry n and enthalpy AH° can be determined for a particular 
binding interaction. The binding constant K is related to the concentration of enzyme 
[E], the substrate concentration [S] and the concentration of enzyme bound with 
substrate [ES] by Equation 4.
K ES]
[E][S]
Equation 4
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The inverse of the binding constant is the dissociation constant Kd (Equation 5).
„  [E][S]
d [ES]
Equation 5
The ITC instrument consists of two identical cells, one of which acts as the 
reference and the other as the sample cell. The sample cell usually contains a 
macromolecule, such as a protein, into which a ligand is titrated. The ligand is titrated 
automatically via a highly accurate syringe which also spins to ensure adequate mixing. 
A constant power is applied to both cells during the experiment which slowly increases 
the temperature in both cells at the same rate. The energy changes that occur upon the 
ligand binding to the macromolecule are detected as temperature differences between 
the sample and reference cell. The energy difference is quantified by applying or 
lowering the power applied to the sample cell to maintain constant temperature. The 
power applied for each injection of ligand can be plotted against time as shown in the
I o c
example given in the top panel of Figure 10. " Integration of the peaks gives the heat 
associated with the binding interaction and by plotting these values against the molar 
ratio of ligand to macromolecule, a binding isotherm, such as the example shown in the 
bottom panel of Figure 10, can be obtained. By using the appropriate model, a curve 
can be fitted to those data from which the binding constant K , stoichometry n and 
enthalpy change AH° can be determined.13^
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Figure 10. ITC data for the interaction between benzaldoxime 118 and Chymotrypsin.
Using ITC the binding constants K for the proposed substrates 115 and 116, the 
substrate precursor 118 and the cycloadducts 127 and 128 were determined and the 
corresponding dissociation constants Kd were calculated and are displayed in Table 5. 
The dissociation constant of benzaldoxime 118 was 2.5 mM. The alkene 115 had a 
dissociation constant of 42 mM and the corresponding cycloadduct 127 had a 
dissociation constant of 1 mM. The binding data obtained for the cycloadduct 127 
indicated that a single binding event was occurring between the cycloadduct 127 and 
Chymotrypsin. As it is assumed that the cycloadduct 127 is present as a racemic mixture 
this observation indicates that either both enantiomers have similar binding affinities or
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that the data represents the binding affinity of one enantiomer which binds preferentially 
to the enzyme due to diastereomeric interactions whilst the other enantiomer has a much 
weaker binding affinity. If this is the case, the binding affinity of the tighter binding 
enantiomer of the cycloadduct 127 is double that recorded using the racemic mixture. 
The alkene 116 was found to have a dissociation constant of 21 mM while the 
corresponding cycloadduct 128 had a dissociation constant of 1.2 mM. As with the 
cycloadduct 127, a single binding interaction was observed between the cycloadduct 
128 and Chymotrypsin which indicates that either both enantiomers of the cycloadduct 
128 bind with similar affinity to Chymotrypsin or that one enantiomer is binding much 
more strongly than the other enantiomer through diastereoselective interactions. 
Assuming this is the case, the binding affinity of the tighter binding enantiomer of the 
cycloadduct 128 is double that measured using the racemic mixture. Both cycloadducts 
127 and 128 exhibited tighter binding than the proposed substrates 115 and 116 which 
indicates the binding interactions of the substrates 115 and 116 are matched in the 
cycloadducts 127 and 128. To the extent that the binding data for the oxime 118 is 
representative of benzonitrile oxide 114, the binding affinities of the cycloadducts 127 
and 128 are tighter than that of the benzonitrile oxide 114. Therefore it was assumed 
that the binding interactions of benzonitrile oxide 114 are also matched in the products 
127 and 128. The tighter binding of the cycloadducts 127 and 128 is also a sign that the 
putative substrates 115, 116 and 114 bind to Chymotrypsin with the correct geometry for 
reaction and that catalysis might be expected. Although, the binding affinities of the 
cycloadducts 127 and 128 are greater than those of the substrates 115 and 116 and the 
precursor 118 they are not much greater.
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Compound K (M'1) Kd (mM)
/ O H
fX"
118
400 2.5
© ©
c f 3 c o 2 n h 2A/vx
h 2 n  n  X
H
115
24 42
©©
c f 3c o 2 N H 2x  ^ \ \  / /
H ^ ------ /
127
1000 1
© ©
c f 3c o 2 n h 2x ^  ^
H 2 I\F ^ l \ T  
H
116
47 21
© ©
c f 3c o 2 n h 2
h 2 n  n  \
H I / N
128 W/
800 1.2
Table 5. Binding constants and dissociation constants of the proposed substrates and 
their corresponding cycloadducts with chymotrypsin.
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This meant concentrations of the proposed substrates 115, 116 and 114 could be chosen 
that would allow the enzyme to be sufficiently bound with substrates, whilst product 
formation, especially at early stages of the reaction, would not inhibit the enzyme and 
prevent substrate binding.
Catalysis of the cycloaddition between the alkene 115 and benzonitrile oxide 
114 was initially investigated. To increase the possibility of observing catalysis and 
minimise the contribution from non-enzyme catalysed reaction, conditions were chosen 
that would lead to a large proportion of the proposed substrates 114 and 115 being 
bound to the enzyme. Chymotrypsin was used at a concentration of 10 mM as this was 
the highest practicable due to the solubility limits of this enzyme. The alkene 115 was 
used at a concentration of 2 mM. At this concentration and based on Equation 5 
approximately 20% of the alkene 115 should be bound to Chymotrypsin. Similarly, 
benzonitrile oxide 114 was used at 2 mM and based on Equation 5 and assuming similar 
binding for the oxime 118 and benzonitrile oxide 114 at this concentration 
approximately 80% of the benzonitrile oxide 114 should be bound to Chymotrypsin. The 
reactions were carried out at 25 °C for up to 6 days along with a control experiment, 
without Chymotrypsin, to allow the non-enzyme catalysed rate to be determined. The 
reaction mixtures were then analysed by HPLC and the concentration of the cycloadduct 
127 was determined through integration of the chromatograms when monitored at 259 
nm and comparison of the peak areas to standard curves. The control experiment 
showed that a concentration of approximately 0.4% reaction had occurred over 6 days. 
The reaction mixture which also contained Chymotrypsin was then analysed by HPLC, 
however, the identification of the peak for the cycloadduct 127 became troublesome due 
a large number of impurities present in the mixture. These impurities were likely to be
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from autolysis of Chymotrypsin136 or were already present in the crude enzyme 
preparation. After extensively altering the HPLC conditions, the peak for the 
cycloadduct 127 still could not be isolated due to its small size and overlap with other 
peaks. The area of the peak which represented the mixture including the cycloadduct 
127 was found to be slightly greater than that found in the control experiment.
As mentioned previously, under the experimental conditions approximately 20% 
of the alkene 115 and 80% of the benzonitrile oxide 114 would be bound to 
Chymotrypsin, therefore 80% of the alkene 115 and 20% of the benzonitrile oxide 114 
would remain unbound and would be free to react in solution in the non-enzyme 
catalysed reaction. Since the non-enzyme catalysed reaction is a bimolecular reaction, 
the rate of reaction between the unbound alkene 115 and the unbound benzonitrile oxide 
114 would be approximately 16% (i.e., 0.8 x 0.2) of that of the non-enzyme catalysed 
reaction rate in the control reaction without Chymotrypsin. Therefore, as the amount of 
product 127 formed in the presence of Chymotrypsin is similar to that formed in the 
control reaction, it indicates that some of the product 127 is forming on the enzyme. The 
concentration of Chymotrypsin bound with the alkene 115 was calculated as 0.4 mM 
(i.e., 20% of 2 mM) or 4% of the total enzyme (i.e., 0.4 mM / 10 mM) and the 
concentration of Chymotrypsin bound with the benzonitrile oxide 114 was calculated as 
1.6 mM (i.e., 80% of 2 mM) or 16% of the total enzyme (i.e., 16 mM / 10 mM). The 
statistical probability of the enzyme binding both the substrates 114 and 115 
simultaneously was calculated as less than 1% from the product of the percentage of 
Chymotrypsin bound with the alkene 115 (4%) and the percentage of Chymotrypsin 
bound with the benzonitrile oxide 114 (16%). For the reaction mixture containing 
Chymotrypsin to produce a similar amount of the product 127 as in the control reaction,
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given the fact that less than 1% of the Chymotrypsin likely had both the substrates 114 
and 115 bound simultaneously, the rate of reaction of the components 114 and 115 in 
that 1% (0.1 mM) would have to be accelerated 400 fold (i.e., 2 mM x 2 mM / 0.1 mM 
x 0.1 mM) to match the background rate in the absence of the enzyme. These results 
indicate that there may be some reaction occurring on the enzyme which is leading to 
catalysis; however, as the yield of the product 127 was low and its quantification was 
difficult due to impurities in the crude product mixture it was difficult to accurately 
determine the effectiveness of catalysis in this system.
The cycloaddition between the alkene 116 and benzonitrile oxide 114 was also 
to be investigated, however, as the reaction rate was likely to be similar to that of the 
alkene 115 with benzonitrile oxide 114, the problems encountered in the previous 
system were also likely and the possibility of catalysis in this system was therefore not 
considered further. Instead, it was decided to re-design the alkene to provide a substrate 
that would be more activated towards cycloaddition with benzonitrile oxide 114. This 
would allow the reaction to be carried out over a shorter time period therefore 
minimising the amount of impurities formed from the degradation of Chymotrypsin and 
allowing for easier detection and quantification of the cycloadducts. Electron rich and
i o
electron poor alkenes are known to be more reactive than aliphatic alkenes such as the 
alkenes 115 and 116. Cycloadditions between activated monosubstituted alkenes and 
nitrile oxides are highly regioselective and yield mainly 5-substituted isoxazolines, 
however, there are instances where the 4-substituted regioisomers have also been 
isolated, usually in trace amounts. Therefore, the effect of Chymotrypsin on the 
distribution of the regioisomers from the reaction between the activated alkene and 
benzonitrile oxide 114 could also be investigated. Thus modeling was carried out with
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the expectation that both the 5- and 4-substituted regioisomers would be formed from 
the reaction between benzonitrile oxide 114 and the proposed alkene. Modeling was 
carried out in an analogous fashion to that used to design the alkenes 115 and 116. The 
structures of the proposed substrates and their cycloadducts were overlapped with that 
of the dipeptide 113 in ChemDraw and optimised by varying the number and types of 
bonds until a suitable pair of substrates was found. Thus, the alkene 129 was proposed 
as a substrate based on the modeling of both the 4- and 5-substituted isoxazoline 
products. The alkene 129 incorporates the guanidine group required for binding at the 
Si’ subsite of Chymotrypsin and attached via an alkyl chain is an acrylamido group, of 
which the electron deficient alkene was expected to be more reactive towards 
benzonitrile oxide 114 than that of the olefinic moiety of the alkenes 115 and 116.
129
5.6 Substrate synthesis
The alkene 129 was sythesised according to the method depicted in Scheme 37.
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The amine 130 was prepared by treating N, Af’-bis(rm-butoxycarbonyl)-,S- 
methylisothiourea 121 with 1,3-diaminopropane, according to a previously described 
method.137 The ESI(+ve) mass spectrum of the amine 130 presented a peak at m/z 317 
for the protonated molecular ion, confirming the reaction was successful. The ‘H NMR 
spectrum displayed a multiplet resonance at 1.44 ppm for the terminal amino group 
protons and a singlet resonance at 1.48 ppm for the rm-butoxycarbonyl groups. Next, 
formation of the alkene 131 was achieved by treating the amine 130 with acryloyl 
chloride. A signal at m/z 393 was observed in the ESI(+ve) mass spectrum of the alkene 
131 for the sodiated molecular ion. The *H NMR spectrum displayed a multiplet 
resonance at 6.29 ppm for the terminal olefinic protons and a doublet of doublet 
resonance at 5.57 ppm for the methine proton of the olefinic moiety. The *H NMR 
spectrum also presented resonances between 3.49 ppm and 1.68 ppm for the propyl 
protons and singlet resonances at 1.51 ppm and 1.49 ppm for the rm-butoxycarbonyl 
groups. Finally, the alkene 131 was deprotected upon treatment with trifluoroacetic acid 
to give the alkene 129. The ESI(+ve) mass spectrum displayed a peak for the protonated
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molecular ion at mJz 171, confirming the reaction was successful. The 'H NMR 
spectrum of the alkene 129 no longer displayed signals corresponding to the tert- 
butoxycarbonyl groups. Signals for the propyl protons were observed at 3.30 ppm, 3.21 
ppm and 1.82 ppm. In addition, the 'H NMR spectrum displayed a multiplet resonance 
at 6.24 ppm and a doublet of doublet resonance at 5.78 ppm for the olefinic protons.
5.7 Cycloadduct synthesis
Analogous to the synthesis of the cycloadducts 127 and 128. the cycloadducts 132 and 
133 were prepared as depicted in Scheme 38.
129 132
© ©
o
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Scheme 38
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The cycloadducts 132 and 133 were prepared by treating a concentrated solution of the 
alkene 129 with benzonitrile oxide 114, which was generated in situ by treating 
benzohydroximinoyl chloride 119 with triethylamine. The crude material was then 
subjected to reverse phase HPLC. The chromatograph showed that a major component 
and a minor component were present and fractions were collected of each. The ESI(+ve) 
mass spectrum of both fractions displayed a signal at m/z 290 corresponding to the 
protonated molecular ion of the regioisomers 132 and 133. The ratio of formation of the 
regioisomers 132 and 133 was determined to be 97:3 from the integration of the HPLC 
chromatogram when monitored at 259 nm. This is based on the assumption that since 
the two compounds are similar in structure their response ratios will also be similar. The 
regioisomers 132 and 133 were assigned based on the chemical shifts of the signals of 
the isoxazoline ring protons. The signal for the methine proton of the 5-substituted 
regioisomer is normally shifted downfield relative to that of the signal for the methine 
proton of the 4-substituted isoxazoline and the signals for the methylene protons of the 
5-substituted isoxazolines are shifted upfield compared to the signals of the methylene 
protons of the 4-substituted isoxazoline.138 The fractions collected of the major 
component displayed a doublet of doublet resonance at 5.13 ppm in the 'H NMR 
spectrum which was assigned to the methine proton of the 5-substituted isoxazoline 
132. The 'H NMR spectrum also displayed doublet of doublet resonances at 3.77 ppm 
and 3.61 ppm for the methylene protons of the isoxazoline ring and multiplet resonances 
at 7.70 ppm and 7.45 ppm corresponding to the aromatic protons. The 5-substituted 
isoxazoline 132 was isolated in a yield of 59%. The ‘H NMR spectrum of the fractions 
collected of the minor component indicated that a number of species were present. The 
major component of this mixture displayed resonances between 4.40 ppm and 4.70 ppm 
in the 'H NMR spectrum which are consistent with signals of the isoxazoline ring
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protons of similar 4-substituted isoxazolines, therefore the material was identified as 
the 4-substituted isoxazoline 133. The 'H NMR spectrum also displayed signals for the 
aromatic protons of the isoxazoline 133 between 7.25 ppm and 7.53 ppm. The 
isoxazoline 133 was obtained in less than a 2% yield. It is assumed that both of the 
isoxazolines 132 and 133 were prepared as racemic mixtures, as no external influence 
on the stereochemical outcome of the reaction had been applied.
As mentioned previously, the alkene 129 was designed to be more reactive 
towards cycloaddition with benzonitrile oxide 114 than the alkene 115. This was to 
increase the reaction rate to allow a greater yield of the products to be formed in a 
shorter time period so they would more easily be quantified. To determine if the rate of 
reaction between the alkene 129 and benzonitrile oxide 114 was faster than that between 
the alkene 115 and benzonitrile oxide 114, the second-order rate constant for the 
reaction between the alkene 129 and benzonitrile oxide 114 was required. It was 
decided to measure the rate of cycloaddition using 'H NMR spectroscopy, however, as 
the alkene 129 is soluble in water and benzohydroximinoyl chloride 119 is only 
sparingly soluble in water unless chymotrypsin is present, it was decided to use the 
alkene 131 as a model for the alkene 129 as it and benzohydroximinoyl chloride 119 are 
both soluble in deuterated chloroform. As the rate of a cycloaddition reaction is not 
solvent dependent, the rate determined for the reaction between the alkene 131 and 
benzonitrile oxide 114 in deuterated chloroform was expected to be a reasonable 
approximation of the rate of reaction between the alkene 129 and benzonitrile oxide 114 
in aqueous solution. Thus, a solution of the alkene 131 and benzohydroximinoyl 
chloride 119 in deuterated chloroform, each at a concentration of 100 mM, was treated 
with triethylamine and after 5 minutes and then 10 minutes the ’H NMR spectrum of the
138
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reaction mixture was recorded. The ‘H NMR spectrum showed the reaction was 
approximately 50% complete at 10 minutes by the equal magnitude of the resonances of 
the C5 proton of the isoxazoline 132 and the methine proton of the alkene 131 and the 
second-order rate constant for the reaction between benzonitrile oxide 114 and the 
alkene 129 was therefore crudely calculated as 8 x 10~3 M'1 s’1. This is approximately 
105 times faster than that of the reaction between the alkene 115 and benzonitrile oxide 
114 and was therefore expected to allow the catalysis experiments to be carried out over 
shorter time periods.
5.8 Binding studies
The binding constants for the alkene 129 and the isoxazoline 132 with Chymotrypsin 
were determined by ITC. It was impractical to determine the binding constant for the 4- 
substituted isoxazoline 133 as the material was not obtained in a sufficiently high yield 
or purity. Since the isoxazoline 133 was only a minor product of the cycloaddition 
between the alkene 129 and benzonitrile oxide 114, the binding affinity of the 
isoxazoline 133 would have to be very tight for formation of this species to cause 
product inhibition and prevent the binding of the putative substrates 114 and 129 to 
Chymotrypsin. Even if the binding affinity of the isoxazoline 133 was tighter than that 
of the isoxazoline 132, it was anticipated that formation of the isoxazoline 133 would 
then be favoured over the formation of the isoxazoline 132 and this would be reflected 
in the product ratios. Thus, the binding constants for the alkene 129, the isoxazoline 132
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and benzaldoxime 118 along with their calculated dissociation constants, are presented 
in Table 6.
The dissociation constant for the alkene 129 was found to be 22 mM and the 
dissociation constant for the isoxazoline 132 was 1.8 mM. The binding data obtained for 
the isoxazoline 132 indicated that a single binding event was occurring with 
chymotrypsin. As it is assumed that the isoxazoline 132 was present as a racemic 
mixture this observation indicates as it did for the isoxazolines 127 and 128 that either 
both enantiomers have similar binding affinities or that the data represents the binding 
affinity of one enantiomer which binds preferentially to the enzyme due to 
diastereomeric interactions, whilst the other enantiomer has a much weaker binding 
affinity. If this is the case, the binding affinity of the tighter binding enantiomer of the 
isoxazoline 132 is double that measured for the racemic mixture. The isoxazoline 132 
displayed a greater affinity for the enzyme than the alkene 129 and to the extent that the 
binding affinity of the oxime 118 is representative of that of benzonitrile oxide 114, the 
binding affinity of the isoxazoline 132 is also greater than that of benzonitrile oxide 
114. This indicates that the binding interactions of the proposed substrates 129 and 114 
are matched in the cycloadduct 132, therefore it was expected that the proposed 
substrates 129 and 114 would bind to chymotrypsin with the correct geometry for 
reaction and that catalysis could be expected. Also, since the binding affinity of the 
isoxazoline 132 was only slightly greater than that of benzaldoxime 118, it meant the 
proposed substrates 129 and 114 could be used at a high enough concentration that 
would ensure the enzyme was bound with substrate but would not become inhibited 
with the isoxazoline 132 at early stages of the reaction.
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K Kd
Compound (M'1) (mM)
^ O H
Q T "
400 2.5
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Table 6. Binding constants and dissociation constants of the proposed substrates and their 
corresponding cycloadduct with Chymotrypsin.
The experimental conditions to investigate catalysis of the reaction between the 
alkene 129 and benzonitrile oxide 114 by Chymotrypsin could now be decided.
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Concentrations of the alkene 129 and benzonitrile oxide 114 equal to their Kd values of 
22 mM and 2.5 mM, respectively, were chosen and a concentration of 10 mM was 
chosen for chymotrypsin. Under these conditions and based on Equation 5, 20% of the 
alkene 129 should be bound to chymotrypsin and assuming similar binding for the 
oxime 118, 75% of the benzonitrile oxide 114 should be bound to chymotrypsin. This 
means that the concentration of chymotrypsin bound with the alkene 129 would be 4.4 
mM (i.e., 20% of 22 mM) or 44% of the total enzyme concentration (i.e., 4.4 mM / 10 
mM) and the concentration of chymotrypsin bound with benzonitrile oxide 114 should 
be 1.9 mM (i.e., 75% of 2.5 mM) or 19% of the total enzyme (i.e., 1.9 mM / 10 mM). 
Thus, under these conditions the statistical probability of chymotrypsin being bound 
simultaneously with both the alkene 129 and benzonitrile oxide 114 would be 
approximately 9% (i.e., 19% x 44%). Therefore this would provide a 9-fold increase in 
the chance of catalysis compared to the previous system in which less than 1% of the 
enzyme had both substrates 114 and 115 bound simultaneously. As mentioned above, 
20% of the alkene 129 and 75% of the benzonitrile oxide 114 should be bound to 
chymotrypsin under the chosen experimental conditions; this means that 80% of the 
alkene 129 and 25% of the benzonitrile oxide 114 are free to react in solution. As this 
reaction is bimolecular, the rate of reaction occurring in free solution in the non-enzyme 
catalysed case in the presence of chymotrypsin would be approximately 20% (i.e., 0.8 x 
0.25) of that of the non-enzyme catalysed reaction in the absence of chymotrypsin. This 
value is similar to that calculated for the non-enzyme catalysed relative rate in the 
presence of chymotrypsin for the previous system (16%), but given the higher 
concentrations of reactants used in that case, the ratio of background cycloaddition to 
enzyme-catalysed reaction is likely to be similar.
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Thus, reactions were performed which contained the alkene 129 and 
benzohydroximinoyl chloride 119 at concentrations of 22 mM and 2.5 mM, 
respectively. One of the reaction mixtures contained Chymotrypsin at a concentration of 
10 mM, whereas the other did not to allow the non-enzyme catalysed rate to be 
determined as well as the distribution of the regioisomers 132 and 133 in the absence of 
the enzyme. The reaction mixtures were incubated at 25 °C and analysed at 1, 3, 5, 7 
and 9 hours by HPLC by integrating the chromatograms when monitored at 259 nM. 
The molar response of the cycloadducts 132 and 133 was assumed to be equivalent 
since the two compounds are similar in structure. The retention times for the 
cycloadducts 132 and 133 were determined from authentic samples and by mass 
spectrometry of the fractions that eluted for these peaks. Analysis of both of the reaction 
mixtures determined that each reaction was complete after 1 hour as no increases in the 
product peak areas were observed after this time. Each reaction was found to produce 
the regioisomers 132 and 133, however, the reaction mixture containing the enzyme was 
found to yield a lower amount of each of the regioisomers 132 and 133 and in a 
different ratio to that of the reaction without Chymotrypsin. The yield of the 4- 
substituted regioisomer 133 was found to be 25% less in the presence of Chymotrypsin 
whilst the yield of the 5-substituted regioisomer 132 was 14% less. The presence of 
Chymotrypsin was found to increase the ratio of the 5-substituted regioisomer 132 to the 
4-substituted regioisomer 133 from 13.5:1 in the absence of Chymotrypsin to 15.6:1 in 
the presence of Chymotrypsin. As the reactions did not proceed after the first hour, the 
rates of the reactions could not be determined, however, as there is a change in the ratio 
of the regioisomers 132 and 133 in the prescence of Chymotrypsin, it seemed some 
reaction could be occurring on the enzyme.
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In an attempt to measure the cycloaddition reaction rate, a further experiment 
was conducted in which the concentrations of both the alkene 129 and benzonitrile 
oxide 114 were lowered 5-fold, to 4.4 mM and 0.5 mM, respectively. Lowering the 
concentrations of both of the reactants 129 and 114 5-fold was expected to lower the 
overall rate by a factor of 25 since the reaction between these species is bimolecular. 
This would then extend the reaction time. In addition to this reaction, a further 
experiment was conducted in which the alkene 129 concentration was lowered to 0.8 
mM, to again lower the cycloaddition reaction rate further by a factor of 5. Each 
experiment was carried out with Chymotrypsin at a concentration of 10 mM along with a 
control experiment without Chymotrypsin. The reactions were carried out and analysed 
according to the procedure given above except that the reaction mixtures were analysed 
in the first instance after 30 minutes then at 1 hour intervals up to 3.5 hours. The data 
obtained for these experiments, as well as the previous experiment, are displayed in 
Table 7. Analysis of the reaction mixtures with concentrations of 4.4 mM and 0.8 mM 
of the alkene 129 in the absence and presence of Chymotrypsin, showed the reactions 
were complete after 30 minutes and the yields of the cycloadducts 132 and 133 were 
substantially lower than previously found for the reaction with 22 mM of the alkene 
129. The concentrations of the substrates 129 and 114 were lowered with the intention 
of increasing the cycloaddition reaction time and allowing the rate of reaction to be 
determined. As all of the reactions did not proceed beyond the first analysis and the 
yields are lower than the previous experiment it suggests that competing reactions are 
occurring.
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Substrates Enzyme Products
Benzonitrile Alkene 129 Chymotrypsin Isoxazoline Isoxazoline
oxide 114 
(mM)
(mM) (mM) 132
(Peak area)
133
(Peak area) 
(% total)
2.5 22 0 6,020,000 442,000
(6.8%)
2.5 22 10 5,210,000 334,000
(6.0%)
0.5 4.4 0 545,000 41,900
(7.1%)
0.5 4.4 10 352,000 23,600
(6.3%)
0.5 0.8 0 92000 9800
(10.6%)
0.5 0.8 10 65000 6400
(9.8%)
Table 7. HPLC data for the cycloaddition between the alkene 129 and benzonitrile 
oxide 114 in the presence and absence of Chymotrypsin.
The major competing reaction is likely to be of benzonitrile oxide 114 since the 
alkene 129 is used in excess and is therefore unlikely to be limiting. Changing the 
concentration of the alkene 129 from 4.4 mM to 0.8 mM, by a factor of 5, decreased the
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yield of the cycloadducts 132 and 133 by a factor of approximately 5. This indicates that 
the competing reaction is first order so it is not dimerisation of the benzonitrile oxide 
114 to give the corresponding furoxan, as that would be second order.
As mentioned previously, in the reaction between the alkene 129 and 
benzonitrile oxide 114 at concentrations of 22 mM and 2.5 mM, respectively, and with 
Chymotrypsin at a concentration of 10 mM, approximately 20% of the alkene 129 and 
75% of the benzonitrile oxide 114 would be bound to Chymotrypsin under these 
conditions. Therefore, the rate of the non-enzyme catalysed reaction that occurs 
between the unbound alkene 129 and the unbound benzonitrile oxide 114 would be 20% 
(i.e., 0.25 x 0.8) of that of the rate of the non-enzyme catalysed reaction without 
Chymotrypsin under these conditions. The amount of the product 132 formed in the 
presence of Chymotrypsin was 87% of that of the reaction carried out in the absence of 
Chymotrypsin (i.e. 5,210,000/6,020.000). This result may indicate that some reaction 
has occurred on the enzyme, however, as no rate information was obtained from the 
experiment an alternative explanation is that the enzyme may be restricting the reactions 
that are competing with the cycloadditon through the binding of the substrates 129 and 
114 to the enzyme, thus favouring the products 132 and 133.
Although catalysis cannot be confirmed in this system there is some evidence 
that the cycloadditon reaction is occurring on the enzyme. The ratio of the major 
cycloadduct 132 to the minor cycloadduct 133 shows a small but consistent increase in 
the presence of Chymotrypsin. The ratio changes from 13.5:1 to 15.6:1 for the alkene 
129 concentration of 22 mM, 12.9:1 to 14.9:1 for the alkene 129 concentration of 4.4 
mM and 9.38:1 to 10.2:1 for the alkene 129 concentration of 0.8 mM in the presence of 
chymotrypsin. At each different concentration of the alkene 129 there is a decrease in
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the yield of the 4-substituted cycloadduct 133 relative to that of the 5-substituted isomer 
132 of approximately 10% in the presence of the enzyme. Even if the reaction occurring 
on the enzyme is completely regiospecific for the 5-substituted regioisomer 132, this 
suggests 10% of the reaction is occurring on the enzyme.
In summary, catalysis of the cycloaddition reactions between the alkene 115 and 
benzonitrile oxide 114 and the alkene 129 and benzonitrile oxide 114 by Chymotrypsin 
was not conclusively established. There was, however, an indication that in both 
systems some reaction may have occurred on the enzyme. The reaction between the 
alkene 115 and benzonitrile oxide 114 in the presence of Chymotrypsin produced a 
greater amount of the product 127 than what was expected from the reaction between 
the unbound substrates 114 and 115 in the non-enzyme catalysed reaction, however, 
quantification of the product 127 was difficult due to the presence of impurities. The 
reaction between the alkene 129 and benzonitrile oxide 114 in the presence of 
Chymotrypsin was found to increase the ratio of the 5-substituted cycloadduct 132 to the 
4-substituted cycloadduct 133 and indicated that, if completely regioselective, about 
10% of the reaction occurs on the enzyme.
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Chapter Six
Conclusions
In Chapter 3, the development of a new assay for tyrosyl-tRNA synthetase was 
presented. The assay is simple, robust, does not require any coupling enzymes or extra 
reagents and produces little waste in comparison to the existing assays. The assay was 
also shown to be applicable to other enzymes that interconvert AMP 44, ADP 97 and 
ATP 39 such as pyruvate kinase and potato apyrase. To further develop the assay, 
automation of the quenching method would provide full automation and this could be 
achieved with an appropriate HPLC autosampler.
In Chapter 4, the investigation into tyrosyl-tRNA synthetase as a catalyst for the 
cycloadditon reaction between the azide 46 and the alkyne 47 was investigated, but 
catalysis was not detected in this system. The rate of the non-catalysed reaction was 
found to be too slow to be detected under the conditions used and even if catalysis was 
occurring it was not sufficient to increase the rate to a detectable level. Variation of the 
reaction conditions, as discussed on pages 95-96, was not likely to lead to a detectable 
level of catalysis. The experiment carried out highlighted the fact that only weak 
catalysis could be expected. It also highlighted some of the limitations placed on the 
reaction conditions by the binding affinities of the substrates. Had the Kj values of the 
azide 46 and the alkyne 47 been greater, the concentrations of the substrates could have
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been increased. This would have led to an increase in the rate of cycloaddition and may 
have allowed the products to be detected.
The results presented in Chapter 5 further highlighted the difficulties in relation 
to the development of enzyme catalysis of cycloaddtion reactions. A rate increase was 
not observed for the reaction between the alkene 115 and benzonitrile oxide 114 in the 
presence of Chymotrypsin. However, the results did show that in the presence of 
Chymotrypsin the yield of the cycloadduct 127 was greater than expected from the non­
enzyme catalysed reaction. If this effect was being caused by catalysis it would reflect a 
rate enhancement of 400 fold by Chymotrypsin. However, the yield of the product 127 
was not accurately determined due to impurities from the degradation of Chymotrypsin. 
If the reaction rate between the alkene 115 and benzonitrile oxide 114 had been greater 
the presence of the impurities would have been less of a problem as the product 127 
would have been more easily detected but the rate was dependent on the species used 
and could not be controlled. Increasing the concentration of the substrates would 
increase the rate of the non-enzyme catalysed reaction further which would mask any 
catalysis. Decreasing the concentration of Chymotrypsin, to lower the amount of 
impurities being formed, was also likely to have a negative effect as this would lower 
the amount of enzyme bound with both substrates, which was already less than 1%, 
under the conditions used, and would mean a greater rate enhancement would be 
required for catalysis to be detected.
The catalysis of the reaction between the acrylamide 129 and benzonitrile oxide 
114 was investigated as it was expected the reaction rate would be greater between these 
species than that between the alkene 115 and benzonitrile oxide 114. Again, catalysis 
was not observed in this system as it was established that the benzonitrile oxide 114 was
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reacting quickly in a competing reaction rather than the cycloaddition which prevented 
the rate of cycloaddition being determined. However, it was found that in the presence 
of Chymotrypsin there was a change in the regioselectivity of the reaction with 
approximately a 10% decrease in the yield of the 4-substituted regioisomer 133 relative 
to that of the 5-substituted regioisomer 132 which indicated that if completely 
regioselective 10% of the reaction may be occurring on the enzyme.
Together, the results show that enzyme catalysis of cycloaddition reactions is 
difficult and relies on a number of factors such as the stability of the reactants, the 
binding affinities of the substrates and the reaction rates. It seems that to achieve 
efficient catalysis through the increased local concentration of the substrates alone 
requires a significantly higher proportion of the enzyme to be bound with both 
substrates than that of those used in this study. To achieve this, higher concentrations of 
the substrates would be required, but as mentioned previously, increasing the 
concentration, especially above the Kj values of the substrates, leads to a higher 
proportion of substrate in solution rather than bound to the enzyme. This would increase 
the non-enzyme catalysed reaction rate which is likely to mask any catalysis. Obtaining 
a high proportion of enzyme bound with both the substrates at low substrate 
concentration would lead to more favourable conditions for achieveing catalysis but 
would require substrates that bind tightly to the enzyme. However, tight binding 
substrates are likely to form even tighter binding products. These are likely to inhibit the 
enzyme at early stages of reaction and prevent the binding of the substrates and further 
catalysis. In conclusion, it seems unlikely that efficient enzyme catalysis of 
cycloaddition reactions with appreciable substrate turnover can be achieved.
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Chapter Seven
Experimental
7.1 General
Melting points were determined using a Stanford Research Systems MPA 100 Optimelt 
Automated Melting Point apparatus.
'H and l3C NMR spectra were recorded on either a Varian Mercury 300 
spectrometer operating at 300 MHz for proton or 75 MHz for carbon; or a Varian Inova 
500 spectrometer operating at 500 MHz for proton or 125 MHz for carbon. Chemical 
shifts (5) are reported in parts per million (ppm) and coupling constants (7) are reported 
in Hertz. The multiplicities of NMR signals are reported as s, singlet; d, doublet; t, 
triplet; q, quartet; m, multiplet and br, broad. Deuterated solvents were purchased from 
Cambridge Isotope Laboratories. Chloroform-<7 (CDCI3) was referenced to 7.26 ppm for 
proton and 77.0 ppm for carbon spectra, methanol-^ (MeOD) was referenced to 3.30 
ppm for proton and 49.0 ppm for carbon spectra, dimethyl sulfoxide-^ ((CD^SO) was 
referenced to 2.49 ppm for proton and deuterated water (D2O) was referenced externally
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with a coaxial insert containing 3-(trimethvlsilyl)-3,3,2,2-tetradeuteropropionic acid 
sodium salt (c/4-TSPA) to 0.00 ppm for both proton and carbon spectra.
Electrospray ionisation mass spectrometry (ESI) was performed using a 
Micromass VG Quattro II mass spectrometer and a Waters LCT Premier XE 
spectrometer. Electron impact mass spectrometry (El) was performed using a 
Micromass VG AutoSpec M mass spectrometer. Mass spectral data are reported as 
mass-to-charge ratios {ml7) with their percentage abundance.
Elemental analyses were carried out by the Australian National University 
Microanalytical Service and were performed using a Carlo Erba 1106 Autoanalyser.
Analytical high performance liquid chromatography (HPLC) was carried out on 
a Waters Alliance 2695 Separations Module in conjuction with a Waters 2996 
photodiode array detector. An Alltech Alltima HP C18 5 pM (4.6 x 250 mm) column 
and Vydac Denali C18 5 pM (4.6 x 250 mm) column, each fitted with an Alltech 
Allguard HP C l8  guard cartridge, were used for analytical analyses. For semi­
preparative high performance liquid chromatography, a Waters 600 Controller, Waters 
717plus autosampler and a Waters Alliance 2996 photodiode array detector were used. 
A Waters SymmetryPrep C l8  7pM (19 x 300 mm) column and Alltech Alltima C18 5 
pM (10 x 250 mm) column were used for semi-preparative separations. The HPLC data 
were collected and processed using the Empower pro-Empower-2 software.
Thin layer chromatography (TLC) was performed using Merck Kiesel gel 
60 F254 aluminium-backed silica TLC plates. TLC plates were visualised under a UV 
lamp (254 nm) or developed with potassium permanganate or phosphomolybdic acid
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stain. Flash column chromatography was performed with Scharlau silica gel 60 (230- 
400 mesh ASTM).
Ultraviolet-visible spectra were recorded using a Shimadzu UV-2450 UV- 
Visible spectrophotometer or a labsystems Multiskan ascent plate reader.
Isothermal titration calorimetry (ITC) was carried out using a MicroCal VP-ITC 
MicroCalorimeter. The ITC data were collected and processed using Origin 7 software.
Fast protein liquid chromatography (FPLC) was carried out using an Amersham 
Biosciences ÄKTA FPLC system. Columns packed with DEAE or Q-sepharose gels, 
both obtained from GE Healthcare, were used for protein separations. The FPLC data 
were collected and processed using UNICORN 5.10 software.
All chemicals and enzymes were purchased from Sigma-Aldrich with the 
exception of butane-1,4-diol which was obtained from Fluka and tRNA from E. coli 
MRE 600 which was obtained from Roche. HPLC solvents were purchased from Merck 
and purified water was obtained using an Elga Purelab Classic UV water purification 
system.
7.2 Experimental for Chapter Two
l-Acetoxy-3-propanol 58
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Acetic anhydride (1.63 g, 16.0 mmol) was added dropwise to a rapidly stirred solution 
of 1,3-propanediol (5.00 g, 65.8 mmol), pyridine (1.43 g, 18.1 mmol) and 4- 
(dimethyiamino)pyridine (50 mg, 0.409 mmol) in DCM (30 mL). After 12 hours the 
mixture was washed with dilute hydrochloric acid (3 x 25 mL). The combined aqueous 
layers were saturated with sodium chloride and extracted with DCM (3 x 25 mL). The 
organic fractions were combined and dried over sodium sulphate and concentrated 
under reduced pressure. The crude material was chromatographed on silica gel, eluting 
with ethyl acetate/petrol (bp 40-60 °C) (40:60) to give the title compound 58 (1.39 g, 
74%) as a colourless oil.
'H NMR (300 MHz, CDCH): 6 4.16 (t, J = 6 Hz, 2H), 3.64 (t. J = 6 Hz, 2H), 2.87 (br s, 
1H), 2.02 (s, 3H), 1.82 (quin, 7 = 6 Hz, 2H). 13C NMR (75 MHz, CDCI3): d 171.6,61.4, 
58.9, 31.5, 20.9. The 1H NMR signals are consistent with literature data.77
3-Acetoxypropyl 4-methylbenzenesulfonate 66
66
p-Toluenesulphonyl chloride (4.86 g, 25.5 mmol) was added to a solution of 1-acetoxy- 
3-propanol 58 (2.00 g, 16.9 mmol) in dry pyridine (20 mL). The mixture was stirred
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overnight at 0 °C then diluted with water (50 mL) and extracted with DCM (3 x 50 mL). 
The combined organic extracts were dried over sodium sulphate and concentrated under 
vacuum to yield an oil which was subjected to column chromatography, eluting with 
ethyl acetate/petrol (bp 40-60 °C) (50:50) to give the title compound 66 (2.83 g, 61 %) 
as a colourless oil.
'H NMR (300 MHz, CDC13): 6 7.76 (d, J  = 8.4 Hz, 2H), 7.33 (d, J  = 7.8 Hz, 2H), 4.06 
(m,4H), 2.43 (s, 3H), 1.95 (m, 2H), 1.94 (s, 3H). 13C NMR (75 MHz, CDC13): 6 170.7, 
144.9, 132.7, 129.8, 127.9, 66.7, 60.0, 28.0, 21.6, 20.7. MS (ESI) (+ve): 295 m/z 
([M+Na]\ 80%). HRMS (ESI) calcd. for C12H16Na05S [M+Na|+ 295.0616 m/z, found 
295.0616.
9-(3-Acetoxypropyl)adenine 64
64
To a stirred solution of 3-acetoxy propyl 4-methylbenzenesulfonate 66 (2.50 g, 9.18 
mmol) in DMF (20 mL) was added caesium carbonate (2.99 g, 9.21 mmol), adenine
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(0.957 g, 7.08 mmol) and tetrabutylammonium iodide (0.10 g, 0.271 mmol). The 
mixture was stirred overnight at 70 °C under an atmosphere of nitrogen then diluted 
with water (50 mL) and extracted with diethyl ether (3 x 20 mL). The combined ether 
extracts were dried over sodium sulphate and the crude material was chromatographed 
on silica gel, eluting with methanol/DCM (6:94) to give the title compound 64 (0.848 g, 
51 %) as an off white solid.
Mp. 160-161 °C 'H NMR (300 MHz, CDCI3): 6  8.36 (s, 1H), 7.81 (s, 1H), 5.85 (br s, 
2H), 4.31 (t. J  = 6.9 Hz, 2H), 4.10 (t, J = 6 Hz, 2H), 2.52 (m, 2H), 2.04 (s, 3H). I3C
NMR (75 MHz, CDCI3): 6  170.8, 155.6, 152.9, 149.9, 140.4, 119.7, 61.1,40.9, 28.9, 
20.8. MS (ESI) (+ve): 236 mJz ([M+H]+, 100%). The 'H NMR signals are consistent 
with literature data.
9-(3-Hydroxypropyl)adenine 67
67
To a suspension of 9-(3-acetoxypropyl)adenine 64 (100 mg, 0.43 mmol) in methanol (5 
mL) was added lithium hydroxide monohydrate (26.0 mg, 0.62 mmol). The mixture was
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stirred for 20 minutes at room temperature then concentrated in vacuo. The crude solid 
was chromatographed on silica gel, eluting with methanol/DCM (10:90) to give the title 
compound 67 (77.0 mg, 93%) as a white solid.
Mp. 210-213 °C (lit,82 215-216 °C) lU NMR (300 MHz, CD3OD): 6 8.19 (s, 1H), 8.12 
(s, 1H), 4.34 (t, J = 6.9 Hz, 2H), 3.45 (t, J = 6 Hz, 2H), 2.06 (quin, J = 6.9 Hz, 2H). MS 
(ESI) (+ve): 194 m/z ([M+H]+, 100%).
9-(Propanaloxime)adenine 52
52
To a solution of 9-(3-hydroxypropyl)adenine 67 (40.0 mg, 207 pmol) in dry DMSO (1 
mL) was added A,A’-dicyclohexylcarbodiimide (128 mg, 621 pmo\) and dichloroacetic 
acid (13.4 mg, 104 pmol) whilst being cooled on an ice bath. After stirring for 90 
minutes under a nitrogen atmosphere oxalic acid dihydrate (52.2 mg, 414 pmo\) was 
added. The mixture was stirred for a further 20 minutes, then sodium acetate (31.3 mg, 
382 pmo\) and hydroxylamine hydrochloride (14.8 mg, 212 pmol) were added. The 
mixture was removed from the ice bath and allowed to warm to room temperature 
overnight and stirring was continued. The solution was concentrated under a stream of
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nitrogen gas, resuspended in DCM (30 mL) and filtered. The filtrate was extracted with 
water (3 x 20 mL) and concentrated to dryness. The crude material was crystallised 
from methanol to give the title compound 52 (12.0 mg, 28%) as white crystals.
'H NMR (300 MHz, CD3OD): 6 8.21 (s, 0.5H), 8.20 (s, 0.5H), 8.13 (s, 0.5H), 8.11 (s, 
0.5H), 7.38 (t, J = 5.5 Hz, 0.5H), 6.74 (t, J = 5.5 Hz, 0.5H), 4.43 (t, J = 6.9 Hz, 2H), 
2.93 (m, 1H), 2.74 (m, 1H). MS (ESI) (+ve): 207 m/z ([M+H]+, 100%). HRMS (ESI) 
cal cd. for C8HnN60  [M+H]+ 207.0994 m/z, found 207.0996.
I-Acetoxy-5-pentanol 69
69
Acetic anhydride (19.6 g, 192 mmol) was added dropwise to a rapidly stirred solution of 
1,5-pentanediol (20 g, 192 mmol), pyridine (37.9 g, 480 mmol) and 4- 
(dimethylamino)pyridine (230 mg, 1.92 mmol) in DCM (200 mL). After 24 hours the 
mixture was washed with 1 M hydrochloric acid (2 x 100 mL) and water (2 x 100 mL). 
The combined organic layers were dried over sodium sulfate and concentrated under 
reduced pressure. The crude material was chromatographed on silica gel, eluting with
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ethyl acetate/petrol(bp 40-60 °C) (50:50) to give the title compound 69 (6.02 g, 21%) as 
a colourless oil.
'H NMR (300 MHz, CDC13): 6 4.06 (t, J  = 6.6 Hz, 2H), 3.65 (t, J  =  6.6 Hz, 2H), 2.04 
(s,3H), 1.63 (m, 5H), 1.44 (m, 2H). MS (ESI) (+ve): 169 (|M +Na|\ 10%). The'H
NMR signals are consistent with literature data.“
1,5-Pentanediol 1-acetate 5-(/?-toluenesulfonate) 70
70
To a stirred solution of p-toluenesulfonyl chloride (3.43 g, 18.0 mmol) in pyridine (30 
mL) was added dropvvise a solution of 5-acetoxy-l-pentanol 69 (1.73 g, 11.8 mmol) in 
pyridine (5 mL). The mixture was stirred overnight at 0 °C then diluted with water (50 
mL) and extracted with ethyl acetate (3 x 50 mL). The combined organic extracts were 
washed with water (3 x 50 mL) and hydrochloric acid then dried over sodium sulphate. 
The solution was concentrated under vacuum to give an oil which was subjected to 
column chromatography, eluting with ethyl acetate/petrol(bp 40-60 °C) (20:80 then 
40:60) to yield the title compound 70 (1.42 g, 40%) as a pale yellow oil.
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'H NMR (300 MHz, CDC13): 8 7.75 (m, 2H), 7.32 (m, 2H), 3.98 (m, 4H), 2.42 (s, 3H), 
2.00 (s, 3H), 1.64 (m, 2H), 1.55 (m. 2H), 1.36 (m, 2H). MS (ESI) (+ve): 323 m/z 
(|M+Na]+, 100%). The 'H NMR signals are consistent with literature data.*7
9-(5-Acetoxypentyl)adenine 71
To a stirred solution of 1,5-pentanediol 1-acetate 5-(/?-toluenesulfonate) 70 (1.00 g, 3.33 
mmol) in dry DMF (20 mL) was added caesium carbonate (1.30 g, 4.00 mmol), adenine 
(540 mg, 4.00 mmol) and tetrabutylammonium iodide (123 mg, 333 pmo\). The mixture 
was stirred overnight at 80 °C under an atmosphere of nitrogen then diluted with water 
(100 mL) and extracted with DCM (3 x 30 mL). The combined organic extracts were 
dried over sodium sulfate and concentrated in vacuo to give a white solid which was 
crystallised from DCM to yield the title compound 71 (0.314 g, 36%) as a white 
crystalline solid.
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Mp. 150-152 °C (lit,85 154 °C) ‘H NMR (300 MHz, CD3OD): 6 8.20 (s, 1H), 8.13 (s, 
1H), 4.24 (t, 7=6.9, 2H), 4.03 (t, 7 = 6.3 Hz, 2H), 1.98 (s, 3H), 1.91 (m, 2H), 1.67 (m, 
2H), 1.38 (m,2H). MS (ESI) (+ve): 264 m/z (|M+H|+, 100%).
9-(5-Hydroxypentyl)adenine 72
To a suspension of 9-(5-acetoxypentyl)adenine 71 (314 mg, 1.19 mmol) in methanol (30 
mL) was added lithium hydroxide monohydrate (60.2 mg, 1.43 mmol). The mixture was 
stirred overnight at room temperature then concentrated in vacuo. The crude solid was 
chromatographed on silica gel eluting with methanol/DCM (20:80) to give the title 
compound 72 (231 mg, 88%) as a white solid.
Mp. 193-194 °C (lit,84 194-195 °C). *H NMR (300 MHz, CD3OD): Ö 8.19 (s, 1H), 8.13 
(s, 1H), 4.24 (t, 7 = 6.9 Hz, 2H), 3.45 (t, 7 = 6.3 Hz, 2H), 1.90 (m, 2H), 1.57 (m, 2H), 
1.39 (m, 2H). 13C NMR (75 MHz, CD3OD): 6 157.3, 153.6, 150.6, 142.7, 120.0, 62.5, 
44.9, 32.9, 30.9, 23.9. MS (ESI) (+ve): 222 m/z ([M+Hf, 100%). HRMS (ESI) calcd.
149
Chapter 7
for CioH16N50  |M+HI+ 222.1355 m/z, found 222.1354. Anal, calcd. for C10H15N5O: C, 
54.28; H, 6.83; N, 31.65. Found: C, 54.47; H, 6.88; N, 31.70%.
9-(Pentanaloxime)adenine 50
To a solution of 9-(5-hydroxypentyl)adenine 72 (231 mg, 1.04 mmol) in dry DMSO (20 
mL) was added MN’-dicyclohexylcarbodiimide (647 mg, 3.14 mmol) and 
dichloroacetic acid (67.0 mg, 520 pmol) whilst being cooled on an ice bath. After 
stirring for 90 minutes under a nitrogen atmosphere, oxalic acid dihydrate (264 mg, 2.09 
mmol) was added. The mixture was stirred for a further 20 minutes, then sodium acetate 
(129 mg, 1.57 mmol) and hydroxylamine hydrochloride (109 mg, 1.57 mmol) were 
added. The mixture was removed from the ice bath and allowed to warm to room 
temperature overnight. The solution was then concentrated under a stream of nitrogen 
gas, resuspended in DCM (30 mL) and filtered. The filtrate was extracted with water (3 
x 20 mL) and the combined extracts were concentrated under reduced pressure to yield 
a solid. The crude material was subjected to high performance liquid chromatography to 
give the title compound 50 (46 mg, 19%) as a white solid.
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‘H NMR (300 MHz, CD3OD): 5 8.20 (s, 1H), 8.15 (s, 1H), 7.33 (t, J  = 5.6 Hz, 0.5H), 
6.45 (t, 7 = 5.6 Hz, 0.5H), 4.26 (m, 2H), 2.39 (m, 1H),2.21 (m, 1H), 1.91 (m, 2H), 1.50 
(m, 2H). MS (ESI) (+ve): m/z 235 (|M+H)+, 90%). HRMS (ESI) calcd. for C i0H i6N6O 
[M+H|+ 235.1307 m/z, found 235.1304.
HPLC: tu 17.0 to 22 min (column: Alltech Alltima C18 5u, 250 x 10 mm; (25:75) 
methanohO.l % TFA in water; flow rate: 4 mL min“1)
1,4-Butanediol di-/?-toluenesulfonate 74
To a stirred solution of p-toluenesulfonyl chloride (23.3 g, 122 mmol) in pyridine (100 
mL) was added dropwise butane-1,4-diol (4.50 g, 50.0 mmol). The mixture was stirred 
for 3 hours at 0 °C then was placed in a refrigerator overnight. Water (20 mL) was 
added and the solution was concentrated to two thirds of the volume under reduced 
pressure. A further portion of water (40 mL) was added and the mixture was extracted 
with ethyl acetate (4 x 50 mL). The combined organic fractions were washed with water 
(3 x 50 mL) and 1 M hydrochloric acid until the extract remained acidic. The solvent 
was removed in vacuo and the crude solid was crystallised from petrol (bp 40-60 °C) 
and dichloromethane to yield the title compound 74 (7.11 g, 36%) as white plates.
TsO
74
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Mp. 70-72 °C (lit,88 65-68 °C) 'H NMR (300 MHz, CDC13): 6 7.76 (d, J  = 6.6 Hz, 4H), 
7.36 (d, J  = 6.6 Hz, 4H), 3.98 (m, 4H), 2.45 (s, 6H), 1.69 (m, 4H) MS (ESI) (+ve): 399 
m/z (|M+H)+,10%). HRMS (ESI) calcd. for C18H23N06S2 (M+H]+ 399.0936 m/z, found 
399.0956.
4-Azidobutyl 4-methylbenzenesulfonate 75
75
To a solution of 1,4-Butanediol di-/?-toluenesulfonate 74 (5.00 g, 12.6 mmol) in DMF (8 
mL) was added sodium azide (0.815 g, 12.6 mmol). The mixture was stirred overnight 
at room temperature and quenched by the addition of 20 mL of water. The solution was 
extracted with ethyl acetate (3 x 30 mL). The combined organic layers were dried over 
sodium sulfate and filtered. The solution was concentrated under vacuum to yield an oil 
which was purified by flash column chromatography on silica gel, eluting with ethyl 
acetate/petrol (bp 40-60 °C) (15:85) to yield the title compound 75 (1.24 g, 36.7%) as a 
colourless oil.
'H NMR (300 MHz, CDCb): 6 7.79 (d, J  = 8.4 Hz, 2H), 7.34 (d, J = 8.7 Hz, 2H), 4.04 
(t, 7 = 6.3 Hz, 2H), 3.26 (t, J = 6.3 Hz, 2H), 2.45 (s, 3H), 1.61 (m, 2H), 1.74 (m, 2H). 
'•’C NMR (75 MHz, CDC13): 5 145.1, 133.1, 130.1, 128.1,69.9, 50.9, 26.3,25.2,21.9.
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MS (ESI) (+ve): 292 m/z ([M+Na|+, 15%). HRMS (ESI) calcd. for C,iHi5N3Na03S 
[M+Na]+ m/z 292.0731, found 292.0726. IR: 2099, 1598, 1358, 1189, 1176 cm'1. Anal. 
Calcd. for C11H15N3O3S: C, 49.06; H, 5.61; N, 15.60, S 11.90. Found; C, 49.06; H, 5.56; 
N, 15.74; S, 11.60%.
9-(4-Azidobutyl)-adenine 46
To a suspension of 4-azidobutyl 4-methyl benzenesulfonate 75 (1.00 g, 3.72 mmol) and 
adenine (0.602 g, 4.46 mmol) in DMF (12 mL) was added caesium carbonate (1.45 g, 
4.46 mmol). The mixture was stirred for 6 days at room temperature and quenched by 
the addition of water (50 mL). The solution was extracted with ethyl acetate (3 x 50 
mL) and the combined organics were washed once with water (50 mL) and dried over 
sodium sulfate. The solution was filtered and concentrated in vacuo to give a solid 
which was purified by flash column chromatography eluting with methanol/DCM (8:92) 
to yield the title compound 46 (0.430 g, 49.8%) as an off white solid.
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Mp. 126-127 °C. 'H NMR (300 MHz, CDC13): ö 8.33 (s, 1H), 7.81 (s, 1H), 6.41 (br s, 
2H), 4.23 ( t , ./ = 7.2 Hz, 2H), 3.33 (t, J  = 6.9 Hz, 2H), 1.98 (m, 2H), 1.60 (m, 2H). ,3C 
NMR (75 MHz, CD3OD): Ö 155.7, 155.6, 149.9, 140.1, 119.5, 50.7, 43.2, 27.4, 25.9. 
MS (ESI) (+ve): 233 mtz ([M+H]+, 30%). HRMS (ESI) calcd. for C9H i3N8 [M+H]+ 
233.1263 m/z, found 233.1261. IR: 2098, 1668. 1599, 1574 cm’1. Anal, calcd. for 
C9H i2N8: C, 46.54; H, 5.21; N, 48.25. Found: C, 46.53; H, 5.30; N, 48.17%.
9-(2-Azidoethyl)-adenine 76
To a stirred solution of 2-bromoethanol (0.50g, 4.0 mmol) in ethanol was added sodium 
azide (0.39 g, 6 mmol). The solution was heated to reflux for 48 hours then the solution 
was concentrated in vacuo. The crude product mixture was suspended in pyridine (10 
mL) and /?-toluenesulfonyl chloride (1.14g, 6 mmol) was added. The solution was 
cooled on an ice bath and stirred overnight. Water (10 mL) was added to the solution 
which was then extracted with ethyl acetate (3 x 15 mL), the organic layers were 
combined, dried over sodium sulfate and concentrated under vacuum. The crude 
material was suspended in dry DMF (1 mL) then adenine (20.8 mg, 0.15 mmol) and
76
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caesium carbonate (65 mg, 0.2 mmol) were added. The mixture was stirred with heating 
to 70 °C overnight. Water (20 mL) was added and the solution was extracted with DCM 
(3 x 20 mL), the organic layers were combined, dried over sodium sulfate and 
concentrated under reduced pressure. The crude material was subjected to flash column 
chromatography eluting with 8% methanol 92% DCM. The resulting material was then 
crystallised from chloroform to yield the title compound 76 (7 mg, 23%) as colourless 
plates.
lH NMR (300 MHz, CDC13): 6 8.34 (s, 1H), 7.86 (s, 1H), 6.37 (br s, 2H), 4.34 (t, J  = 
5.4 Hz, 2H), 3.80 (t, J  = 5.4 Hz, 2H). The ‘H NMR signals are consistent with literature 
data.90
Af,ö-I)i-(ter/-butoxycarbonyl)-(S)-tyrosine 80
80
To a suspension of (S)-tyrosine (5.00 g, 27.6 mmol) in water (62.5 mL) and isopropanol 
(37.5 mL) was added di-rm-butyldicarbonate (18.0 g, 82.8 mmol). The solution was 
stirred at room temperature whilst the pH was adjusted with a solution of 8 M potassium 
hydroxide to pH 12. The pH was maintained for 4 hours then water (lOOmL) was added
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and the solution was extracted with diethyl ether (3 x 50 mL). The combined ether 
extracts were then extracted with 0.1 M sodium hydroxide solution (3 x 50 mL). The 
combined aqueous layers were acidified to pH 2 with hydrochloric acid (170 mL, 1 M) 
and extracted with ethyl acetate (3 x 200 mL). The organic layer was dried over sodium 
sulphate, filtered, and then concentrated in vacuo. The crude solid was subjected to 
column chromatography on silica gel, eluting with dichloromethane and methanol 
(100:0 to 95:5). The solid was then crystallised from petrol (bp 40-60 °C) and 
dichloromethane to yield the title compound 80 (5.90 g, 56%) as white needles.
Mp. 104-106 °C (lit,92 95-97 °C). 'H NMR (300 MHz, CD,OD): 6 7.25 (d. J = 8.1 Hz, 
2H), 7.04 (d ../ = 8.1 Hz, 2H), 3.43 (dd, J = 8.7, 4.8 Hz, 1H), 3.15 (dd, J  = 14.1,5.1 Hz, 
1H), 2.90 (dd, ./ = 13.5, 9 Hz, IH), 1.51 (s, 9H), 1.37 (s, 9H). I3C NMR (75 MHz, 
CDjOD): 6 174.1, 156.6, 152.3, 150.2, 135.1, 130.2, 121.0. 83.1,79.4, 55.0, 36.8, 27.4, 
26.8. MS (ESI) (+ve): m/z 404 (|M +N a|+). HRMS (ESI) calcd. for C]9H27NNa0 7  
[M+Na|+ m/z 404.1685, found 404.1689. Anal, calcd. for C 19H27N07: C, 59.83; H, 
7.13; N, 3.67. Found: C, 59.98; H, 7.05; N, 3.45%.
Af/?-Di-(terFbutoxycarbonyI)-(S)-tyrosine propargy lamide 81
BocO-
BocHN
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To a solution of yV,0-di-(r<?rr-butoxycarbonyl)-(S)-tyrosine 80 (2.50 g, 6.56 mmol) in 
DCM (60 mL) stirred at 0 °C was added propargylamine (0.434 g, 7.87 mmol), 1- 
hydroxybenzotriazole hydrate (0.886 g, 6.56 mmol) and /V-(3-dimethylaminopropyl)-./V'- 
ethylcarbodiimide hydrochloride (1.27 g, 6.62 mmol). The solution was allowed to 
warm to room temperature and left to stir overnight. The mixture was washed with 0.5 
M hydrochloric acid (3 x 50 mL), saturated sodium hydrogen carbonate solution (3 x 50 
mL) and water (3 x 50 mL). The organic layer was dried over sodium sulfate and 
concentrated under reduced pressure. The crude solid was crystallized from ethanol to 
yield the title compound 81 (1.76 g, 64%) as white needles.
Mp. 155-156 °C. 'll  NMR (300 MHz, CDC13): b 7.25 (d, J  = 8.1 Hz, 2H), 7.04 (d, J  = 
8.1 Hz, 2H), 6.28 (m, lH ),5 .04(m , lH ),4 .32(m , 1H), 3.97 (d, J = 2.4 Hz, 2H), 3.04 (d, 
J = 6 Hz, 2H), 2 .19 (t, J  = 2.4 Hz, 1H), 1.54 (s, 9H), 1.39 (s, 9H). 13C NMR (75 MHz, 
CDC13): 6 170.9, 155.4, 151.8, 149.9, 133.9, 130.3, 121.4, 83.6, 80.4, 78.9, 71.7, 55.5, 
37.7, 29.0, 28.2, 27.6. MS (ESI) (+ve): 419 m/z (|M+H1+, 20%). HRMS (ESI) calcd. 
for C22H3oN2Na06 |M+Na]+ 441.2000 m/z, found 441.2000. Anal, calcd. for 
C22H3oN20 6: C, 63.14; H, 7.23; N, 6.69. Found: C, 63.08; H, 7.05; N, 6.57 %.
(S)-Tyrosine propargylamide hydrochloride 47
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Compound 81 (1.00 g, 2.39 mmol) was suspended in a solution of hydrochloric acid in 
dioxane (20 mL, 4 M) and stirred at room temperature. After 2 hours the solvent was 
removed in vacuo to yield a crude solid which was subjected to flash column 
chromatography, eluting with DCM/methanol (80:20) to afford the title compound 47 
(0.350 g, 57%) as a viscous oil.
'H  NMR (300 MHz, CD3OD): Ö 7.01 (d, J = 8.4 Hz, 2H), 6.71 (d, J = 8.4 Hz, 2H), 3.91 
(d, J = 2.4 Hz. 2H), 3.45 (t, J = 6.7 Hz, 1H), 2.87 (dd. J = 13.5, 6.3 Hz, 1H), 2.66 (dd, J 
= 13.2, 6.3, 1H), 2.57 (t, J = 2.4 Hz, 1H). 13C NMR (75 MHz, CD3OD): 175.2, 156.3, 
130.4, 127.4, 115.4, 79.0, 71.4, 56.2, 39.7, 28.4. MS (ESI) (+ve): 219 mlz (|M-C1]+, 
30%). HRMS (ESI) calcd. for C ^ H ^ C h  IM -ClT 219.1133 mlz, found 219.1134.
Af/?-Di-(ter^butoxycarbonyl)-(S)-tyrosyl-(/?S)-serine methyl ester 82
BocO-
BocHN
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To a stirred solution of (/?S)-serine methyl ester hydrochloride (1.23 g, 7.87 mmol) in 
dry DCM (20 mL) was added triethylamine (0.95 g, 9.39 mmol). The mixture was 
stirred for 1 hour then was added to a solution of N,0-d\-(tert-butoxycarbony\)-(S)- 
tyrosine 80 (3.00 g, 7.87 mmol), 1-hydroxybenzotriazole (1.06 g, 7.87 mmol) and N-(3- 
dimethylaminopropyl)-iV'-ethylcarbodiimide hydrochloride (1.51 g, 7.87 mmol) in dry 
DCM (50 mL) whilst being cooled on an ice bath. The mixture was stirred overnight 
under a nitrogen atmosphere and allowed to warm to room temperatue. The mixture was 
washed successively with 0.5 M HC1 (3 x 50 mL), saturated NaHCCL solution (3 x 50 
mL) and water (3 x 50 mL) then dried over sodium sulphate. The solution was then 
concentrated under vacuum and subjected to column chromatography on silica gel, 
eluting with methanohDCM (5:95) to yield the title compound 82 (2.54 g, 67%) as a 
white crystalline solid.
Mp. 58-79 °C. ‘H NMR (300 MHz, CDCI3): 5 7.27 (m, 2H), 7.04 (m, 2H), 4.51 (m, 
1H), 4.37 (dd, J = 9.0, 3.9 Hz, 1H), 3.92-3.68 (m, 2H), 3.74 (s, 1.5H), 3.72 (s, 1.5H), 
3.14 (dd, J = 13.8, 5.1 Hz, 1H), 2.84(m, 1H), 1.53 (s, 9H), 1.39 (s, 9H). ,3C NMR (75 
MHz, CDCI3): 5 171.2, 170.5, 170.5, 155.6, 155.3, 152.6, 152.0, 150.0, 149.8, 134.5, 
133.9, 130.3, 130.3, 121.8, 121.5, 84.2, 83.7, 80.6, 80.4, 62.6, 62.5, 56.27, 55.7, 54.7, 
53.6, 52.7, 38.7, 28.3, 28.2, 27.6, 27.6. MS (ESI) (+ve): m/z 505 ([M+Na|+, 100%). 
HRMS (ESI) cal cd. for C23H35N2O9 |M+H|+ m/z 483.2343, found 483.2339. Anal, 
calcd. for C r ^ N T V  C, 57.25; H, 7.10; N, 5.81. Found: C, 57.44; H, 7.10; N, 5.77%.
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A/?-Di-(te/7-butoxycarbonyl)-(S)-tyrosyl-0-benzoyl-ORS)-serine methyl ester 83
BocO
BocHN
To a solution of A^,0-di-(^rr-butoxycarbonyl)-(5')-tyrosine-(/?5')-serine methyl ester 82 
(3.5 g, 7.26 mmol) in DCM (40 mL) was added triethylamine (2.57 g, 25.4 mmol) 
followed by benzoyl chloride (2.52 g, 17.9 mmol). The mixture was stirred for 3 hours 
at room temperature then washed with saturated NaHC03 solution (3 x 30 mL) then 
dried over sodium sulphate. The solution was concentrated under reduced pressure and 
the crude material was chromatographed on silica gel, eluting with ethyl 
acetate/petrol (bp 40-60 °C) (40:60) to give the title compound 83 (3.14 g, 74%) as an 
off-white solid.
Mp. 93-108 °C. *H NMR (300 MHz, CDC13): 6 7.94 (m, 2H), 7.54 (m, 1H), 7.40 (m. 
2H), 7.19-7.00 (m, 5H), 5.13 (m, 1H), 4.90 (m, 1H), 4.65-4.42 (m, 3H), 3.74 (s, 1.5H), 
3.72 (s, 1.5H) 3.06 (m, 2H), 1.52 (s, 9H), 1.34 (s, 9H). 13C NMR (7.5 MHz, CDC13): 8 
171.23, 171.18, 169.6, 169.4, 169.1, 165.99, 165.91, 155.5, 155.4, 155.3, 151.7, 150.0, 
149.9, 133.9, 133.83, 133.3, 133.2, 130.2, 130.0, 129.7, 129.21, 129.18, 128.4, 128.3, 
121.4, 83.5, 83.4, 80.4, 64.3, 64.2, 55.9, 55.4, 52.90, 52.89, 51.9, 51.7, 37.2, 28.1, 27.6. 
MS (ESI) (+ve): mlz 609 ([M+Na]+, 100%). HRMS (ESI) calcd. for C30H38N2OioNa 
|M+Na|+ mlz 609.2424, found 609.2433. Anal, calcd. for C3oH3bN2Oio: C,61.42; H, 
6.53; N, 4.87. Found: C, 61.28; H, 6.43; N, 4.57%.
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A(,0-Di-(terTbutoxycarbonyl)-(*S)-tyrosinedehydroalanine methyl ester 84
BocO-
BocHN
To a solution of A^,0-di-(^rf-butoxycarbonyl)-(5')-tyrosine-0-benzoyl-(/?5')-serine 
methyl ester 83 (1.00 g, 1.70 mmol) in DCM (50 mL) was added dropvvise 1,8- 
diazabicyclof 5.4.0 ]undec-7-ene (0.31 g, 2.05 mmol). The mixture was stirred overnight 
under a nitrogen atmosphere then concentrated under reduced pressure. The crude 
material was subjected to column chromatography, eluting with ethyl acetate/petrol(bp 
40-60 °C) (30:70) to give the title compound 84 (580 mg, 73%) as awhite solid.
Mp. 47-49 °C. 'H NMR (300 MHz, CDC13): 8 8.24 (br s, 1H), 7.19 (m, 2H), 7.11 (m, 
2H), 6.59 (s, 1H), 5.88 (s, 1H), 5.02 (br d, J = 6.3 Hz, 1H), 4.43 (m, 1H), 3.79 (s, 3H), 
3.10 (d, J = 6.3 Hz, ,2H) 1.53 (s, 9H), 1.40 (s, 9H). 13C NMR (125 MHz, CDC13): 5
169.9, 163.9, 155.3, 151.8, 150.1, 133.7, 130.5, 130.2, 121.5, 109.3, 83.6, 80.6, 56.3,
52.9, 37.2, 28.2, 27.7. MS (ESI) (+ve): m/z 487 (|M +Na|\ 100%). HRMS (ESI) calcd. 
for C23H33N20 8 [M+H]+ m/z 465.2237, found 465.2220. Anal, calcd. for C23H32N2Os: 
C, 59.47; H, 6.94; N, 6.03. Found: C, 59.41; H, 6.93; N, 6.12%.
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(S)-Tyrosinedehydroalanine methyl ester trifluoroacetate 49
A^,0-Di-(/m-butoxycarbonyl)-(5')-tyrosinedehydroalanine methyl ester 84 (0.58 g, 1.25 
mmol) was suspended in a solution of trifluoroacetic acid (2 mL) and DCM (50 mL) 
and stirred for 5 hours. The mixture was concentrated in vacuo to yield the title 
compound 49 (199 mg, 42%) as a yellow oil.
'H NMR (300 MHz, CD3OD): 5 7.09 (m, 2H), 6.76 (m, 2H), 6.38 (s, 1H), 5.94 (s, 1H), 
4.26 (t, J = 6.9 Hz, 1H), 3.79 (s, 3H), 3.06 (m, 2H). ,3C NMR (75 MHz, CD3OD): 5 
168.9, 164.8, 158.1, 132.8, 131.5, 125.8, 116.8, 112.5, 56.2, 53.3, 37.8. MS (ESI) 
(+ve): m/z 265 ([M-CF3CO2T ,25%). HRMS (ESI) calcd. for Ci3H17N20 4 [M-CF3CO2 
]+ m/z 265.1188, found 265.1184.
7.3 Experimental for Chapter Three
7.3.1 General
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Enzyme assays were carried out at 37 °C in reaction buffer (40 mM Tris-HCl buffer (pH 
7.6) with 0.8 mM magnesium chloride and 3.2 mM potassium chloride).
7.3.2 EnzChek' pyrophosphate assay conditions
A typical analysis mixture was prepared in a quartz cuvette and contained 2- 
amino-6-mercapto-7-methylpurine-ribonucleoside 86 (63 pg, 200 nmol), inorganic 
pyrophosphatase (0.03 units) and purine nucleoside phosphorylase (1 unit), tyrosine 38 
(1.81 pg, 10 nmol), ATP disodium salt 39 (551 pg, 1 pmol) and tRNA (mixture from E. 
coli MRE 600) (100 pg) in reaction buffer and was incubated at 37 °C for 10 minutes 
before the addition of tyrosyl-tRNA synthetase (474 ng, 10 pmol) which brought the 
total reaction volume to 1 mL. The absorbance of the reaction mixture at 360 nm was 
monitored using a UV-Visible spectrophotometer.
7.3.3 PjPer™ Pyrophosphate assay conditions
A typical set of analyses were conducted in a 96-well microplate with each reaction 
mixture containing 10-acetyl-3,7-dihydroxyphenoxazine 95 (1.29 pg, 5 nmol), maltose 
phosphorylase from E. coli (0.2 units), maltose (7.2 pg, 20 nmol), glucose oxidase from 
Asperigillus niger (0.1 units), horseradish peroxidase (0.02 units), tyrosine 38 (0.45 pg,
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2.5 nmol), ATP disodium salt 39 (138 jig, 0.25 pmol) and tRNA (mixture from E. coli 
MRE 600) (17.5 jag). The reactions were initiated by the addition of tyrosyl-tRNA 
synthetase (47.4 ng -  47.4 jag, 1.0 pmol -  1.0 nmol) which brought the total reaction 
volume to 100 pL. The absorbance of the reaction mixture at 540 nm was monitored 
using a microplate reader.
7.3.4 AMP assay conditions
A typical analysis mixture was prepared in a quartz cuvette and contained lactic 
dehydrogenase from rabbit muscle (5 units), pyruvate kinase from rabbit muscle (5 
units), myokinase from rabbit muscle (5 units), phosphoenol pyruvic acid 
monopotassium salt 98 (0.21 mg, 1.0 pmol), NADH dipotassium salt 100 (0.14 mg, 200 
nmol), tyrosine 38 (18 pg, 100 nmol), ATP disodium salt 39 (551 pg, 1 pmol) and 
tRNA (mixture from E. coli MRE 600) (2.5 mg) in reaction buffer and was incubated at 
37 °C for 3 minutes before the addition of tyrosyl-tRNA synthetase (23.7 pg, 0.5 nmol) 
which brought the total reaction volume to 1 mL. The absorbance of the reaction 
mixture at 340 nm was monitored using a UV-Visible spectrophotometer.
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7.3.5 AMP HPLC assay conditions
7.3.5.1 Assay for tyrosyl-tRNA synthetase
A typical reaction mixture was prepared in a 0.5 mL microcentrifuge tube and contained 
tyrosine 38 (2.2 pg, 12 nmol), ATP disodium salt 39 (33 pg, 60 nmol) and tRNAlyr (2.4 
nmol) in reaction buffer and was incubated at 37 °C for 3 minutes before the addition of 
tyrosyl-tRNA synthetase (0.43 pg, 2.4 nmol) which brought the total reaction volume to 
60 pL. At 30 second intervals a 10 pL aliquot was taken from the reaction mixture and 
quenched into a 10 pL volume of sodium dodecylsulfate solution (0.02% w/v) 5 pL of 
which was analysed by HPLC using an Alltech Alltima C18 5pM analytical column 
fitted with a matching guard column and eluted with 60 mM ammonium phosphate pH 
5.0 with 5 mM tetrabutylammonium phosphate (A) and 5 mM tetrabutylammonium 
phosphate in methanol (B) under the isocratic conditions of 82% A to 18% B. The ratio 
of the AMP 44 peak area Cr = 5.2 min) to the ATP 39 peak area (4> = 14.3 min) in the 
HPLC chromatograms was used to calculate the amount of AMP 44 produced at each 
time point.
7.3.5.2 Assay for pyruvate kinase
A typical reaction mixture was prepared in a 1.5 mL microcentrifuge tube and contained 
ADP disodium salt 97 (0.5 mg, 1.0 pmol) and phosphoenol pyruvic acid 
monopotassium salt 98 and was incubated at 37 °C for 3 minutes before the addition of
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pyruvate kinase from rabbit muscle (1 unit) which brought the total reaction volume to 1 
mL. At 1 minute intervals a 20 pL aliquot was taken and quenched into a 20 pL volume 
of sodium dodecylsulfate solution (0.02% w/v) which was analysed by HPLC using an 
Alltech Alltima C l8 5pM analytical column fitted with a matching guard column and 
eluted with 60 mM ammonium phosphate pH 5.0 with 5 mM tetrabutylammonium 
phosphate (A) and 5 mM tetrabutylammonium phosphate in methanol (B) under the 
isocratic conditions of 82% A to 18% B. The ratio of the ADP 97 peak area (tu = 8.1 
min) to the ATP 39 peak area (tu = 14.3 min) in the HPLC chromatograms was used to 
calculate the amount of ATP 39 produced at each time point.
7.3.5.3 Assay for potato apyrase
A typical reaction mixture was prepared in a Waters total recovery HPLC vial and 
contained ADP monoptassium salt 97 (0.5 mg, 1.0 pmol) which was incubated at 37 °C 
for 3 minutes before the addition of potato apyrase (0.008 units) which brought the total 
reaction volume to 1 mL. At 10 minute intervals a 5 pL aliquot was automatically 
sampled and analysed by HPLC using an Alltech Alltima C18 5pM analytical column 
fitted with a matching guard column and eluted with 60 mM ammonium phosphate pH 
5.0 with 5 mM tetrabutylammonium phosphate (A) and 5 mM tetrabutylammonium 
phosphate in methanol (B) under the isocratic conditions of 75% A to 25% B. The ratio 
of the ADP 97 peak area (tu = 5.8 min) to the AMP 44 peak area (tu = 4.3 min) in the 
HPLC chromatograms was used to calculate the amount of AMP 44 produced at each 
time point.
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7.4 Experimental for Chapter Four
7.4.1 Synthesis
(S)-2-Amino-A^-((l-(4-(6-amino-9//-purin-9-yl)butyl)-l//-l,2,3-triazol-4-yl)methyl)- 
3-(4-hydroxyphenyl)propanamide 103 and (S)-2-amino-A-((3-(4-(6-amino-9//- 
purin-9-yl)butyl)-3//-l,2,3-triazol-4-yl)methyl)-3-(4-hydroxyphenyl)propanamide 
104
A solution of the azide 46 (175 mg, 0.756 mmol) and the alkyne 49 (192 mg, 0.756 
mmol) in water (2 mL) was heated to 100 °C with stirring overnight. The solution was 
filtered and the filtrate was concentrated under reduced pressure. The crude material 
was subjected to high performance liquid chromatography to yield the title compounds 
103 (228 mg, 67%) and 104 (98 mg, 29%) as colourless oils.
104
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103: 'H NMR (500 MHz, (CD3)2SO): 5 8.85 (t, J = 5.5 Hz, IH), 8.35 (s, 1H), 8.34 (s, 
1H), 8.13 (br s, 4H), 7.66 (s, 1H), 6.96 (d, ./ = 7.5 Hz, 2H), 6.65 (d, J = 7.5 Hz, 2H) 
4.38-4.22 (m, 6H), 3.86 (m, 2H), 2.89 (m, 2H), 1.77 (m, 4H). ,3C NMR (75 MHz, 
(CD3OD): 5 169.6, 158.0, 151.9, 150.3, 145.4, 145.2, 131.6, 129.9, 126.9, 124.3, 119.7, 
116.6, 55.7, 50.6, 44.7, 37.7, 35.5, 28.2, 27.9. MS (ESI) (+ve): m/z 451 (|M+H]+, 40%). 
HRMS (ESI) cal cd. for C21H127N10O2 |M+H|+ m/z 451.2318, found 451.2318.
HPLC: tR 20.3 min (column: Waters SymmetryPrep™ C18 7pM, 300 x 19 mm; 
gradient conditions: 1:99 (methanohO.l % TFA in water) to 32:68 over 20 minutes then 
100:0 for 4 minutes; flow rate: 10 mLmin’1).
104: *H NMR (500 MHz, (CD3)2SO): 5 8.91 (t, J = 5.5 Hz, 1H), 8.29 (s, 1H), 8.27 (s, 
1H), 8.16 (br s, 4H), 7.45 (s, 1H), 6.93 (d. ./ = 8.5 Hz, 2H), 6.66 (d, J = 8.5 Hz, 2H) 
4.39-4.19 (m, 6H), 3.87 (m, 2H), 2.87 (m, 2H), 1.78 (m, 4H). 13C NMR (125 MHz, 
D20): 5 171.2, 157.3, 151.8, 150.6, 147.0, 146.4, 136.8, 135.7, 132.6, 127.0, 120.3, 
117.8, 56.4, 49.9, 46.3, 38.1,33.2, 28.6, 28.3. MS (ESI) (+ve): m/z 451 ([M+H|+, 40%). 
HRMS (ESI) cal cd. for C21Hi27N]0O2 [M+H]+ m/z 451.2318, found 451.2297.
HPLC: ?r 19.8 min (column: Waters SymmetryPrep™ C l8 7 pM, 300 x 19 mm: 
gradient conditions: 1:99 (methanol:0.1% TFA in water) to 32:68 over 20 minutes then 
100:0 for 4 minutes; flow rate: 10 mLmin1)
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7.4.2 Determination of IC50 values
Tyrosyl-tRNA synthetase inhibition assays were prepared in 0.5 mL microcentrifuge 
tubes and contained tyrosine 38 (2.2 pg, 12 nmol), ATP disodium salt 39 (33 pg, 60 
nmol) and tRNAlyr (2.4 nmol) and the inhibitor at the chosen concentration in reaction 
buffer and were incubated at 37 °C for 3 minutes before the addition of tyrosyl-tRNA 
synthetase (0.43 pg, 2.4 nmol) which brought the total reaction volume to 60 pL. After 
2 minutes a 10 pi. aliquot was taken from the reaction mixture, quenched into a 10 pL 
volume of sodium dodecylsulfate solution (0.02% w/v) and analysed by HPLC using an 
Alltech Alltima C18 5 pm analytical column fitted with a matching guard column and 
eluted with 60 mM ammonium phosphate pH 5.0 with 5 mM tetrabutylammonium 
phosphate (A) and 5 mM tetrabutylammonium phosphate in methanol (B) under the 
isocratic conditions of 82% A to 18% B. The ratio of the AMP 44 peak area {tu = 5.2 
min) to the ATP 39 peak area (rR = 14.3 min) in the HPLC chromatograms was used to 
calculate the amount of AMP 44 produced. IC50 values of compounds 46, 47, 103 and 
104 were determined from the plots presented in Figures 11 and 8.
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Figure 11. Concentration of AMP 44 plotted against concentration of the compounds 46,103
and 104.
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7.4.3 Catalysis experiments
A solution of the azide 46 (0.26 mg, 1.1 pmol), the alkyne 47 (6.4 pg, 25 nmol) and 
tyrosyl-tRNA synthetase (0.1 mM) in 200pL of 40 mM Tris-HCl buffer (pH 7.6) with 
0.8 mM magnesium chloride and 3.2 mM potassium chloride was incubated at 37 °C. 
An identical solution without tyrosyl-tRNA synthetase was also prepared to serve as the 
control reaction and was incubated at 37 °C. The reactions were sampled at intervals up 
to 7 days and analysed by analytical reverse phase HPLC, eluting with methanol and 
0.1% TFA ( 0:100 to 20:80 over 25 minutes then 100:0 over 5 minutes). The triazoles 
103 and 104 were not detected in the samples.
7.5 Experimental for Chapter Five
7.5.1 Synthesis
Benzaldoxime 118
118
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A solution of sodium hydroxide (40.0 mL, 12.5 M, 0.50 mol) was added dropvvise with 
stirring to a solution of benzaldehyde (21.2 g, 0.20 mol) and hydroxylamine 
hydrochloride (15.3 g, 0.22 mol) in a mixture of ethanol (50 mL) and water (50 mL) 
whilst being cooled on an ice bath. After 4 hours the solution was neutralized with 
dilute hydrochloric acid and evaporated to half the original volume under reduced 
pressure. The solution was diluted with water (50 mL) then extracted with diethyl ether 
(3 x 50 mL). The organic material was dried over sodium sulfate and the solvent was 
removed in vacuo to give an orange solid. The crude material was subjected to column 
chromatography on silica gel to give the title compound 118 (23.5 g, 97%) as a 
colourless oil.
'H NMR (300 MHz, CDC13): 5 8.16 (s, 1H), 7.59 (m, 2H), 7.40 (m, 3H). The 'H NMR 
signals are consistent with literature data.129
Benzohydroximinoyl chloride 119
ci
119
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To a stirred solution of benzaldoxime 118 (3.75 g, 31.0 mmol) in DMF (31 mL) was 
added /V-chlorosuccinimide (4.51 g, 33.8 mmol) in small portions over a 2 hour period. 
The solution was stirred for a further 2 hours at room temperature then water (150 mL) 
was added and the mixture was extracted with diethyl ether (3 x 50 mL). The combined 
organics were dried over sodium sulfate and concentrated under reduced pressure to 
give an off-white solid which was subjected to column chromatography on silica, 
eluting with ethyl acetate/petrol (bp 40-60 °C) (20:80) to give the title compound 119 
(3.20 g, 66%) as a white crystalline solid.
Mp. 46-48 °C (lit,131 49-51 °C). ‘H NMR (300 MHz, CDCI3): 5 8.12 (s, IH), 7.85 (m, 
2H), 7.42 (m,3H).
AyV'-Bis-(ter/-butoxycarbonyl)-S-methylisothiourea 121
NBoc
BocHN S'
121
Di-rm-butyl dicarbonate (15.7 g, 72.0 mmol) was added to a solution of S- 
methylisothiourea hemisulfate salt (5.00 g, 35.9 mmol) and sodium hydroxide (2.90 g, 
72.5 mmol) in a mixture of water (50 mL) and dioxane (50 mL). The solution was 
stirred vigorously overnight at room temperature, evaporated to half the original volume 
and the resulting precipitate was separated by filtration. The white solid was suspended
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in water (200 mL) and stirred at 50 °C. After 5 minutes the solution was filtered and the 
solid was collected and dried under reduced pressure. The crude material was then 
subjected to column chromatography on silica gel, eluting with ethyl acetate/petrol(bp 
40-60 °C) (1:99), to give the title compound 121 (2.70 g, 26%) as a white solid.
Mp. 119-120 °C (lit,132 122-123 °C). lH NMR (300 MHz, CDC13): 5 11.63 (br s, 1H), 
2.40 (s, 3H), 1.52 (s, 9H), 1.50 (s, 9H). The 'H NMR signals are consistent with 
literature data.132
l-(AyV'-Bis-(ter/-butoxycarbonyl)guanidino)but-3-ene 53
BocHN
NBoc
122
A solution of AL/V'-bis-(rm-butoxycarbonyl)-S-methylisothiourea 121 (1.20 g, 4.13 
mmol), 3-butenylamine hydrochloride (1.40 g, 13.0 mmol), 4-(dimethylamino)pyridine 
(52.6 mg, 0.43 mmol) and triethylamine (1.43 g, 14.2 mmol) was stirred at room 
temperature overnight. The solution was then diluted with water (150 mL) and extracted 
with diethyl ether (3 x 30 mL). The combined organic extracts were dried over sodium 
sulphate then evaporated under reduced pressure. The resulting white solid was
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subjected to column chromatography, eluting with ethyl acetate/petrol (bp 40-60 °C) 
(5:95 then 10:90), to give the title compound 122 (0.937 g, 72%) as a white solid.
Mp. 79-80 °C. NMR (300 MHz, CDC13): 5 11.46 (br s, 1H), 8.32 (br s, 1H), 5.75 
(m, 1H), 5.13 (m, 2H), 3.47 (m, 2H), 2.29 (m, 2H), 1.46 (s, 9H), 1.45 (s, 9H). ,3C NMR
MS (ESI) (+ve): m/z 336 ([M +N af, 40%). HRMS (ESI) calcd. for Ci5H28N30 4 
|M +H |+ m/z 314.2080, found 314.2079. Anal, calcd. for C15H27N30 4: C, 57.49; H, 8.68; 
N, 13.41. Found: C, 57.40; H, 8.73; N, 13.10%.
l-Guanidinobut-3-ene trittuoroaeetate 115
To a 50% solution of trifluroacetic acid (25mL) in DCM (25mL) was added 1-(A%V’- 
bis-(rm-butoxycarbonyl)guanidino)but-3-ene 122 (1.62 g, 5.19 mmol). The mixture 
was stirred at room temperature overnight and the solvent was removed in vacuo. The 
residue was resuspended in water (50 mL) and extracted with DCM (3 x 30 mL). The 
aqueous layer was evaporated to dryness, resuspended in water (50 mL) and evaporated 
twice more to yield the title compound 115 (1.06 g, 90%) as a white solid
(75 MHz, CDC13): 5 163.8, 156.4, 153.4, 134.9, 117.7, 83.2, 79.4, 40.2, 33.4, 28.3, 28.2.
© ©
CF,CO,NH,
115
175
Chapter 7
Mp. 97-98 °C. 'H NMR (300 MHz, D20): 5 5.81 (m, 1H), 5.16 (m, 2H), 3.26 (t, 7 = 6.6 
Hz, 2H), 2.35 (q, J = 6.6, 2H). I3C NMR (75 MHz, D20): 5 159.1, 136.8, 119.8, 42.7, 
34.7. MS (ESI) (+ve): m/z 114 ([M-CF3C02T , 100%). HRMS (ESI) calcd. for 
C5Hi2N3 [M-CF3C02 ]+ m/z 114.1031, found 114.1034. Anal, calcd. for C5H12F3N30 2: 
C, 37.01; H, 5.32; N, 18.50. Found: C, 36.94; H, 5.35; N, 18.19%.
l-(AyV'-Bis-(te/t-butoxycarbonyl)guanidino)pent-4-ene 126
126
A solution of 5-bromo-l-pentene (23.4 g, 0.16 mol) and potassium phthalimide (32.0 g, 
0.19 mol) in DMF was stirred at 60 °C for 24 hours. After cooling to room temperature 
the mixture was filtered. The filtrate was treated with a 50% solution of saturated 
sodium chloride in water (300 mL) and extracted with diethyl ether (3 x 100 mL). The 
combined ether extracts were washed with saturated sodium chloride solution (2 x 50 
mL) and dried over sodium sulfate. The crude material was then suspended in ethanol 
(200 mL) and treated with hydrazine monohydrate (7.85 g, 0.16 mol) and heated to 60 
°C with stirring overnight. Once cooled to room temperature, concentrated hydrochloric 
acid (55.0 mL, 0.66 mol) was added dropwise to the stirred solution and the mixture 
was heated to reflux for 2 hours. The solution was allowed to cool before being placed
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in a refrigerator overnight. The resulting precipitate was filtered off and washed with a 
small portion of ethanol. The filtrate was concentrated in vacuo at 60 °C to yield the 
crude hydrochloride salt (11 g) as a yellow solid. A solution of the crude hydrochloride 
salt (3.34 g), AfA'-bis-(te^butoxycarbonyl)-S,-methylisothiourea 121 (2.00 g, 6.90 
mmol), 4-(dimethylamino)pyridine (84.0 mg, 0.69 mmol) and triethylamine (3.06 g, 
30.3 mmol) in DMF (50 mL) was stirred at room temperature overnight. The solution 
was then diluted with water (200 mL) and extracted with diethyl ether (3 x 30 mL). The 
combined organic extracts were washed with water (3 x 30 mL) and dried over sodium 
sulphate. The crude material was subjected to column chromatography on silica gel, 
eluting with ethyl acetate/petrol(bp 40-60 °C) (10:90) to give the title compound 126 
(1.35 g, 60%) as a white solid.
Mp. 60-61 °C. ‘H NMR (300 MHz, CDC13): 5 11.48 (br s, 1H), 8.30 (br s, 1H), 5.75 
(m, 1H), 4.98 (m, 2H), 3.39 (m, 2H), 2.08 (m, 2H), 1.63 (quin, J = 7.5 Hz, 2H), 1.46 (s, 
9H), 1.45 (s, 9H). 13C NMR (75 MHz, CDC13): 6 163.3, 155.7, 152.9, 137.2, 115.2, 
82.8, 78.9, 39.9, 30.7, 28.1, 27.9, 27.8. MS (ESI) (+ve): m/z 350 (|M +Na|+, 100%). 
HRMS (ESI) cal cd. for Q6H30N3O4 |M +Hp m/z 328.2236, found 328.2229. Anal, 
cal cd. for C16H29N3O4: C, 58.69; H, 8.93; N, 12.83. Found: C, 58.75; H, 8.57; N, 
12.61%.
l-Guanidinopent-4-ene trifluoroacetate 116
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A solution of l-(AL/V’-bis-(terf-butoxycarbonyl)guanidino)pent-4-ene 126 (1.78 g, 5.44 
mmol) in trifluoroacetic acid (30 mL) in DCM (30 mL) was stirred at room temperature 
overnight. The solvent was then evaporated under reduced pressure and the residue was 
suspended in water (50 mL) and extracted with DCM (3 x 30 mL). The aqueous layer 
was evaporated to give a red oil which was subjected to high performance liquid 
chromatography to give the title compound 116 (598 mg, 46%) as a white solid.
Mp. 71-72 °C. 'H NMR (300 MHz, D20): 5 5.88 (m, 1H), 5.07 (m, 2H), 3.19 (t, 7 = 6.9 
Hz, 2H), 2.13 (q, J  = 6.9 Hz, 2H), 1.69 (quin, J  = 6.9 Hz, 2H). 13C NMR (75 MHz, 
D20): 5 159.5, 140.9, 118.1,43.3, 32.9, 29.9. MS (ESI) (+ve): m/z 128 ([M-CF3C 0 2 ]+, 
85%). HRMS (ESI) calcd. for C6H,4 N3 [M-CF3C 0 2 ]+ m/z 128.1188, found 128.1185. 
Anal, calcd. for C8Hi4F3N30 2: C, 39.84; H, 5.85; N, 17.42. Found: C, 39.88; H, 5.88; N, 
17.38%.
HPLC: ?r 8.99 min (column: Alltech Alltima C18 5u, 250 x 10 mm; (gradient 
conditions: 10:90 to 100:0 over 10 minutes) methanol:0.1% TFA in water; flow rate: 4 
mLmin’1).
(2-(4,5-Dihydro-3-phenylisoxazol-5-yl)ethyl)guanidine trifluoroacetate 127
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To a solution of l-guanidinobut-3-ene trifluoroacetate 115 (0.35 g, 1.54 mmol) and 
benzohydroximinoyl chloride 119 (0.24 g, 1.54 mmol) in chloroform (0.84 mL) and 
ethanol (0.23 mL) was added triethylamine (0.34 g, 3.39 mmol). The mixture was 
stirred overnight at 25 °C then filtered. The filtrate was evaporated under reduced 
pressure and the crude material was subjected to high performance liquid 
chromatography to give the title compound 127 (0.27 mg, 51%) as a white solid.
Mp. 140-141 °C. 'H NMR (300 MHz. D20): 5 7.69 (m, 2H), 7.53 (m, 3H), 4.90 (m, 
partially obscured by HOD resonance, 1H), 3.64 (dd, J  = 17.4, 10.5 Hz, 1H), 3.36 (t, J -  
6.9 Hz, 2H), 3.24 (dd, J  = 17.4, 7.2 Hz, 1H), 1.99 (q, J  = 6.9, 2H). ,3C NMR (75 MHz, 
D20): 5 161.5, 159.0, 133.3, 131.3, 130.5, 129.1, 81.3, 42.2, 40.2, 35.6. MS (ESI) 
(+ve): m/z 233 (|M-CF3C02']+, 40%). HRMS (ESI) calcd. for Ci2H17N40  [M-CF3C02 
]+ m/z 233.1402, found 233.1401. Anal, calcd. for Ci4Hi7F3N40 3: C, 48.56; H, 4.95; N, 
16.18. Found: C, 48.52; H, 4.69; N, 16.31 %.
HPLC: tu 10.29 min (column: Alltech Alltima C18 5u, 250 x 10 mm; (gradient 
conditions: 10:90 to 100:0 over 10 minutes then 100:0 for 3 minutes) methanol:0.1% 
TFA in water; flow rate: 4 mLmin ')
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(3-(4,5-Dihydro-3-phenylisoxazol-5-yl)propyl)guanidine trifluoroacetate 128
To l-guanidinopent-4-ene trifluoroacetate 116 (0.25 g, 1.04 mmol) and
benzohydroximinoyl chloride 119 (0.16 g, 1.04 mmol) in a mixture of chloroform (0.56 
mL) and ethanol (0.15 mL) was added triethvlamine (0.23 g, 2.28 mmol). The mixture 
was stirred overnight at 25 °C then filtered. The filtrate was evaporated under reduced 
pressure and the crude material was subjected to high performance liquid 
chromatography to give the title compound 128 (0.21 mg, 55%) as a white solid.
Mp. 119-121 °C. 'H NMR (300 MHz, D20): 5 7.71 (m, 2H), 7.54 (m, 3H), 4.86 (m, 
partially obscured by HOD resonance, 1H), 3.64 (dd, J  = 17.4, 10.2 Hz, 1H), 3.24 (m, 
2H) 3.22 (m, partially obscured by CH2 resonance, 1H), 1.77 (m, 4H). 13C NMR (75 
MHz, D20 ) :5  162.6, 159.6, 133.8, 131.9, 131.2, 129.7, 84.1,43.7,42.6,34.1,26.9. MS 
(ESI) (+ve): m/z 247 ([M-CF3CO2T, 80%). HRMS (ESI) calcd. for Q3H19N4O |M- 
CF3CO2T m/z 247.1559, found 247.1557. Anal, calcd. for Q4H17F3N4O3: C, 50.00; H, 
5.31; N, 15.55. Found: C, 49.68; H, 5.45; N, 15.40%.
© ©
CF^CO, NHp
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HPLC: tu 10.69 min (column: Alltech Alltima C18 5u, 250 x 10 mm; (gradient 
conditions: 10:90 to 100:0 over 10 minutes then 100:0 for 3 minutes) methanol:0.1% 
TFA in water; flow rate: 4 mLmin *)
1 - Amino-3-(AyV'-bis-(terf-butoxycarbonyl)guanidino)propane 130
NBoc
BocHN
130
To a rapidly stirred solution of 1,3-diaminopropane (0.55 g, 7.42 mmol) in a mixture of 
THF (14 mL) and water (7 mL) was added dropwise Ar,A'-bis-(rm-butoxycarbonyl)-5- 
methylisothiourea 121 (0.82 g, 2.82 mmol). The mixture was heated to 50 °C for one 
hour after which the solution was concentrated under reduced pressure. The residue was 
suspended in DCM (30 mL) and washed with 10% sodium hydrogen carbonate solution 
(3 x 30 mL). The organic phase was dried over sodium sulphate and evaporated to 
dryness. The crude material was subjected to column chromatography on silica gel, 
eluting with DCM/triethylamine (95:5) to give the title compound 130 (319 mg, 36%) 
as a yellow oil.
'H NMR (300 MHz, CDCH): 5 11.47 (br s, 1H), 8.40 (br s, 1H), 3.49 (q, J  = 6.9, 2H), 
2.76 (t, J  = 6.9, 2H), 1.69 (quin, J  = 6.9, 2H), 1.48 (s, 18H), 1.44 (m, partially obscured
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by (CH3)3 resonance, 2H). MS (ESI) (+ve): m/z 317 (|M+H]+, 10%). The ’H NMR 
signals are consistent with literature data.137
l-Acrylamido-3-(AyV'-bis-(te/t-butoxycarbonyl)guanidino)propane 131
131
A solution of acryloyl chloride (0.11 g, l .22 mmol) in chloroform (4 mL) was cooled on 
an ice bath whilst a solution of l -amino-3-(A,A’-bis-(rm- 
butoxycarbonvl)guanidino)propane 130 (0.32 mg, 1. mmol) and triethylamine (0.11 g, 
1.09 mmol) in chloroform (3 mL) was added dropwise with stirring. The reaction 
mixture was removed from the ice bath and stirred at room temperature for a further 2 
hours then concentrated in vacuo. The residue was resuspended in water (30 mL) and 
extracted with chloroform (3x10 mL). The combined organic extracts were dried over 
sodium sulfate and the solvent was evaporated to yield an oil which was 
chromatographed on silica gel, eluting with ethyl acetate/petrol(bp 40-60 °C) (55:45) to 
give the title compound 131 (200 mg, 54%) as a white semi-solid.
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*H NMR (300 MHz, CDC13): 5 11.44(s, 1H), 8.47 (hr t, J  = 6, 1H), 7.92 (br t, 1H),6.29 
(m, 2H), 5.57 (dd, J  = 7.5, 4.5, 1H), 3.49 (q, J  = 6.6, 2H), 3.33 (q, J  = 6, 2H), 1.68 (m, 
2H), 1.51 (s, 9H), 1.49 (s, 9H). 13C NMR (75 MHz, CDC13): 5 165.4, 162.8, 157.1, 
152.9, 131.6, 125.3, 83.4, 79.4, 36.9, 34.6, 29.6, 28.2, 27.9. MS (ESI) (+ve): m/z 393 
([M+Na|+, 30%). HRMS (ESI) calcd. for C17H31N4O5 [M+H]+ m/z 371.2294, found 
357.2292. Anal, calcd. for C17H30N4O5: C, 55.12; H, 8.16; N, 15.12. Found: C, 55.17; 
H, 8.19; N, 15.03%.
l-Acrylamido-3-guanidinopropane trifluoroacetate 129
© ©
cf3co2nh2
129
l-Acrylamido-3-(N,AT-bis-(terf-butoxycarbonyl)guanidino)propane 131 (1.77 g, 4.78 
mmol) was suspended in a 50% trifluoroacetic acid (30mL) solution in DCM (30mL) 
and stirred overnight at room temperature. The solution was concentrated under reduced 
pressure and then resuspended in water (20 mL) and extracted with DCM (3 x 20 mL). 
The aqueous layer was evaporated to dryess to give the title compound 129 (1.20 g, 
88%) as a colourless viscous oil.
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'H NMR (300 MHz, D20): 5 6.24 (m, 2H), 5.78 (dd. J  = 9.3, 1.2, 1H), 3.30 (t, J  = 6.6. 
2H), 3.21 (t, J  = 6.6, 2H), 1.82 (quin, J  = 6.6, 2H). 13C NMR (75 MHz, D20): 8 170.9. 
164.3, 132.1, 129.5, 40.9, 38.7, 29.7. MS (ESI) (+ve): 171 ([M-CF3CO2T , 10%).
HRMS (ESI) calcd. for C7H15N40  [M-CF3C02T  m /z  171.1246, found 171.1247.
(3-(4,5-dihydro-3-phenylisoxazole-5-carboxamido)propyl)guanidine trifluoroacetate 132
To l-acrylamido-3-guanidinopropane trifluoroacetate 129 (500 mg, 1.76 mmol) and 
benzohydroximinoyl chloride 119 (273 mg, 1.76 mmol) in a mixture of chloroform 
(0.38 mL) and ethanol (0.11 mL) was added triethylamine (391 mg, 3.87 mmol). The 
mixture was stirred overnight at 25 °C then filtered. The filtrate was evaporated under 
reduced pressure and the crude material was subjected to high performance liquid 
chromatography to give the title compound 132 (302 mg, 43%) as an oil.
'H NMR (300 MHz, CD,OD): 5 7.70 (m, 2H), 7.45 (m, 3H), 5.13 (dd, 11.4, 6.3 Hz, 
1H), 3.77 (dd, J  = 17.4, 11.7 Hz, 1H), 3.61 (dd, 17.4, 6.3 Hz, 1H), 3.30 (t, partially 
obscured by CD3OH resonance, 2H), 3.17 (t, J  = 6.9 Hz, 2H), 1.77 (quin, J  = 6.9 Hz, 
2H). I3C NMR (75 MHz, CD,OD): 5 173.6, 158.6, 158.4, 131.7, 129.9, 129.8, 127.9,
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80.2, 40.3, 39.9, 37.5, 29.6. MS (ESI) (+ve): m/z 290 ([M-CF3C 0 2 ] +, 100%). HRMS 
(ESI) calcd. for C 14H2()N502 |M-CF3C 0 2T  m/z 290.1617, found. 290.1609. Anal, 
calcd. for C i6H21F3N5O i/2: C, 46.49; H, 5.12; N, 16.94. Found: C, 46.43; H, 5.50; N, 
16.94%.
The 1 Fl NMR of the product mixture also displayed signals corresponding to the 
isoxazoline ring protons the 4-substitued regioisomer 133 between 4.40 ppm and 4.70 
ppm. The ratio of formation of the regioisomers 132 and 133 was determined to be 97:3 
from the integration of the FIPLC chromatogram when monitored at 259 nm.
7.5.2 Determination of binding constants
ITC was performed using a Microcal VP-ITC unit. All experiments were conducted at 
25 °C. Solutions of compounds 115, 118, 116, 127, 128, 129 and 132 were prepared in 
40 mM Tris-HCl buffer (pH 7.6) with 0.8 mM magnesium chloride and 3.2 mM 
potassium chloride at concentrations ranging from 40 mM to 106 mM. Titrations of 
compounds 115, 118, 116, 127, 128, 129 and 132 involved the addition of 7 pL 
aliquouts to a 0.5 mM solution of Chymotrypsin in 40 mM Tris-HCl buffer (pH 7.6) 
with 0.8 mM magnesium chloride and 3.2 mM potassium chloride at 3 minute intervals. 
Heats of dilution for the compounds 115, 118, 116, 127, 128, 129 and 132 were 
determined by titration into the same buffer without Chymotrypsin and were substracted 
from the titration data before curve fitting. Curve fitting was carried out using Origin v 
5.0 software by applying a single site binding model where the stoichiometry parameter
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was set to 1.0. The ITC data for compounds 115, 116, 127, 128, 129 and 132 are 
presented in Figure 12. The ITC data for compound 118 is presented in Figure 10.
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Figure 12. ITC data for the interaction between compounds (a) 115, (b) 116, (c) 127 and (d)
128 and Chymotrypsin.
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Figure 12 continued. ITC data for the interaction between compounds (e) 129 and (f) 132 and
Chymotrypsin.
7.5.3 Catalysis experiments involving the alkene 115
To a solution of the alkene 115 (45 pg, 0.2 nmol), benzohydroximinoyl chloride 119 (31 
pg, 0.2 pmol) and Chymotrypsin (10 mM) in lOOpL of 40 mM Tris-HCl buffer (pH 7.6) 
with 0.8 mM magnesium chloride and 3.2 mM potassium chloride was added 
triethylamine (44 ng, 0.44 nmol) An identical solution without Chymotrypsin was also 
prepared to serve as the control reaction. Both solutions were incubated at 25 °C. The 
solutions were sampled at intervals up to 6 days and analysed by analytical reverse 
phase HPLC, eluting with acetonitrile and 0.1% TFA (isocratic 5:95 for 50 minutes then
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gradient conditions to 100% acetonitrile over 30 minutes. The isoxazoline 127 has a 
retention time of 61.8 minutes and was quantified by integration of the chromatogram at 
200 nm.
7.5.4 Catalysis experiments involving the alkene 129
To a solution of the alkene 129 (625, 125, 25 pg, 2.2, 0.44, 0.088 pmol), 
benzohydroximinoyl chloride 119 (39, 7.8 pg, 0.25, 0.05 pmol) and Chymotrypsin (10 
mM) in lOOpL of 40 mM Tris-HCl buffer (pH 7.6) with 0.8 mM magnesium chloride 
and 3.2 mM potassium chloride was added triethylamine (44 ng, 0.44 pmol). Control 
reactions were also prepared without chymotrypsin. The solutions were incubated at 25 
°C. The solutions containing 625 pg of the alkene 129 were sampled at 1,3, 5, 7 and 9 
hours. All other solutions were sampled at 30 minutes, then at hourly intervals up to 3.5 
hours. Samples were analysed by analytical reverse phase HPLC eluting with methanol 
and 0.1% TFA (10:90 to 50:50 over 25 minutes). The isoxazoline 132 has a retention 
time of 20.2 minutes and the isoxazoline 133 has a retention time of 14.3 minutes and 
each were quantified by integration of the chromatogram at 259 nm.
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Appendix
X-Ray Crystallographic Structural Report for 9-(4-Azidobutyl)-adenine 46
The crystallographic asymmetric unit consists of one molecule of CtH^ N*. All H atoms 
were observed in a difference electron density map prior to their inclusion. They were 
added at calculated positions and then refined positionally. There were no outstanding 
features in the final difference electron density map.
Experimental
The compound was prepared by AB and recrystallized from chloroform. The sample ID 
is XB-56.
Crystal data
Comment
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Empirical formula c 7h 8n 8
Formula weight 204.19
Crystal system Monoclinic
Space group P2\/n
Lattice parameter a =  10.8356 (5) Ä 
b = 8.3947 (3) Ä 
c — 11.1732 (4) Ä
ß =  115.098(14)°
V= 920.37 (6) Ä3
Z value 4
Dx 1.474 Mg m-3
Cell parameters from 19719 reflections
6 3-27°
p(Mo Ka) 0.105 mm-1
T 200 K
Crystal colour, habit Colourless, Plate
Crystal dimensions 0.53 x 0.21 x 0.04 mm
Crystal source Local laboratory
Intensity Measurements
Diffractometer Nonius Kappa CCD
Radiation Mo Ka (X = 0.71073 Ä)
Absorption correction by integration via Gaussian method
208
(Coppens, 1970)
T min 0.970
f m a x
Number of reflections measured
0.996
Total: 18184
Unique: 2113
Number of observations 
(/>2.00w(/))
1769
R i n t 0.05
$  m a x 25.0°
h -4 —> 4
k -24 24
l -22 —> 21
Structure Solution and Refinement
Refinement on F R  0.0332
coR 0.0336
S 1.1130
Number of reflections 1461
Number of parameters 161
( A / ( j ) m a x 0.000398
^ P m a x 0.23 e Ä'3
A p m i n 0.16 eÄ~3
Extinction correction: Larson 1970 Crystallographic Computing eq 22
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Extinction coefficient 99 (16)
Scattering factors from International Tables for X-ray Crystallography (Vol. IV) 
Only coordinates of H atoms refined
Table A l .  Selected geometric parameters (A, °)
N 1-C 2 1.3327(17) C 7-N 8 1.3940(16)
C 2-N 3 1.3569(16) N 8-C 9 1.3138(17)
C 2-C 7 1.4108 (17) C9-N 10 1.3676(16)
N 3-C 4 1.3399(16) N10-C11 1.4576(16)
C 4-N 5 1.3283 (17) C11-C12 1.511 (2)
N 5-C 6 1.3472(16) C12-N13 1.4753 (18)
C 6-C 7 1.3844(18) N13-N14 1.2286(18)
C6-N 10 1.3731 (16) N14-N15 1.1297(19)
N 1 -C 2 -N 3 118.54(11) C 6 -C 7 -N 8 110.47(11)
N 1 -C 2 -C 7 124.32(11) C 7 -N 8 -C 9 103.57(11)
N 3 -C 2 -C 7 117.14(11) N 8 -C 9 -N 1 0 114.11 (12)
C 2 -N 3 -C 4 118.84(11) C 6 -N 1 0 -C 9 105.85 (10)
N 3 -C 4 —N5 129.60(12) C 6-N 10-C 11 26.28 (11)
C 4 -N 5 -C 6 110.18(11) C 9 -N 1 0 -C 1 1 127.86(11)
N 5 -C 6 -C 7 127.27(12) N 10-C 11-C 12 110.50(11)
N 5 -C 6 -N 10 126.73 (12) C 11-C 12-N 13 111.29(12)
C 7 -C 6 -N 10 106.00(11) C 12-N 13-N 14 116.17(13)
C 2 -C 7 -C 6 116.95(11) N 13-N 14-N 15 172.44(15)
C 2 -C 7 -N 8 132.56(12)
D -H - • A
Table A2. Hydrogen-bonding geometry (Ä, °) 
D -H  H- • A D - A D -H - • -A
N l-H ll -  • N8i 0.934(16) 2.108(16) 3.0404(16) 176.1 (14)
N1-H12- • N3i 0.931 (17) 2.065 (16) 2.9623 (16) 161.5 (14)
Table A3. Fractional atomic coordinates and equivalent isotropic displacement parameters (A~)
Ueq = ( l /3 ) I /I ; ( / 'W a ,a /.
X z Ueq
N1 0.23937(13) 0.45681 (14) 0.23913 (11) 0.0332
C2 0.29237(13) 0.49354(15) 0.36723(12) 0.0263
N3 0.29919(11) 0.64921 (13) 0.40216(10) 0.0293
C4 0.35050(14) 0.68679(16) 0.53075 (13) 0.0311
N5 0.39818 (12) 0.59226(13) 0.63601 (11) 0.0316
C6 0.39212(13) 0.43893 (15) 0.59832(12) 0.0269
210
Cl 0.34185 (13) 0.38069(15) 0.47045 (12) 0.0266
N8 0.35375 (12) 0.21531 (13) 0.47133(11) 0.0314
C9 0.41048(14) 0.17957(16) 0.59773 (13) 0.0319
N 10 0.43615 (11) 0.30847(13) 0.67966(10) 0.0291
C ll 0.49991 (14) 0.31023 (18) 0.82371 (12) 0.0319
C12 0.39289(16) 0.3179 (2) 0.87671 (13) 0.0378
N 13 0.45564(16) 0.33006(15) 1.02216(12) 0.0472
N 14 0.49926(14) 0.20541 (16) 1.08313 (12) 0.0425
N 15 0.54151 (19) 0.10004(19) 1.15130(15) 0.0643
H 11 0.2101 (15) 0.5393 (19) 0.1773 (16) 0.0371
H12 0.2414(16) 0.352 (2) 0.2129(15) 0.0371
H41 0.3508 (15) 0.8044(19) 0.5479(15) 0.0369
H91 0.4349(15) 0.0749(19) 0.6345 (15) 0.0370
Hi l l 0.5600(15) 0.401 (2) 0.8538 (15) 0.0364
HI 12 0.5577(15) 0.2136(19) 0.8551 (15) 0.0364
H121 0.3380(17) 0.415(2) 0.8441 (16) 0.0450
HI 22 0.3328 (17) 0.224 (2) 0.8484(16) 0.0450
Table A4. Anisotropic displacement parameters (A2)
N 1 0.0472 (7) 0.0242 (5) 0.0215 (6) 0.0006 (5) 0.0082 (5) 0.0008 (5)
C2 0.0287 (6) 0.0244 (6) 0.0252 (7) -0.0019(5) 0.0109 (5) 0.0000 (5)
N3 0.0367 (6) 0.0239 (5) 0.0257 (6) 0.0002 (4) 0.0118 (5) -0.0002 (4)
C4 0.0388 (7) 0.0249 (6) 0.0296 (7) 0.0007 (5) 0.0144(5) -0.0015 (5)
N5 0.0414(6) 0.0271 (5) 0.0261 (6) -0.0008 (5) 0.0142 (5) -0.0025 (5)
C6 0.0305 (6) 0.0269 (6) 0.0231 (6) -0.0013 (5) 0.0112(5) 0.0012(5)
Cl 0.0309 (7) 0.0233 (6) 0.0247 (6) -0.0025 (5) 0.0109 (5) 0.0000 (5)
N8 0.0404 (6) 0.0239 (5) 0.0260 (5) -0.0023 (5) 0.0104(5) 0.0009 (4)
C9 0.0410(7) 0.0254 (6) 0.0255 (6) -0.0020 (6) 0.0105 (5) 0.0019(5)
N 10 0.0374 (6) 0.0270 (5) 0.0212(5) -0.0015 (5) 0.0107 (4) 0.0016(4)
C ll 0.0380 (7) 0.0327 (7) 0.0209 (6) -0.0029 (6) 0.0084 (5) 0.0006 (5)
C12 0.0466 (8) 0.0407 (8) 0.0268 (7) -0.0039 (7) 0.0164(6) 0.0010(6)
N 13 0.0812(10) 0.0346 (7) 0.0280 (6) -0.0056 (6) 0.0252 (6) 0.0012(5)
N 14 0.0597 (8) 0.0373 (7) 0.0295 (6) -0.0076 (6) 0.0179 (6) -0.0016(6)
N15 0.0908 (12) 0.0457 (8) 0.0422 (8) 0.0024 (8) 0.0146 (8) 0.0084 (7)
Table A5. Geometric parameters (Ä, °)
N 1 -C 2 1.3327(17) N 8 -C 9 1.3138 (17)
N l - H l l 0.933 (16) C 9-N 1 0 1.3676(16)
N 1-H 12 0.932(17) C 9 -H 9 10.958 (16)
C 2 -N 3 1.3569(16) N 10—Cl 1 1.4576(16)
C 2 -C 7 1.4108(17) C 11-C 12 1.511 (2)
N 3 -C 4 1.3399(16) Cl 1 — HI 11 0.968(16)
C 4 -N 5 1.3283 (17) Cl 1 — HI 12 0.994(16)
C 4-H 41 1.006(16) C 12-N 13 1.4753 (18)
N 5 -C 6 1.3472(16) C12-H 121 0.983 (18)
C 6 -C 7 1.3844(18) C 12-H 122 0.986(17)
C 6-N 1 0 1.3731 (16) N 13-N 14 1.2286(18)
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C 7 -N 8 1.3940(16) N 14-N 15 1.1297(19)
C2—N l- H 11 118.7(9) N 8 -C 9 -H 9 1 126.1 (9)
C2—N l - H 12 120.0 (9) N 1 0 -C 9 -H 9 1 119.8 (9)
H ll —N 1-H 12 120.9(13) C 6 -N 1 0 -C 9 105.85 (10)
NI —C 2 -N 3 118.54(11) C 6 -N 1 0 -C 1 1 126.28 (11)
N 1 -C 2 -C 7 124.32(11) C 9 -N 1 0 -C 1 1 127.86(11)
N 3 -C 2 -C 7 117.14(11) N 1 0 -C 1 1 -C 1 2 110.50(11)
C 2 -N 3 -C 4 118.84(11) N10—Cl 1 — HI 11 109.0 (9)
N3 —C 4 -N 5 129.60(12) C12—Cl 1 — HI 11 110.2 (9)
N3 —C 4-H 41 113.7 (9) N10—Cl 1 — HI 12 108.3(9)
N 5 -C 4 -H 4 1 116.7 (9) C12—Cl 1 —HI 12 111.7(9)
C 4 -N 5 -C 6 110.18(11) HI 11 — Cl 1 — HI 1 107.1 (12)
N 5 -C 6 -C 7 127.27(12) C 1 1 -C 1 2 -N 1 3 111.29(12)
N 5 -C 6 -N 1 0 126.73 (12) C 11-C 12-H 121 109.5 (10)
C 7 -C 6 -N 1 0 106.00(11) N 1 3 -C 1 2 -H 1 2 106.0(10)
C 2 - C 7 -C 6 116.95(11) C 1 1 -C 1 2 -H 1 2 2 110.6(10)
C 2 -C 7 -N 8 132.56(12) N 13-C 1 2 -H 1 2 2 110.0(10)
C 6 -C 7 -N 8 110.47(11) H 121-C 12-H 122 109.4(13)
C 7 -N 8 -C 9 103.57(11) C 1 2 -N 1 3 -N 1 4 116.17(13)
N 8 -C 9 -N 1 0 114.11 (12) N13 — N 14-N 15 172.44(15)
N 1 - C 2 - N 3 - C 4 179.0(1) N 1 0 -C 6 -N 5 -C 4 177.9(1)
N 1 - C 2 - C 7 - N 8 2.2 (3) N 1 0 -C 6 -C 7 -C 2 -178.7(1)
NI —C 2 -C 7 -C 6 -179.2(2) N 1 0 -C 9 —N 8 -C 7 0.3 (2)
N3 — C2—C 7 -N 8 -178.2 (2) N10—Cl 1 —C12—N -176.4(1)
N 3 - C 2 - C 7 - C 6 0.4(2) N14—N13 —C12—Cl 1 -79.1 (2)
N 3 - C 4 - N 5 - C 6 1.2 (2) C 2 - C 7 - N 8 - C 9 178.4(2)
N 5 - C 4 - N 3 - C 2 -0.3 (3) C 4 - N 3 - C 2 - C 7 -0.6 (2)
N 5 -C 6 -N 1 0 -C 9 -179.4(2) C 4 - N 5 - C 6 - C 7 -1.4(2)
N 5 -C 6 -N 1 0 —Cl -0.7 (2) C 6 -N 1 0 -C 1 1 -C 1 2 83.1 (2)
N 5 - C 6 - C 7 - N 8 179.6(1) C 6 - C 7 - N 8 - C 9 -0.3 (2)
N 5 - C 6 - C 7 - C 2 0.7 (2) C 7 -C 6 -N 1 0 -C 9 -0.0 (2)
N 8 -C 7 -C 6 -N 1 0 0.2 (2) C 7 -C 6 -N 1 0 -C 1 1 178.7(1)
N 8 -C 9 -N 1 0 -C 6 -0.2 (2) C9— N10—C 11-C 12 -98.5 (2)
N 8 - C 9 - N 1 0 - C 1 1 -178.8 (1)
Table A6. Contact distances (A)
Nl- • -N3' 2.962 (2)
Nl- • -N8" 3.040 (2)
Nl - • •C9ili 3.425 (2)
Nl- • -C41 3.562 (2)
Nl - • -N5iv 3.591 (2)
N3- • -N14v 3.340 (2)
N3- • -N10'v 3.378 (2)
N3- • -C6iv 3.428 (2)
N3- • -C9iv 3.458 (2)
N3- • -N15v 3.505 (2)
N3- • -C7,v 3.539 (2)
N3- • -N13v 3.553 (2)
N3- • -N8'v 3.595 (2)
N5- • • N14vi 3.318(2)
N5- • -N15V1 3.381 (2)
N5- • •C71V 3.499 (2)
N5- • •N13vi 3.520 (2)
N8- • •C4iv 3.318 (2)
N8- • Cl 1‘" 3.479 (2)
N13- • -Nl 3vi 3.117(3)
N13- • C12vi 3.336 (2)
N13- • -C4v,i 3.337(2)
N13- • Cl l vi 3.408 (2)
N 14- • C4vii 3.452 (2)
N 14- • -N15viil 3.557 (2)
N15- • -cirui 3.500 (2)
N15- • -C9viii 3.522 (2)
N15- • -N15vm 3.533 (3)
C2- • •C6'v 3.323 (2)
C4- • •C7,v 3.387 (2)
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3.445 (2) C4- • C12v 3.398 (3)
